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Abstract
Vaishali Krishnadoss
BIO-IONIC LIQUID FUNCTIONALIZED HYDROGELS TOWARDS SMART
TISSUE REGENERATION
2020-2021
Iman Noshadi, Ph.D.
Doctor of Philosophy
A blend of scaffolds, biologically active molecules, and cells are required to
assemble functional constructs to repair and regenerate damaged tissue or organ via tissue
engineering. The scaffold supports cell growth and proliferation and acts as a medium for
diverse cellular activities. Even though hydrogel's high-water content and flexible nature
make it a pronounced applicant as a scaffold, they exhibit significant technical
limitations. In this thesis, a novel material platform is evaluated and studied to address the
concerns mentioned earlier. The biopolymer is made by conjugating a Bio-Ionic Liquid
(BIL) onto a natural and synthetic polymer backbone. Introduction of choline functionality
significantly enhances the polymer's physical, mechanical, rheological, adhesive, and
electro-chemical properties. Initially, the adhesive properties and functionality of the
synthesized biopolymers were analyzed. In addition, evaluating the biopolymer's ability to
be used in in-situ 3D printing in-vivo electrical stimulation studies was performed.
Furthermore, to demonstrate the biopolymer's performance as a conductive gel electrolyte,
electrochemical functioning was considered. In conclusion, as an application, selfoxygenating tissue scaffolds were developed based on biocompatible electrochemical cell
technology, combining the properties exhibited by the new class of biomaterials, an
oxygen-generating setup that alleviates anoxia in a 3D microenvironment was confirmed,
thus serving as an interface between bioelectronics and biomaterials.
v
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Chapter 1
Introduction
1.1 Motivation and Background
Ionic liquids are classified as organic salt, which exhibit properties such as water
solubility, ionic conductivity, and low melting point electrochemical stability [1]. Lately,
ionic liquids have developed as favorable substitutes for material synthesis, due to diverse
properties. They are made of ions and presents melting point below hundred Celsius. The
first ionic liquid, Ethyl ammonium nitrate was reported in 1914 by Paul Walden [2,3].
During the past two decades, ILs have gained wide attention as innovative fluids which
signifies many researchers are employed in studying their properties and application in
wide fields. Various subjects such as material science, chemical engineering, chemistry,
and environment science has employed Ionic Liquids (ILs) and subjected to diverse
research. In this thesis we elaborate on the use of biocompatible ionic liquid, BILs in tissue
engineering applications [4]. Several combinations of cations, anions, and zwitterions in
the backbone of ILs, leads to a distinct properties and thus diverse applications.
Nevertheless, ionic liquids due to its versatility endure more looked-for than established
solvents in wide chemical and physical processes [5]. Ionic liquids are the good substitute
for green solvents in chemical reactions, due to their features such as increased thermal and
chemical stability including their low vapor pressure [6,7]. The likelihood of diverse ionic
combinations incites a wide range of ionic liquids, allowing their intrinsic characteristics,
like viscosity, solvation power, hydrophobicity, hydrophilicity, density, conductivity
making them versatile and denoted as designer solvents, proving it ability to be used in
1

different applications [8,9]. Due to the versatile nature, it can be used in different tissue
engineering and biomedical applications.
Typically, ionic liquid has a high solvation power, thus advancing its use in drug
delivery system, catalysis, in production of polymers and as plasticizers [10]. Additionally,
due to the ionic charge they exhibit expansive electrochemical window and studied as
electrolytes in numerous uses, such as conductive hydrogels, polymer electrolytes, and gel
electrolytes for tissue repair and regeneration application [11]. Among the range of ionic
liquid, biocompatible ionic liquids have expanded due to superior biocompatibility and
reduced cytotoxicity. Particularly, choline-based bio-ionic liquids (BILs), as choline
compounds are a predecessor of phospholipids. Cell membranes is made up of
phosphatidylcholine and sphingomyelin [12,13]. Bio ionic liquids based on choline have
been broadly studied in various tissue engineering applications as a nontoxic biomaterial.
Also, earlier studies have shown that choline can be degraded to ethanolamine, three
methyl substituents attached to the amino function. Biocompatible ionic liquids made up
of choline are bio compatible and degradable, as they comprise of compounds that a
derivative of naturally occurring molecule.
BIL conjugated materials are being investigated in various fields such as
bioelectronics and biomedical application due to its excellent ionic conductivity [14,15].
Hydrogels made up of chitosan integrated with [Ch]Cl and choline dihydrogen phosphate
have shown to be used as a biocompatible ionic liquid based multi responsive drug delivery
system [16]. Thin film polymer electrolyte composed of chitosan and bio ionic liquid
choline nitrate was developed and shown to have high ionic conductivity, and superior
mechanical properties thus making it an excellent candidate for applications in implantable
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medical device like biomonitoring systems [17]. Further, due to their fundamental
conductive ability they can be expended to synthesis and fabricate bioelectronics that are
flexible for biomedical applications [18]. In a study, Pereira et al, have used ionic liquid to
generate silk/silica hybrid materials for biomedical applications, they report mesoporous
silk fibrin silica hybrid materials, which has hybrid silk fibrin-based biomaterials, it
exhibits certain outstanding properties these hybrids are hard and not easy to be fabricated
into desired shapes [19]. In recent years, others have investigated the anti-microbial
properties of ILs, a novel eco-friendly imidazolium-based ionic liquids were synthesized
against bacteria, C. albicans strain which showed a promising result but also indicating the
inability to provide an optimum environment that supports tissue regeneration [20].
Although ILs are pronounced as ecofriendly solvents, studies indicate that regularly used
ionic liquids demonstrate a certain level of toxicity. As a result, the ionic liquid removal
from hydrogels is a vital step in the process which in certain cases is not feasible and thus
leading to cytotoxicity. Researchers have presented and studied methods to synthesis
electroconductive hydrogels that are biocompatible, choline-based bio ionic liquid
conjugated to polymers backbone [13]. They have used bio ionic liquid to develop
electroconductive fibrous patch, that acts a scaffold and provides mechanical support to the
myocardium and establishes cell growth and proliferation.
The use of polycationic ionic liquids is another favorable application, especially
[poly (3-butyl- 1 vinylimidazolium) L-prolinate] is used as a vector for gene delivery. The
vectors are commonly positively charged and interact with negatively charged cell
membranes and DNA [21]. Quaternary ammonium and pyridinium combinations have
been used for a range of application in clinical settings, like disinfection of noncritical
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surfaces, application to mucous membranes, and preoperative disinfection of unbroken
skin [22]. Despite all the research in the field of Ionic liquid, there is still an unmet need of
IL that can incorporate all the properties such as adhesion to wet surface, biocompatibility,
biodegradability, antimicrobial activity which are prerequisite for a material to be used in
biomedical applications [23].
Finally, due to the current limitations, a novel BILs conjugation method to the
biocompatible polymer which can be used in such as electro conductive hydrogels,
hemostatic, antimicrobial, and anti-fouling adhesive dressing for wound healing in
traumatic injuries is shown. To indicate the significance of the BILs we here address the
major issue in field of 3D printing and bioengineering with the use of BIL.
1.2 Project Summary
Fabricating multi-functional tissue scaffold, soft bioelectronics is a new and
innovational way of fabricating therapeutics for regenerative medicine. Employing
hydrogel and fabricating using 3D bioprinting aims to manufacture tissue in vitro, which
can then be implanted in vivo. However, this process is associated with safety concerns and
risks in addition to requirement of complicated implantation procedures along with
superior properties of the material. Thus, engineering of tissues, implicit of human tissue
characteristics along with the ability to perform as an electronic system, remains a topic of
high importance. Even though hydrogels exhibit cytocompatibility they have limited
applications due to poor physical and functional properties. Certain hydrogels also display
limited cell affinity and adhesion leading to limited cell proliferation and expansion. In
addition, the hydrogel’s conductivity is inadequate to support signal propagation, a
requisite of scaffolds for cardiac, muscle and neural tissue regeneration. Yet another
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desirable requirement is the ability to adhere and exhibit molecular gelation optimally to
enable assembly and maintain structural integrity. Thus, the developed material platform
has been developed to integrate these properties onto a tailorable biopolymeric structure
that can be used as a user interface between the electronic circuits and biological systems.
The other major disadvantage of artificial tissue implants and fabricating large size tissue
scaffolds is the inability to have a homogenous oxygen concentration throughout the
construct. Thus, to address the unmet need, the synthesized biopolymer is established to
bring together differing properties optimally desirable in tissue engineering applications.
The tailor-ability of properties by varying the functionalization or the extent of crosslinking
allows to become a general material platform for synthesis of versatile, easily direct 3D bio
printable organ size tissue engineering structures with the ability to diversify into integrated
bioelectronics. This vastly expands the application repertoire, such as bioelectronicsintegrated usage in tissue engineering for rapid drug prototyping, clinical translation, and
regenerative medicine.
As an application of the synthesized biomaterial, we fabricated a self-oxygenating
tissue, electrolysis that can convert water into oxygen and hydrogen by passing a mild and
cyto-compatible electrical current through the liquid as a proof of concept. Conventional
electrolysis reactions are performed in alkaline or acidic medium, making these systems
toxic and unsuitable for biological applications [24]. For the biocompatible electrolysis
system to be used in the engineering of tissues, a solid-state electrochemical cell is
required. Fabrication of such a system requires the development of a biocompatible ion
conductive hydrogel as the electrolyte for biocompatible electrochemical cell [25]. Here,
we conceptualized Smart Self Oxygenating Tissue (SSOTs) based on biocompatible
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electrochemical cell technology. We hypothesized that the developed SSOTs will provide
controlled oxygen for cells and used a systematic approach to test the hypothesis. The
biocompatible electrochemical cell consists of electrodes and electrolytes. The electrodes
and electrolytes were designed to be biocompatible and biodegradable. A stable Cobalt
phosphate (CoP) was used to fabricate the electrodes and Bio-ionic liquid functionalized
Gelatin Methacryloyl (GelMA) hydrogel (BioGel) as the ion conductive gel electrolyte and
the self-oxygen generating tissue scaffold. BioGel was printed as the biocompatible and
biodegradable electrolyte employing an extrusion based three-dimensional printer. The
combined bioelectronics and tissue scaffold were tested in vitro and in vivo to study the
result and significance of the oxygen generated by SSOTs on tissue regeneration and its
ability to act as an interface between electronics and tissue scaffold. The core goal is to
alleviate the toxic anoxic stresses into hypoxic stimulations by controllably creating a
hypoxic environment in vivo – a highly desired but difficult to achieve feat – angiogenesis
can be orchestrated via user-defined VEGF production and establish a novel material
platform to generate a multifunctional smart tissue.
The biocompatible, biodegradable, and 3D printable electrochemical cell to
generate oxygen within engineered tissues is the first-of-its-kind, promising pathway
towards engineering large tissue constructs. The improved tissue adhesion in the BioGel
and BioPEG has a superior adhesion property compared to non-conjugated hydrogel
(GelMA) or PEGDA and commercially available sealant. The presence of BILs improves
the electrostatic bonding within the hydrogel and native tissue causing in the enhancement
of adhesive properties. Further, bioprinting cell laden BioGel as a transparent ion
conductive gel is a novel methodology which will be the first time that a new class of ion
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conductive hydrogel will be bio printed and used as a 3D cell-laden tissue scaffold. BioGel
has the potential to be used as an electrolyte in bioelectronics fabrication, the described
synthetic method opens a new pathway for fabrication of biocompatible and biodegradable
power sources for implantable and wearable bioelectronics (US patent). Thus, a new class
of biocompatible ion conductive hydrogel (BioGel) synthesized through the conjugation of
FDA approved bio-ionic liquid with biopolymers (US Patent) [25,26] exhibits an inbuilt to
the polymer network, thus eliminating the the need for supplementary conductive
materials. The developed synthesis method is a universal method to induce electrolytic
conductivity to a wide range of synthetic and natural biopolymer, like Gelatin, Elastin,
Hyaluronic Acid, Alginate, Polyethylene Glycol diacrylate (PEGDA), 2-Hydroxyethyl
Methacrylate (HeMA), Poly Glycerol Sebacate (PGS) and can be harnessed for various
tissue engineering applications.
1.3 Dissertation Summary
This dissertation summarizes the synthesis, application of a novel biomaterials via
conjugation of BILs on the backbone of biocompatible hydrogels for application in tissue
engineering and regeneration. In Chapter 3, the synthesis, characterization of BIL
functionalized polymer to engineer multifunctional, biocompatible, and degradable,
hemostatic adhesives is detailed. It’s shown that the conjunction of choline-based bio ionic
liquid to polymer drastically increase the adhesive strength, hemostatic properties. For
clinical application, adhesion to wet surfaces is a vital parameter. In vitro studies are carried
out to illustrate the bio-adhesive physically and chemically such as mechanical testing,
degradation and swelling study, biocompatibility. Also, the hemostatic properties and
efficiency was evaluated using in vivo bleeding models. In addition, Chapter 4 discusses a
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novel material platform to engineer biodegradable, adhesive, biocompatible and
antimicrobial surgical adhesives, based on conjugation of polyethylene glycol diacrylate
(PEGDA) with bio-ionic liquid (BILs), a photo cross linkable Bio-Ionic Liquid
functionalized PEGDA (BioPEG) to be used for repairing corneal tears, and corneal
grafting. In vitro investigations and analysis, showed that the mechanical properties of the
bio adhesive are tunable and comparable to native cornea, also, compared to the other bio
adhesive under study BioPEG is transparent, can be retained for long periods while
permitting integration with the surrounding native tissue/cells. Further in vivo experiment
in rabbit and porcine stromal defect model substantiates the ability of BioPEG to sustain
regeneration and re epithelialization. Thus, making the BioPEG a superior alternative to
current standard of care and can be used as a simple and fast repair for corneal injuries.
Furthermore, choline BIL is photo-conjugated with a pre-functionalized gelatin
methacrylate (GelMA) biopolymer resulting in crosslinked polymer that has the desired
properties to be able to use as an adhesive and conductive scaffold in Chapter 5. Photoconjugation and crosslinking allows the use of this bio ink material platform for easy and
rapid direct in situ 3D bioprinting of tissue engineering scaffolds with complicated 3D
scaffold designs with an ALLEVI extrusion bioprinter. The physical, chemical, and
electrical properties of the bioprinter structure were studied and the cell-laden printed
structures were found to be conductive and adherent to the epidermal layer of porcine skin.
Thus, this novel bio ink material was shown to bring together divergent properties
optimally desirable in tissue engineering applications. The tailor-ability of properties by
varying the functionalization or the extent of crosslinking allows this to become a general
material platform for generation of versatile, easily direct 3D bio printable organ size tissue
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engineering structures with the ability to diversify into integrated bioelectronics. This
vastly expands the application repertoire for use bioelectronics-integrated usage in tissue
engineering for rapid drug prototyping, clinical translation, and regenerative medicine.
In Chapter 6 a material platform based on a new class of biocompatible gel
electrolytes made by photo-conjugating a BILs onto a polymer backbone is examined.
Introduction of a choline functional groups on the GelMA and PEGDA based polymer
backbones drastically improves the electrical properties and mechanical properties. A
graphene hydrogel-laponite blend was rheologically optimized as electrode material and
the combination made into energy storage Micro supercapacitor (MSC) structures by a
scalable 3D printing process. The conjugation of BIL and its application as an electrolyte
stipulates a novel assessment on practical and scalable energy storage possibilities for
flexible bio-implantable and biomedical devices. In conclusion as a potential application
of the synthesized conductive and adhesive biomaterial, electrocatalysis for oxygen
generation under hypoxia condition was hypothesized and studied in Chapter 7, using the
bio-ionic liquid (BIL) conjugated hydrogel as electrolyte. It’s shown that the addition of
bio ionic liquid to the polymer backbone considerably enhances the conductivity and can
be used as a conductive scaffold for oxygen generation. When combining both the CoP
catalyst and the electrolyte we were able to make oxygen within the setup that could be
used under hypoxic condition to deliver oxygen for the cells that is been encapsulated in
the polymer gel electrolyte In vitro methods are carried out to characterize the catalyst and
the electrolyte, degradation and swelling study, biocompatibility was also performed.

9

Chapter 2
Characterization Methods
2.1 Introduction
In this section, the general approaches used to understand and study the
biocompatible polymer are discussed. Characterization of the synthesized hydrogel plays
a fundamental role in designing hydrogels. The desired properties, structure, and function,
and choosing the appropriate tools and techniques that help determine the structure and
composition of hydrogel, method of fabrication quantitative and qualitative data of the
structures, compositions of biopolymer aids in successful fabrication with respect to the
applications.
2.2 Mechanical and Rheological Properties
For various biomedical, tissue engineering and regeneration applications, the
strength, and viscoelastic properties of the hydrogels plays a fundamental role in designing
them according to the application. These properties in turn depends on the crossing linking
percentage, material composition, water content and monomer arrangements. The
mechanical property of hydrogel is characterized by studying the tensile strength and
compressive strength. A Shimadzu universal testing machine, software Trapexium X was
used, a 100 N force sensor at a load range of 0-30N, a constant pulling speed of 1
mm/minute was employed to measure force (N) per delta distance (mm), which translated
into stress and strain, equivalent kilopascals. The slope of the corresponding graph
generated by N/mm2 was used to calculate young’s modulus.
For 3D printing, determining the viscoelasticity of the hydrogel advantages in
optimizing the material. Rheology is a common technique used in characterizing the
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viscoelastic response. In this process, the stiffness and gelation properties are studied by
applying shear strain or stress. The strain and stress are measured with respect to the
angular frequency. The significant parameter that describes the viscoelastic properties of
the hydrogel are shear storage modulus (G’), shear loss modulus (G”), corresponding to
the loss factor (G”/G’).
2.3 Swelling and Degradation Ratio
To determine the water content and estimate the rate at which the hydrogel degrades
invitro, we analyzed the synthesized biopolymer’s degradation rate and the swelling ratio.
The percentage of water and diffusion kinetics plays a central role in the hydrogel structure
and the mechanical strength. The swelling ratio of hydrogels depends on environmental
conditions such as pH, temperature, humidity, and other properties like ion, hydrophilicity,
ionic strength. By comparing the wet weight and dry weight of the hydrogel, the swelling
ratio is estimated as,

𝑆𝑤𝑒𝑙𝑙𝑖𝑛𝑔 𝑅𝑎𝑡𝑖𝑜 =

!" $ !%

(1)

!%

Where Wd and Ww is dry and wet weight, the ability of the hydrogel to store and
release ions depends on the swelling ratio. Also, the cross-linking density of a polymer
chain affects hydrogel properties and varies with different properties.
The ability of the hydrogel to degrade with a rate analogous to that of extra cellular
matrix production provides flexibility in controlling the cell microenvironment. To meet
the demand to advance hydrogels with adjustable degradation to regenerate complex tissue
and assess the synthesized material’s properties is essential. To estimate the degradation
11

rate, the samples are lyophilized and incubated with the enzyme at optimal conditions. The
degradation percentage of the hydrogels was assessed using the equation,

!& – !(

𝐷𝑒𝑔𝑟𝑎𝑑𝑎𝑡𝑖𝑜𝑛 𝑃𝑒𝑟𝑐𝑒𝑛𝑡𝑎𝑔𝑒 = 3

!&

4 𝑋 100

(2)

Where Wt and Wi is the dry weight at given time t and initial dry weight.
2.4 Molecular Interaction and Compositions (NMR and FTIR)
Varian Inova-500 spectrometer was used to perform 1H NMR. The chemical
composition of the hydrogel corresponds to its properties and functionality. Fourier
Transform Infra-Red (FTIR) spectroscopy, Nuclear Magnetic Resonance (NMR)
spectroscopy were used to determine the chemical composition. By tracing the specific
chemical groups associated to chemical structures, FTIR helps in determining the hydrogel
chemical structure. This method is fast, simple, and easy to obtain the chemical bond
fingerprint. Similarly, in NMR, the molecular structure and the content of the hydrogel are
determined, the structure can be studied by matching against the spectral libraries. Based
on the chemical shift, the acrylation of BIL and the incorporation of BIL to the biopolymer
structure can be confirmed.
The synthesized spectra of choline bitartrate, choline acrylate (BIL), prepolymer, and gel
electrolytes were recorded to analyze the bio ionic liquid and hydrogels. The reduction in
the methacrylate’s C=C double bond signal strength (−𝜕(𝐶 = 𝐶) 𝜕𝑡) indicated the
crosslinking extent of composite hydrogel and BIL and polymer conjugation. The decrease
in the area was attributed as follows:
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(3)

PAb, PAa are the areas of methacrylate group peak before and after crosslinking,
respectively. [PAb – PAa] represents the methacrylate groups that were disbursed by
crosslinking.
2.5 Scanning Electron Microscope (SEM)
A scanning electron microscope is employed to acquire surface architecture,
distribution of the pores on the surface, homogeneity, and morphology of the particles on
the material. Like a light microscope that utilizes visible light, the electron microscope uses
electrons to generate an image. In SEM, the electron is generated at the top of the column,
and the beam scans the sample's surface. Further, they are accelerated and attach to the
positively charged anode on the surface. The scattered electrons are detected by using
various types of detectors depending on the electrons and the materials. 3D image of the
sample is obtained by placing the sensor at an angle at the side of the electron. SEM
evaluated the porosity of the electrolytes. The samples were coated with gold before
imaging for acquiring the images using Phenom. The pore size of the electrolytes was
measured using ImageJ software.
2.6 Optical Coherence Tomography
A noninvasive diagnostic system, Optical Coherence Tomography (OCT) is used
to visualize the retina's cross-section and or three-dimensional image and detect the early
onset of eye diseases to study the defects in the eyes. The instrument works on the principle
of light waves and light interference. The light illuminates and scans the retina to a cellular
resolution of 20-25 micrometers. The difference in structure within the eyes due to defect
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leads to the difference in the refractive index and causes light scattering. The scattered light
generates a pattern that is recorded by a detector. Light source is a low coherence
semiconductor super-luminescent diode. The capability to image and visualize the
structure and pathology of the retina in real-time with eliminating the processing of the
tissue, has a significant impact on developmental biology and tissue engineering.
2.7 Electrochemistry
Electrochemical properties of the gel electrolytes, the electrode was measured by
cyclic voltammetry (CV), galvanostatic charge/discharge, and impedance spectroscopy.
The instrument used was a CHI 660E potentiostat from CH Instruments, Inc. This model
series is designed for general purpose electrochemical measurements. It acts as a
potentiostat, and a galvanostat, a three-electrode system, was used for the measurements.
The CV and galvanostatic charge/discharge tests were carried out between 0–1 V. EIS were
carried out between a 105–0.05 Hz frequency range with an open circuit potential
amplitude of 10 mV and varying scan rate from 10 - 200 mV sec-1. Mass-specific
capacitance (C) was computed as follows:
-.(

𝐶 = E/.0F

(4)

I is the constant discharge current, Δt, the discharging time, m, the mass of one
electrode, and ΔV is the voltage drop upon discharging (excluding the IR drop). The
Ragone plot was used to compute Energy and power densities (E & P, respectively) using
equation 3:

1

𝐸 = E2F 𝐶 𝛥𝑉 3
𝑃 =

(5)
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Chapter 3
BIL Conjugation as Universal Approach to Engineer Hemostatic Bio
Adhesives

Adhesion to wet and dynamic surfaces is vital for many biomedical applications.
However, the development of effective tissue adhesives has been challenged by the
required combination of properties, which includes mechanical similarity to the native
tissue, high adhesion to wet surfaces, hemostatic properties, biodegradability, high
biocompatibility, and ease of use. In this study, we report a novel bioinspired design with
bio ionic liquid (BIL) conjugated polymers to engineer multifunctional highly sticky,
biodegradable, biocompatible, and hemostatic adhesives. Choline-based BIL is a structural
precursor of the phospholipid bilayer in the cell membrane. We show that the conjugation
of choline molecules to naturally derived polymers (i.e., gelatin) and synthetic polymers
(i.e., polyethylene glycol) significantly increases their adhesive strength and hemostatic
properties. Synthetic or natural polymers and BILs were mixed at room temperature and
cross-linked via visible light photopolymerization to make hydrogels with tunable
mechanical, physical, adhesive, and hemostatic properties. The hydrogel adhesive exhibits
a close to 50% decrease in the total blood volume loss in tail cut and liver laceration rat
animal models compared to the control. This technology platform for adhesives is expected
to have further reaching application vistas from tissue repair to wound dressings and the
attachment of flexible electronics.
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3.1 Introduction
Adhesives with the ability to bond to biological tissues have numerous applications
including drug delivery [27,28], tissue repair [29,30] wound dressings [31,32] biomedical
implants, and flexible wearable electronic devices [33,34]. The primary requirements of
adhesive materials for in vivo application are the ability to rapidly stem blood loss and
adhere quickly and firmly to the tissue of choice [35-39]. The process of attachment and
adhesion to native tissues often is challenged by the wet and dynamic in vivo environment.
Adhesive hydrogels are also expected to degrade in a timely fashion and have no
cytotoxicity toward the host tissues. Thus, it should accelerate and have no deleterious
influence on the healing of the wound [40 – 42]. Quality, production cost, stability in vivo,
and safety are further considerations [43−46]. Moreover, tunable mechanical strength and
adhesion of the material are often considered as highly desirable [47, 48]. A major
limitation of the currently available commercial tissue adhesives is their poor performance
due to the low adhesion to wet surfaces and in the environments involving dynamic and
cyclic stresses. The lack of adequate flexibility and adhesion is yet another drawback in
currently available commercial adhesives [49].
Cyanoacrylates, for instance, have high adhesive strength but are associated with
cytotoxicity and an unnaturally high stiffness [51]. Fibrin-based sealants such as fibrin glue
are flexible like the soft tissues but only offer weak adhesion strengths, particularly under
wet conditions such as those found in tissues [52]. Despite the commercial availability of
adhesives, superior alternatives are wanted, for the repair of elastic and soft tissues in
wounded lungs, heart, and blood vessels [53]. Achieving such a formulation demands a
material that offers significant adhesion with minimal toxicity and that avoids any damage
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to tissues arising from the mechanical properties of sealants [54-56]. In this paper, we
report a new adhesive biomaterial platform that offers high adhesion and hemostatic
properties under wet conditions, compatible with both synthetic and naturally derived
biomaterials, proffering the advantage of a direct bonding mechanism with the lipid bilayer
cell membrane structure, combining high intrinsic mechanical strength with excellent
tissue adhesion. This bio interaction inspired platform uses strong coulomb interactions
between the polymer structure and the cell membrane’s phospholipid bilayer’s hydrophilic
heads accounting for strong adhesion even in the presence of body fluids and blood. The
mechanism of adhesion is feasible for any kind of tissue, not requiring the use of fibrous
networks for support, and hence can be used in various applications. This is achieved via
the functionalization of polymers biological or synthetic with a BILs. Ionic liquids are
low melting organic salts with high water solubility [57] BILs are a class of ionic liquids
where the inorganic counter anions of the ionic liquid structure are replaced by bio-organic
molecules, such as the cholinium ion as represented here [57−59]. Ionic liquids may have
numerous interesting applications owing to their high thermal stabilities, conductivities,
and antimicrobial and antifouling properties [56,60].
Importantly, choline-based biocompatible, noncytotoxic, and bio metabolizable
ionic liquids are reported [61,62]. Choline is also a structural precursor of the phospholipid
cellular membrane bilayer and can help enhance interactions with cell membranes via
electrostatic bonding [63−65]. In this paper, we describe a method to conjugate BIL to
polymers that are both natural and synthetic to yield bio adhesives. In this study, we assess
the conjugation of choline based BIL to two polymer backbones: a gelatin biopolymer and
a synthetic Polyethylene Glycol Diacrylate (PEGDA) polymer. The naturally derived
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biopolymer used in this study was gelatin methacryloyl (GelMA). The synthesized
adhesive exhibits excellent mechanical integrity and tissue adhesion, even in the presence
of body fluids, and superior hemostatic properties. The conjugation of a choline based BIL
allows the polymer to interact with the phospholipid bilayer cellular membrane in a highly
distinct manner, which can be relevant for applications that require adhesion, mechanical
transduction, or integration.
3.2 Materials and Methods
3.2.1 Materials
Gelatin (Type A), methacrylic anhydride, and PEGDA − Mn 700 were purchased
from Sigma-Aldrich. The photo initiator used (LAP, lithium phenyl- 2,4,6trimethylbenzoylphosphinate) was purchased from Allevi, Inc., and the visible light used
for polymerization was attached to the Allevi 2 bioprinter. All chemicals were of analytical
reagent grade and used without further purification.
3.2.2 Synthesis of the BIL Conjugated GelMA (BioGel) and BIL Conjugated PEGDA
(BioPEG)
Choline bitartrate and acrylic acid (Sigma-Aldrich) were mixed in an equimolar
ratio at 50C for 5 h under an inert nitrogen atmosphere to synthesize choline acrylate (BIL)
followed by overnight vacuum purification of the product at room temperature [62].
GelMA polymer was made using a previously described method [66]. A 10% (w/v) gelatin
(Sigma-Aldrich) solution and 8 mL of methacrylic anhydride (Sigma-Aldrich) were
reacted for 3 h under inert conditions. Unreacted material methacrylic acid was dialyzed
for 5 days and frozen at −80 C for 24 h followed by lyophilization for 5−7 days. PEGDA
has an average Mn of 700 (Sigma-Aldrich). GelMA and PEGDA were used to synthesize
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the bio adhesives, namely, BioGel (25% (w/v) GelMA, 20% (w/v) BIL) and BioPEG (25%
(w/v) PEGDA, 20% (w/v) BIL) adhesives. Methacrylated polymer and choline acrylate
were mixed in various ratios, and their physical and adhesive characteristics were studied.
The adhesive was made from the prepolymer and BIL mixed in varying proportions in
distilled

water.

To

the

mixtures,

0.5%

(w/v)

lithium

phenyl-2,4,6-

trimethylbenzoylphosphinate (LAP) photo initiator was added; LAP is preferred over other
photo initiators due to its high-water solubility and cytocompatibility [67]. Hydrogels were
then applied and rapidly photo-cross-linked in the presence of visible light in the Allevi 2
bioprinter at a wavelength of 450 nm and intensity of 3MW/cm2 for 120 and 60 s for
GelMA and PEGDA, respectively.
3.2.3 1H NMR Analysis of Bio Adhesives
1

H NMR was used to characterize the bio adhesive structure. A Varian Inova-500

NMR spectrometer was used NMR spectra of choline bitartrate, choline acrylate, GelMA
prepolymer, and bio adhesive samples were obtained. The reduction in the rate of C=C
methacrylate double bond (−∂(C=C)/∂t) in GelMA was used to understand the crosslinking of the polymer, in addition to BILs conjugation to polymer.
3.2.4 Mechanical Properties of the Bio Adhesives
Mechanical testing, including calculation of elastic and compressive moduli on
each bio adhesive composition, was performed by using an EZ-SX Mechanical tester
(Shimadzu). Cylindrical test specimens of diameter 5 mm and height 5 mm were made in
polydimethylsiloxane (PDMS) molds. The test specimens were kept in Dulbecco’s
phosphate buffered saline (DPBS) for 4 h at 37 C and allowed to swell prior to testing. For
each test, at least five samples were tested. In the compression tests, the specimens were
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compressed between two plates at 1 mm/min and the load and strain were recorded. For
the tensile tests, the hydrogels were stretched at 1 mm/min until failure. The compression
and elastic moduli were calculated as the slope of the linear region of the stress−strain
curve. For each test, at least five samples were tested to perform the statistical significance
test.
3.2.5 Invitro Degradation Test and Swelling Ratio of the Bio Adhesives
BioGel and BioPEG were produced as previously mentioned (Section 2.2). The test
was performed based on a previously mentioned method [62]. The samples were
lyophilized, weighed, and with 1 mL of DPBS or at 37 C incubated in a 24 well plate for 2
weeks. The DPBS solutions were replenished every 7 days, at days 1, 7, and 14. The
samples were removed and lyophilized for 24 h, and the weight was obtained. Degradation
percentage (D%) of the bio adhesive was estimated in terms of the loss of weight. For each
test, at least five samples were tested to perform the statistical significance test. The
equilibrium swelling ratios of BioGel and BioPEG adhesives were evaluated using
cylinder-shaped adhesives prepared as per the method described for the compression test,
and DPBS was used to wash the sample thrice. Then they were freeze-dried to weigh the
samples in dry conditions and immersed at 37 C in DPBS for 2, 4, 6, 8, and 24 h followed
by weighing again after immersion. The ratio of the swollen sample mass to lyophilized
sample mass was used to compute the swelling ratio and water uptake. For each test, at
least five samples were tested to perform the statistical significance test.
3.2.6 Invitro Adhesive Properties of the Bio Adhesives
Shear strengths of the BioGel and BioPEG adhesives were tested according to the
modified ASTM F2255-05 standard for tissue adhesives [68]. A 1 cm C 1 cm layer of

20

gelatin was applied to two 2 cm X 2 cm square pieces, cut from a glass slide. The gelatin
layer dried overnight functioned as a base layer. The uncoated area, later used for clamping
the glass slide, was covered by tape. 25 μL of hydrogel precursor solution was cross-linked
between the gelatin coated glass slides, and the slides were then placed in a mechanical
tester and pulled apart at a strain rate of 1 mm/min. At the point of detachment, shear
strength was calculated for at least five samples for statistically significant results. Wound
closure of the fabricated adhesives was calculated by using the ASTM F2458-05 standard
[69]. Porcine skin, with excess fat removed, was obtained from a butcher. This was cut into
small strips and immersed into PBS to prevent drying prior to testing. The tissue was razorsliced in the middle to simulate a wound, and to this slit, 100 μL of polymer solution was
applied and photo-cross-linked using visible light. Maximum adhesive strengths of the
samples were obtained at the point of tear, with strain rates of 1 mm/min applied using a
mechanical tester. At least five samples were tested per condition to perform the statistical
significance test. Burst pressures of the fabricated adhesives were calculated by using the
ASTM F2392-04 standard [70]. A 5 mm X 5 mm puncture was made in the center of 5 cm
X 5 cm skin and was placed in connection.
3.2.7 Exvivo Burst Pressure Measurement of the Bio Adhesives
Burst pressures of the fabricated adhesives were calculated by using the ASTM
F2392-04 standard. Porcine heart and lung were obtained from a local butcher. A 5 mm X
5 mm puncture was made in the left chamber of the heart, and it was placed in connection
from a custom-built burst pressure apparatus. The apparatus consisted of a pressure meter,
and air was allowed to flow using at a volumetric rate of 0.5 mL/s. The organ was
punctured, covered with bio adhesive, and cross-linked with visible light. The pump and
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the sensors were then initiated. The burst pressure was computed when the hydrogel
ruptured, after which the airflow was terminated. A similar test was carried out for the lung.
At least five samples were tested per condition to perform the statistical significance test.
3.2.8 Invitro Clotting Study on the Bio Adhesives
SEM imaging was performed to analyze the hemostatic property of the engineered
adhesive using a method previously described [71]. EDTA anticoagulated whole blood (6
mL) was centrifuged at 2300 rpm for 5 min to prepare the RBC pellet. The plasma and
buffy coat layers were discarded. The pellet was washed thrice using 40 mL of isotonic
saline (0.9% w/v aqueous NaCl solution, pH 7.4). The oil mixture, consisting of 1 mL, 2.6
parts by weight of benzyl benzoate and 1 part by weight of cottonseed oil, was then added
to the RBCs. The oil mixture has a density intermediate to RBCs and the isotonic saline.
This oil-RBC suspension was centrifuged for 10 min at 4500 rpm, and supernatant oil was
discarded. The thin oil film over the RBC pellet was removed by tapping with cotton,
incubated with the adhesive sample overnight at 37 C, and dehydrated for freeze drying.
The lyophilized specimen attached to the SEM stubs were coated with gold/palladium
(Au/Pd) prior to SEM imaging, acquired by a Phenom Pure SEM from Nanoscience. The
clotting time was measured from RBC coagulation tests on at least five images of five
samples using ImageJ software.
3.2.9 Invitro Biocompatibility of the Bio Adhesives
On the surface of adhesive, 5 X 104cells/well were cultured in a 24 well plate with
500 μL of DMEM, supplemented with 10% FBS (fetal bovine serum), growth medium. 2D
cultures were kept at 37 C in a 5% CO2 humidified incubator for 7 days, and the DMEM
was replenished after 48 h. The cell viability of primary C2C12 cultured on the surface of
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BioGel and BioPEG was evaluated by an Invitrogen Live/Dead viability kit, as per
manufacturer’s instructions. Cells were stained for 15 min at 37 C with calcein AM (0.5
μL/mL) and ethidium homodimer-1 (EthD-1) in DPBS (2 μL/mL). Fluorescence images
were obtained on days 1, 4, and 7 post-seeding with the Axio Observer Z1 inverted
microscope (Zeiss). The number of live/viable and dead cells as green and red spots,
respectively, was quantified by ImageJ software, and the cell viability was computed as the
ratio of the number of live cells to the total number of cells.
Cell metabolic activity was evaluated at 1, 4, and 7 days by a Presto Blue assay
(Life Technologies). 2D cultures of C2C12 were incubated for 2 h at 37 C in 500 μL of
10% Presto Blue growth medium. Resulting fluorescence at 560nm (excitation) and 590
nm(emission) was measured with control wells being used to determine the background.
Surface spreading of the cells on the bio adhesive was imaged through fluorescence
staining of F-actin filaments and cell nuclei. 2D cultures at days 1, 4, and 7 were incubated
for 45 min with Alexa fluor 488 labeled phalloidin (1:1000 in DPBS, Invitrogen). DPBS
was used for three consecutive washes, samples were counterstained with 1 μL/mL DAPI
(4′,6-diamidino-2-phenylindole, Invitrogen) in DPBS for 5 min, and the fluorescence
images were acquired with an Axio Observer Z1 inverted microscope.
3.2.10 Invivo Biocompatibility and Degradation of the Bio Adhesives
All the animal experiments were approved by the ICAUC as per protocol 2018004, at Rowan School of Osteopathic Medicine. Male Wistar rats weighing 200−250 g
were procured from Charles River (Boston, MA, USA). The animals were kept under
circadian rhythm conditions at the local animal care facility. 4.0% isoflurane induction and
1−2.5% maintenance was used to induce anesthesia. This was followed by administering
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0.02 to 0.05 mg kg-1 subcutaneous buprenorphine for pain control. On the posterior
mediodorsal skin, eight 1 cm incisions were made. Around these incisions, small lateral
subcutaneous pockets were made by blunt dissection. 5 mm disks of the bio adhesives were
implanted into these pockets. The wound was closed anatomically, and the animal’s
allowed recovery from anesthesia. Animals were euthanized by CO2 asphyxiation after 4,
14, and 28 post implantations. The samples were retrieved with the associated tissue.
3.2.11 Invivo Hemorrhage Study of the Bio Adhesives
Tail Cut Model - One group of eight rats underwent a standardized tail cut
technique approved by the Rowan University IACUC and developed by Morgan et al. [72]
for the measurement of uncontrolled hemorrhage in rats. All rats were weighed
preoperatively. Anesthesia was induced inside an induction chamber with inhaled 4%
isoflurane and 100% oxygen followed by a maintenance dose of 1−2% isoflurane delivered
via the nose cone. The depth of anesthesia was confirmed by a pedal pinch. Rat tails were
marked 4 cm from the tip and transected with a scalpel. The tail stump was immediately
placed in a 1.5 mL microcentrifuge tube to collect the shed blood. After 2 min of
uncontrolled hemorrhage, 0.8 mL of BioGel was applied to the wound. Of the eight rats,
four rats received BioGel, and four rats received only the polymer without conjugation of
BIL (25% (w/v) GelMA). After an additional 2 min, 0.2 mL of BioGel was applied to the
wound. A total of 1.0 mL of BioGel was applied to each wound. Blood loss was recorded
in 2 min intervals for the first 14 min of the experiment (2 min before intervention, 2 min
during intervention, and 10 min after intervention) followed by 6 min intervals for the next
12 min of the procedure, for a total of 26 min. Blood loss was calculated as a percentage
of total blood volume. Total blood volume was calculated using body weight (kg)
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multiplied by 65 mL/kg, a known ratio of body weight: blood volume in rats. All rats were
sacrificed with isoflurane overdose at the conclusion of the 26 min hemodynamic
monitoring window, with bilateral thoracotomy as a secondary method of euthanasia.
Liver Wedge Model - One group of 20 rats underwent a standardized liver wedge technique
approved by the Rowan University IACUC and developed by Morgan et al. [72] for the
measurement of uncontrolled hemorrhage in rats. Ten rats received BioGel, five with the
unconjugated polymer (25(w/v) % GelMA) and five with the polymer conjugated with BIL
(BioGel). Ten rats received BioPEG, five with the unconjugated polymer (25% (w/v)
PEGDA) and five with the polymer conjugated with BIL (BioPEG). All rats were weighed
preoperatively. Initial anesthesia with inhaled 4% isoflurane and 100% oxygen were used.
Anesthesia was maintained with 1−2% isoflurane. Rats were placed supine, and their
abdomens were shaved and prepped. A 3.0 cm midline laparotomy was performed to
expose the abdominal cavity, and the left lobe of the liver was delivered onto the rat
abdomen. One 3.0 cm X 1.5 cm wedge of the left liver lobe was removed to cause the
initial liver injury. A pre weighed gauze below the liver collected shed blood. After 2 min,
0.5 mL of product was applied to the liver wound. After an additional 2 min, 0.5 mL of
product was again applied to the liver wound. The gauze was changed and weighed in 2
min intervals for the first 14 min of the experiment (2 min before intervention, 2 min during
intervention, and 10 min after intervention) followed by 6 min intervals for the next 12 min
of the procedure, for a total of 26 min. Blood loss was calculated as a percentage of total
blood volume. Total blood volume was calculated using body weight (kg) multiplied by 65
mL/kg. All rats were sacrificed with isoflurane overdose at the conclusion of the 26 min
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hemodynamic monitoring window. Rats underwent severing of the diaphragm as a
secondary method of euthanasia.
3.3 Results and Discussion
3.3.1 Synthesis and Characterization of the BILs and Bio Adhesives
The synthesis of BIL and the adhesive is illustrated in Figure 1. It entails the
synthesis of BIL as the first step based on the reaction of choline bitartrate and acrylic acid.
The next step entails the conjugation of the synthesized BIL with the polymer (GelMA or
PEGDA). The BIL was conjugated with the polymer at concentrations of 0− 20%(w/v).
The conjugation was carried out by mixing the BIL with a 25% (w/v) solution of GelMA
or PEGDA. The resulting polymer/BIL conjugate was then cross-linked by visible light
induced photopolymerization, using LAP as the photo initiator to form the hemostatic bio
adhesives (BioGel and BioPEG). The acrylation of choline bitartrate to make choline
acrylate was measured using FTIR, while the conjugation of the BIL to the polymers was
measured by 1H NMR, Figure 2. In the FTIR, we notice the appearance of a peak at 1720
cm−1, which primarily indicates the formation of the ester bond via acrylation. Similarly,
in 1H NMR, the hydrogen peak of acrylate at 5.9− 6.3 ppm indicates the acrylation of
choline bitartrate forming choline acrylate. 1H NMR spectra also ascertained the
conjugation of the BIL to the polymer. Methacrylate groups appear in the conjugated
polymer at ∼5.7 and ∼6.1 ppm, confirming polymer-BIL conjugation. This peak was
absent in non-BIL conjugated polymer. The appearance of a sharp peak at δ ∼3.1−3.2 ppm
in the conjugated polymer corresponds to the three hydrogen atoms of choline (ammonium
ion), and this also confirms the conjugation of BIL to the polymer.
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Figure 1
Synthesis of BIL and Adhesive Hydrogels (BioGel and BioPEG), (a) Acrylation of Choline
Bitartrate to Form Choline Acrylate (BIL) and (b) Reaction Between GelMA, PEGDA, and
Bio Ionic Liquid to Form BioGel and Bio-PEG

3.3.2 Invitro Adhesive Properties of the Bio Adhesives
Wound closure is associated with tissue stress and damage. To mitigate these
complications, BioGel and BioPEG based adhesive materials could be an alternative
strategy. We characterized the in vitro lap shear, adhesive and burst strength tests, and the
response to shear, compression, or extension as well as high pressures upon the adherence
of the gel to tissue, all in accordance with the ASTM F2255-05 standard [18,73], Figure
3a. Figure 3b, c shows the shear strengths of BioGel and BioPEG with increasing BIL
concentrations. The shear with 0% BIL to 359.39±18.72 kPa for BioGel with 20% BIL.
Similarly, for BioPEG, the shear strength increased from 73.40±3.84 kPa for the polymer
with 0% BIL to 241.00±12.09 kPa at 20% BIL. The shear strengths of BioGel and BioPEG
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with high BIL concentrations are significantly higher than reported values for
commercially available tissue adhesives such as Ethicon’s Evicel and Baxter’s Coseal used
as a control. The shear strengths of Evicel and Coseal are 207.65±67.3 and 69.7±20.6 KPa,
respectively [74]. The adhesive strength of BioGel increased from 0.23±0.02 kPa (GelMA
with 0% BIL) to 2.25± 0.02 kPa for BioGel with 20% BIL concentration (Figure 3d, e).
Similarly, for BioPEG, the adhesive strength increased from 7.01±0.20 kPa for the polymer
with 0% BIL to 38.70± 0.30 kPa at 20% BIL. The adhesive strength of BioPEG with high
BIL concentration is significantly higher than BioGel and reported values for commercially
available tissue adhesives such as Ethicon’s Evicel and Baxter’s Coseal. The adhesive
strengths of Evicel and Coseal are 24.80±2.51 and 26.32±2.69 kPa, respectively [75]. The
design of polymers for tissue adhesion entails tailoring properties to ensure high tissue
adhesion and appropriate mechanical strength. Hydrogel adhesives for soft tissues need
mechanical characteristics comparable to native tissue to ensure proper tissue movement.
The adhesion properties should be high enough to enable attachment to the surrounding
tissues.
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Figure 2
1
H NMR Analysis of (a) BioGel and (b) BioPEG. BioGel and BioPEG Adhesives were
Formed by Using 0.5% Lithium Phenyl-2,4,6-trimethylbenzoylphosphinate (LAP) at 60 s
of Light Exposure

The ability of an adhesive to withstand pressure from tissues and fluids under the
wound site can be established by the burst pressure test. We tested burst pressure of the
fabricated adhesives based on a variation of the ASTM F2392-04 standard testing for
surgical sealants. The results are shown in Figure 3 f, g. Burst pressures for BioGel and
BioPEG at 0% BIL concentration were 9.17±0.66 and 25.60±0.99 kPa, respectively. This
subsequently increased to 101.74±2.12 and 69.42±1.59 kPa, respectively, for BioGel and
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BioPEG at a final BIL concentration of 20%. These values were also significantly higher
than that of currently available tissue adhesive [76]. We infer from the results that the
introduction of BIL functionalization to GelMA or PEGDA improves the adhesion of the
hydrogel to tissues. The adhesive property is directly related to electrostatic interactions. It
is also related to better film-forming properties, which increase with increasing overall
molecular weight. The molecular weight, in turn, is dependent on the average molecular
mass of repeat units in the polymer, which increases with increasing functionalization by
bulky choline pendant groups. Both GelMA and PEGDA on their own are good film
formers, and they already have the allowance for polar interactions [77,78]. However, the
introduction of BIL-based side groups significantly increases these strong electrostatic
interactions leading to high adhesion and shear as well as burst pressure strength. We also
expect that the surface BIL heads of the adhesive layer will interact with the phospholipid
bilayers of the exposed cells wherein the polar heads may be expected to enhance adhesion.
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Figure 3
Invitro Sealing Properties of the BioGel and BioPEG

Note. (a) Schematic diagram of lap shear, wound closure, and burst pressure tests. (b, c)
Standard lap shear test was used to determine the sealant’s shear strength (n ≥ 5) with
different percentages of BIL concentration. (d,e) Standard wound closure of porcine skin
was used to test the sealant’s adhesion strength (n ≥ 5) with different percentages of BIL
concentration. (f,g) Standard burst pressure test was used to evaluate the sealant’s burst
pressure (n ≥ 5) with different percentages of bio ionic liquid (BIL). Data are mean±SD. P
values were determined by one-way ANOVA followed by Tukey’s multiple comparisons
test (*P < 0.05, **P < 0.01, ***P < 0.001)

3.3.3 Invitro Hemostatic Properties of the Bio Adhesive
The efficacy of biomaterial adherence to wet surfaces can be improved by
endowing the material with hemostatic properties. This property would also allow for
reduction of intra- and post-operative tissue blood loss [79-81]. Although some effective
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hemostatic materials have been developed, none of the current materials also possess strong
adhesive properties [82-85]. We studied the hemostatic properties of BioGel and BioPEG
with varying BIL concentrations from 0−20%, and the results are shown in Figure 4. The
extent and rapidity of clot formation increase significantly with increasing BIL
concentration. The clotting time decreases from 7.5 ± 0.50 to 4.875 ± 0.12 min with 5%
BIL polymers. With a BIL concentration of 20%, the clotting time reduces further to
1.13±0.13 min indicating an increase in coagulation efficiency with increasing BIL
concentration. Similar results were demonstrated in the case of BioPEG. When the bio
adhesive samples were incubated with RBC pellets overnight to perform SEM on the
samples (Figure 4 c, d), the images indicated that, with increasing concentration of the BIL,
the coagulation of the RBCs increased. Cell membranes consist of a phospholipid bilayer,
of which 1,2- dipalmitoyl-glycero-3-phosphatidyl choline (DPPC) is a major constituent
[86]. Choline functionalization imparts a quaternary ammonium moiety the cholinium
head group which, over the mechanism of cellular adhesion, interacts with phosphatidyl
choline groups, forming quaternary nitrogen−phosphorus pairs, creating a quadrupole with
high electrostatic forces [87, 88]. When macromolecules and cellular surfaces interact, the
former adsorbs and brings the surfaces into greater proximity in a bridge conformation.
Also, the exclusion of glycocalyx from the intercellular space pushes the cells together
owing to the osmotic pressure gradient. The same mechanism, when applied to red blood
cells, causes their distortion due to overcoming of their elasticity by the adhesive forces.
Quaternary nitrogen and phosphorus heads make a dipole and provide binding forces for
cellular coagulation and hence hemostasis [89-91].
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Figure 4
Invitro Clotting Assay of BioGel and BioPEG

Note. (a, b) Photograph of the well plate based clotting assay with increasing concentration
of BIL. SEM of RBC coagulation with (c) control (25% (w/v) GelMA) and BioGel (25%
(w/v) GelMA, 20% (w/v) BIL) and (d) control (25% (w/v) PEGDA) and BioPEG (25%
(w/v) PEGDA, 20% (w/v) BIL). (e,f) Quantification of decrease in clotting time with
increasing concentration of bio ionic liquid. Data are means
SD. P values were
determined by one-way ANOVA followed by Tukey’s multiple comparisons test (*P <
0.05, **P < 0.01, ***P < 0.001)

3.3.4 Invitro Swelling, Degradation, and Mechanical Properties of the Bio Adhesive
The ideal requisites of a bio adhesive would entail its flexibility to match the
dynamic environment and movement of native tissues. This requires that the
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biodegradability be controlled, and the metabolites of biodegradation be noncytotoxic.
Hydrogels can be metabolized through various pathways enzymatic degradation or simply
via hydrolysis at either acidic or basic pH conditions [92,93]. Also, for the hydrogel to
prevent rejection as a foreign invasive object and be eventually metabolized, it must be
adequately hydrated via body fluids. However, excessive water uptake and degradation
could lead to impaired mechanical and adhesive properties. Thus, water uptake and
swelling for a tissue adhesive must be optimized to suit the in vivo conditions and the
intended application. Irrespective of the BIL concentration, BioGel grew to ∼120% of the
swelling ratio. For the GelMA (0% BIL), there is a steady increase in the water uptake and
swelling with time, while with BIL concentrations of 5, 10, 15, and 20%, there is an initial
gradual water uptake followed by a sudden increase to reach 120% after 24 h. This effect
is progressively more pronounced with increasing BIL concentration, indicating that BILs
can expedite degradation without significant differences in swelling after 24 h. A similar
trend was seen with BIL incorporated PEGDA (BioPEG). With 0% BIL incorporation, the
polymers swelled much faster. With increasing BIL incorporation, the swelling rate
decreased due to initial intrinsic physical cross-linking induced by electrostatic interactions
mediated by the BIL functional groups. The final swelling achieved for the PEGDAbackbone-based BioPEG polymers was ∼40% lower than that for GelMA-based polymers
due to the intrinsic nature of the PEGDA backbone, which has lower hydrophilic affinity
than GelMA. As the polymer absorbs water, in a semi dilute solution, polymer chain
conformations form overlapping correlation blobs with hydration spheres around each blob
dictated by functional groups with water affinity. For GelMA, this is relatively straight
forward; with no functionalization, the semi dilute regime blobs slowly open in a favorable
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solvent and allow more and more water in until the cross-link conformation resists any
further expansion. With BIL functionalization, there is an increased strong interaction
between monomers inside a single correlation blob, as well as between the monomers in
the periphery of the correlation blob, which act as additional physical cross-links conferring
an initial resistance to polymer expansion with hydration. This situation needs to be slowly
broken by hydrating the hydrophilic groups intrinsically in the GelMA and BIL
functionalized BioGel. Hence, the rate at which the water expands the gel is slower in
functionalized BioGel rather than in GelMA. However, since the GelMA is already highly
hydrophilic, the addition and variation of BIL concentration do little to alter that.
Considering that these are chemically crosslinked to the same extent using LAP, hence, the
final expansion of such a polymer would eventually be arrested by the existence of those
chemical cross-links acting as ultimate tethers. Thus, for polymers, the density of crosslinking determines the final swelling, and hence, the polymers swell to a limited and similar
ultimate extent.[94] This is a desirable property when designing an adhesive formulation
wherein the material must swell and mimic in vivo conditions but not to the extent that it
starts to disintegrate and defeat the primary mechanical requirement of usage.
In vitro degradation tests can simulate the in vivo behavior of hydrogels when
exposed to physiological conditions.[95] Since the compounds are organic in nature, the
degradation products of these polymers are expected to be noncytotoxic. Degradation
studies, for BioGel with a BIL concentration of 0%, the degradation increases from 8.5%
at day 1 to 12.3% at day 14, with the degradation tapering after 7 days. There is a general
increase in the amount of degradation at day 1, day 7, and day 14 with an increase in the
concentration of BIL. For 5% BIL concentration, the degradation increases from 13% at
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day 1 to around 18% at the end of day 7, tapering off at 19% at day 14. The degradation
for 20% BIL in polymer is 19% at day 1 and increases to 24.6% on day 14. While the trend
of degradation is the same, it may be observed that there are greater levels of degradation
with an increase in BIL concentration. It is possible for the quaternary ammonium head in
choline to act as a catalyst along with the water of hydration to cause hydrolysis of the
many integrated functionalities in both the GelMA and PEGDA backbone hence degrading
it, thus increasing degradation with BIL concentration in the polymer. Degradation follows
the same trend in both GelMA and PEGDA-based polymers, but the lower water uptake in
PEGDA results in an intrinsically lower extent of degradation. Mechanical properties of
the bio adhesives were characterized through tensile and compression tests. The elastic
moduli obtained from tensile tests on BioGel and BioPEG hydrogels show that the elastic
moduli and compression moduli of the bio adhesives could be modulated by varying the
percentage of BIL. As a general trend, the mechanical properties increase with the increase
in BIL concentration. With 0% BIL, the compression modulus is 37.79 ± 0.47 kPa and the
tensile modulus is 202.83 ± 1.26 kPa. These values increase to 186.46 ± 7.51 and 355.36
± 18.25 kPa, respectively, for BioGel with 20% BIL concentration. Similarly, BioPEG with
0% BIL (PEGDA) shows a compression modulus of 26.12 ± 2.63 kPa and a tensile
modulus of 102.93 ± 1.61 kPa, which increase to 212.15 ± 13.11 and 361.21 ± 7.25 kPa,
respectively, at 20% BIL concentration in BioPEG. Hydrogels exhibit a tradeoff between
stiffness and flexibility to resist shear, tension, or compression forces while maintaining
structural integrity. The increase in compressive strength and tensile modulus of the
polymers with BIL over unfunctionalized GelMA or PEGDA can be attributed to an
increase in the intensity of electrostatic interactions. The attachment of the bulky choline
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group as side chains to the GelMA or PEGDA structure makes the backbone stiff, hence
increasing the respective moduli. Enhanced mechanical properties are also a result of an
increase in the overall repeat unit molecular weight due to bulky choline side chains. The
polar and hydrogen bond interactions also increase significantly with BIL
functionalization. These strong electrostatic interactions obstruct the uncoiling and slipping
of chains and result in the BIL groups acting as a physical cross-link, tethering the structure
together.
3.3.5 Cell Viability, Proliferation, and Metabolic Activity on the Bio Adhesive
To investigate the biocompatibilities of BioGel and BioPEG, the in vitro live/dead
assay was performed. The assay determined the viability of C2C12 cells on the BioGel and
BioPEG surfaces over a period of 7 days. Cell attachment and spreading on hydrogels were
evaluated through F-actin/DAPI (Figure 5) immunofluorescence staining. The results
indicate (Figure 5f, g) that the viabilities of seeded cells on day 7 were 98.5 ± 0.5 and 97 ±
1.0% for BioGel and BioPEG, respectively. Cells seeded on the surfaces of BioGel and
BioPEG exhibit similar viabilities at day 1 post-seeding. The metabolic activity was
quantified by the Presto Blue assay and was shown (Figure 4 e) to increase significantly
during the period of cell culture from 4910.80 ± 180.13 to 10847.71 ± 797.17 RFU for
BioGel and 4170.60 ± 90.25 to 10954.80 ± 299.44 RFU for BioPEG. These results
underscore the potential of the bio adhesive as a biocompatible sealant material capable of
promoting cell adhesion, growth, and proliferation.
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Figure 5
Invitro Biocompatibilities of BioGel and BioPEG

Note. Representative live/dead images and F-actin/DAPI fluorescent images at days 1, 4,
and 7 post-seeding of (a,b) BioGel and (c,d) BioPEG. (e) Quantification of metabolic
activity, relative fluorescence units (RFU), using PrestoBlue assay. (f) Quantification of
cell viability of live/dead images. (g) Quantification of cell proliferation based on DAPIstained cell nuclei. Data are means SD. P values were determined by one-way ANOVA
followed by Tukey’s multiple comparisons test (*P < 0.05, **P < 0.01, ***P < 0.001)
3.3.6 Invivo Biocompatibility of the Bio Adhesive
The in vivo degradation of BioGel and BioPEG synthesized was evaluated after
subcutaneous implantation into rats (Figure 6a, b). Samples were explanted on days 4, 14,
and 28 to study the compatibility and degradation. In vivo degradation and morphological
changes were characterized by hematoxylin and eosin (H&E) staining; the staining
indicates the presence of the hydrogel until day 4 (Figure 6a-i, b-i), and the tissue
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architecture revealed that there is no significant macrophage infiltration implying that the
bio adhesives cause less, or no adverse inflammatory responses compared to GelMA or
PEGDA. The degradation rate of the sealant must be appropriate to ensure that the sealant
does not degrade completely prior to tissue healing. Fluorescence immune histological
staining for macrophages (CD68) was used to characterize the local immune response.
CD68 macrophage invasion and infiltration, at the adhesive−subcutaneous tissue interface,
were observed at day 4 but not at day 28. This observation suggested that the CD68 cells
can infiltrate the implant and may control the degradation through enzymatic hydrolysis of
the hydrogel matrix.
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Figure 6
Invivo Compatibility of Bio Adhesive

Note. Hematoxylin and eosin (H&E) staining and fluorescence immunohistochemical
analysis of macrophages (CD68) of (a) BioGel and (b) BioPEG explanted with surrounding
tissue after (i) 4, (ii) 14, and (iii) 28 days of implantation, counterstained with nuclei
(DAPI). Scale bar = 100 µm

3.3.7 Exvivo and Invivo Performance of the Bio Adhesive
To characterize the properties of the bio adhesives, burst pressure measurement was
carried out on the explanted porcine heart and lung (Figure 7a−e). The specimen chamber
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was pressurized by pumping in phosphate-buffered saline under a constant flow rate, while
the pressure was recorded with a pressure gauge. GelMA exhibited a burst pressure value
of 9.33±1.20 kPa, which increased 10-fold with increasing concentration of BIL to 100.00
± 2.89 kPa for BioGel. Similarly, the difference between PEGDA and BioPEG increased
from 7.33 ± 1.45 to 61.66 ± 6.01 kPa, respectively. These results corroborated that BioGel
and BioPEG sealants have significantly greater sealing abilities than previously reported
clinically available sealant materials and sutures.[97] Functional evaluation of BioGel and
BioPEG was conducted in a rat model of class I hemorrhage (the tail cut) and class II
hemorrhage (the liver wedge resection) (Figure 7f−i). When we performed the tail cut
model with GelMA and BioGel, the mean losses of TBV were 8.27 ± 2.77 and 6.64 ±
2.62%, respectively. Previously reported controls noted a mean TBV loss of 15.4%. Both
GelMA and BioGel effectively inhibit bleeding. Moreover, while GelMA bled
continuously until the end of the experiment, BioGel fully stopped blood loss within 2 min.
Thus, BioGel is suitable to treat lacerations causing class I hemorrhage.
To estimate the ability of the bio adhesive to treat class II hemorrhage, we
performed a liver wedge resection with GelMA and BioGel. The mean losses of TBV were
34.5 ± 2.9 and 16.2 ± 4.6%, respectively. Previously reported controls noted a mean TBV
loss of 19.8%. Both GelMA and BioGel effectively stop bleeding. Most of the bleeding
occurred in the first 2 min but continued steadily until the 6 min point. In BioGel after the
7th min, the bleeding stopped completely. The mean losses of TBV were 12.06 ±0.98 and
9.282 ± 1.522% for PEGDA and BioPEG, respectively, indicating that with the conjugation
of the BIL the bleeding can be retracted. Blood loss was noticeably reduced after
application and polymerization of both compounds. The decrease in the rate of blood loss
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is reinforced by the substantial decrease in percent total blood volume lost between the
experimental animals and the controls. The liver wedge resection model was designed to
reproduce class II hemorrhage in rats. The wedge resection performed in that study limited
the raw surface of liver resected for bleeding. By making only one incision to remove a
piece of the liver edge, the surface area exposed for bleeding was minimized. To challenge
the hemostatic properties of the experimental compounds, a more extensive liver wedge
resection was performed. We excised a 1.5 cm X 3 cm piece of the liver, creating a right
angle to maximize the surface area of bleeding liver tissue. This more extensive resection
leads to a percent total blood loss of 48.72% in the untreated rat, which would qualify as
class IV hemorrhage (percent total blood loss >40%). Class IV hemorrhage leads to
profound hemodynamic instability in humans and almost always requires operative
intervention for bleeding cessation. Both BioGel and BioPEG were able to successfully
stop bleeding from the liver wedge resection. The ability of the compounds to ensure
hemostasis in a class IV hemorrhage wound solidifies their reliability as hemostatic agents.
We have demonstrated a new technology platform to develop efficient hemostatic and
biocompatible tissue adhesives using conjugation of a choline based BIL to polymer
structures.
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Figure 7
Exvivo and Invivo Performance Characterization of the Bio Adhesives

Note. (a) Puncture, (b) sealing, and (c) patching of the wound in porcine heart. (d,e) Burst
pressure measurement in explanted heart and lung comparing GelMA and PEGDA with
BioGel and BioPEG. (f,g) In vivo tail cut model was performed to estimate the loss in %
total blood volume (TBV). Control value is from ref 42. (h,i) Liver laceration model was
performed to estimate the %TBV comparing GelMA and PEGDA with BioGel and
BioPEG. Data are means SD. P values were determined by one-way ANOVA (*P < 0.05,
**P < 0.01, ***P < 0)

Two polymer families were studied, which demonstrated significant enhancement
in mechanical, adhesion, and hemostatic efficacy with BIL functionalization, likely
achieved by hydrophobic interactions with the cellular membrane. Hydrophilic heads and
hydrophobic heads bunch together to form a part of the bilayer cellular membrane.[98] The
phosphatidyl choline groups stabilize the cellular membrane bilayer via steric effects and
net charge neutrality, preventing it from binding to immunological protein oligomers.[99]
The mechanism of adhesion with the BIL-modified GelMA and PEGDA polymers can be
visualized via the formation of the strong, electrostatically bound quadruple as depicted.
At the extracellular surface, the adhesion comprises the interaction between the
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hydrophobic phosphatidyl choline heads and the choline pendant groups and unreacted
carboxyl pendants of the BioGel structure as illustrated in Figure 8. The two
electrostatically bound couples are (1) the negatively charged phosphatidyl group with a
positively charged cholinium ion from the BioGel pendant and (2) the cholinium head of
the phosphatidyl choline and carboxyl anion pendants from the BioGel polymer. These
pairs form a tightly bound quadruple with high adhesion propensity.

Figure 8
Bio Adhesion Mechanism Using BIL Conjugation to Biomaterials

In the BioPEG structure, electrostatic interactions between pendant cholinium
groups and phosphatidyl heads of the cell bilayer maintain high levels of adhesion.
Macromolecules cause cellular surface aggregations through adsorptive bridging
conformations. The membrane glycocalyx is thought to exclude them from the intercellular
space causing an osmotic-gradient-mediated aggregation of cell. The Suo moto action of a
macromolecule in cellular aggregation may be enhanced with the BIL-functionalization44

mediated adhesive action. As the BIL concentration increases, the adhesive interaction
becomes stronger. This has been seen in the choline phosphate density on carrier polymers
with cellular aggregation by Yu et al. leading to cellular aggregation and proximity
juxtaposition of membranes.[99] The illustrated general mechanism encompasses the
interactions on the outer surface of the membrane bilayer.
3.4 Conclusion
We present a general biopolymer modification platform for making polymeric
tissue adhesives via the incorporation of the BIL functionality in a macromolecule, which
will induce a strong electrostatic interaction due to the cholinium moieties with the
hydrophilic cellular bilayer heads. The development of this general platform, for
converting suitable polymer backbones with the appropriate usage of BIL, is expected to
allow for the rapid and vast development of biocompatible adhesives, tunable to the
property requirement of a given tissue. The adhesives discussed here with the two polymer
families as examples provide a proof of concept with their hemostatic ability and in vivo
compatibility, allowing for wider vistas of applicability opening possibilities for enhancing
the robustness of surgical and in-field application. This development not only offers
adhesive and hemostatic adhesive properties but also potentially begins vistas for other
advantages such as mechano-transduction.
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Chapter 4
Robust and Transparent Bio Adhesive for Corneal Injury and Repair

Corneal trauma is a significant cause of blindness, and current standards of care for
repair require tissue grafting, suture, and tissue adhesive. However, these procedures have
key drawbacks: infection, inflammation, neovascularization, astigmatism, and impaired
visual acuity. Furthermore, the current standards of care are cost intensive. To address the
unmet need, we developed a novel platform to engineer biocompatible, degradable, and
antimicrobial surgical adhesives. They are established by conjugating polyethylene glycol
diacrylate (PEGDA) with bio-ionic liquid (BIL). Bio-Ionic Liquid functionalized PEGDA
(BioPEG) to repair corneal tears and corneal grafting as a photo cross-linkable photo. In
vitro studies presented that the mechanical properties of the bio adhesive are tunable and
comparable to the native cornea. Also, compared to the other bio adhesive understudy
BioPEG is transparent, can be retained for long periods while permitting integration with
the surrounding native tissue/cells. Further in vivo experiment in rabbit and porcine stromal
defect model substantiates the ability of BioPEG to sustain regeneration and reepithelialization. Thus, the BioPEG is a superior alternative to the current standard of care
and can be used as a fast and straightforward repair of corneal injuries.
4.1 Introduction
Ocular trauma serves as the most common cause of unilateral blindness. About half
a million people have blindness due to eye injuries.[100] In the case of corneal abrasion
due to corneal scarring, it leads to damage of tissue and thus the structural integrity.[101]
The corneal epithelium is fragile and can be damaged very quickly. Most cases of traumatic
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eye injuries and post-infection are preventable. Still, the current standard of care for the
treatment includes corneal transplant and surgeries cyanoacrylate glue or grafting has
significant shortcomings. [102-105] The outcome depends on the rigorousness and mode
of the injury. When these injuries are not addressed appropriately, it leads to tissue necrosis
and further complications, including scarring that affects the visual axis. Due to the weak
adhesion among the corneal epithelium and other layers, there could be recurrent corneal
erosion, reduced function and failure, retinal detachment, meshwork damage, and thus loss
of vision.[106]
Low biocompatibility, rough surface, poor integration, and transparency of the
cyanoacrylate glue make it a less desirable candidate for treating abrasions and lacerations.
The other methods, such a tissue grafting, and sutures require specialized equipment, donor
tissue, which can lead to future complications such as fibrosis, scar tissue formation,
increased rate of infection, neovascularization.[107] Other factors to be considered are
ocular hypertension and orbital cellulitis due to the immune reaction or polymicrobial
conditions. Due to the disadvantages of current methods, there is a need for an alternative
approach that is efficient and effective. Due to the increasing demand to treat and address
corneal injuries. Natural and synthetic biomaterials are promising as they meet the principal
design requirement.[108] Naturally derived adhesives based on fibrin, collagen is in use in
surgical settings. They exhibit high biocompatibility and support tissue integration but have
low mechanical stability and decreased adhesion in a wet environment. Alternatively, the
commercially available synthetic adhesive based on cyanoacrylate and polyethylene glycol
possesses high mechanical strength but cannot support tissue regeneration.[109] Also, the
need for devices and materials that can replace the cornea in part or whole is exponential.
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An ideal material must ensure safety, transparency, and the development of a perfect
optical interface.[110] Adhesive biomaterials are a promising approach for curing corneal
injuries in case of trauma as it is proven to exhibit characteristics like the native cornea.
The cornea is a nonlinear, anisotropic, viscoelastic material. For corneal repair and
regeneration, biomaterial should be transparent and have a tunable mechanical property
comparable to the native cornea and support cellular proliferation. Despite significant
research in the field, there are no available bio-adhesive targets for repairing corneal tears
and repair. ReSure from Ocular Therapeutix, polyethylene glycol-based adhesive is the
only approved ocular sealant, designed to seal corneal incisions. Nonetheless, it has poor
adhesion and deficits in filling stromal defects, particularly in wet conditions. Similarly,
OcuSeal is also a polyethylene-based adhesive for fastening corneal lacerations in Europe,
but rapid polymerization is a significant disadvantage as it counteracts sufficient time for
thorough application.[111]
Different hydrogels, like, alginate, gelatin, chitosan, collagen, and fibrin, are
expended at the various stages of repair and regeneration. Many researchers have studied
the ability to use collagen to encapsulate limbal epithelial cells for corneal tissue
regeneration.[112] Even though hydrogels made up of collagen are biodegradable and
biocompatible, they have a characteristically weak structure. Similarly, hydrogels made of
gelatin is studied as a corneal epithelial, endothelial, and keratocyte cell carrier, and as a
medium for cornea regeneration drug delivery.[113] Mimura et al. showed that to help
corneal wound healing in vivo fibroblast precursors combined with gelatin hydrogel can
be transplanted into the corneal stroma and it play a vital role in wound healing. The opaque
nature of gelatin hydrogel might be a hindrance to the visual axis. Even though other
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adhesives that are derived from natural sources have been established for applications in
treating corneal repair and regeneration due to the shortcomings, there is no current FDAapproved adhesive that syndicates adhesive and regenerative properties whilst mimicking
the usual healing of cornea.[114] We engineered polyethylene glycol diacrylate (PEGDA)
and choline acrylate-based transparent, antimicrobial, biocompatible, and biodegradable
adhesive biomaterial to tackle this unmet need BioPEG, which can be used for the repair
of corneal lacerations and injuries. This developed bio-adhesive is made by conjugating
BILs to the backbone of PEGDA through visible light photopolymerization using photo
initiator, thus forming a gel-like transparent film like native cornea that adheres to the
corneal tissue.
4.2 Materials and Methods
4.2.1 Study Design
Here, we developed a novel platform to fabricate adhesive and biocompatible
surgical adhesives with antimicrobial properties. Based on the conjugation of polyethylene
glycol diacrylate (PEGDA) with bio-ionic liquid (BILs). A photo cross-linkable Bio-Ionic
Liquid functionalized PEGDA (BioPEG) to repair corneal tears and corneal grafting. The
solution, once photopolymerized, forms a transparent adhesive sealant. In vitro, adhesive
properties were verified using burst pressure, wound closure, and lap shear studies. In vivo
degradation and re-epithelization were evaluated in a rabbit and porcine stromal defect
model (n = 5). A rabbit stromal defect model infected with gram negative and positive
bacteria was used to assess the antimicrobial properties. After 14 days, the corneas were
explanted to perform immunohistochemistry and immunofluorescence staining further.
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4.2.2 Synthesis of BioPEG Bio Adhesive
BioPEG prepolymer polyethylene glycol (PEGDA) Mw 700 (Sigma-Aldrich). LAP
photo initiator, polymer solutions were prepared by suspending various concentrations of
PEGDA and BILs in the photo initiator solution to synthesis BioPEG. The bio adhesive
solution stirred at room temperature and pipetted into PDMS molds. The prepolymer was
photo crosslinked with 450 to 550 nm visible light for 60 seconds.
4.2.3 1 H NMR Analysis of BioPEG
NMR analysis was executed to ensure cross-linking of BioPEG. Briefly, bio
adhesives were photo polymerized in PDMS mold and lyophilized in cylindrical shape.
Then, PEGDA and BioPEG were dissolved in DMSO-d6. NMR spectra was obtained using
Varian Inova-500 NMR spectrometer.
4.2.4 Mechanical Characterization of BioPEG
BioPEG prepared as described above was used to study the compression and tensile
strength using SHIMADZU tester. For tensile tests, polymerized bio adhesive samples
were fastened to the grips. Stress at a 1 mm/min rate until falling out of samples was applied
to determine the force and tensile strength. The tensile strength of the fabricated
bioadhesives was estimated. For compressive strength estimation, cylindrical samples were
held in the compressive plates and was conducted at a same rate, the values for strain and
load were recorded.
4.2.5 Invitro Adhesion Tests on BioPEG
Adhesion tests performed according to a modified ASTM standard, BioPEG’s
ability to withstand pressure was studied. Briefly, in a burst pressure apparatus, porcine
skin with a 2 mm sized whole created using an 18-gauge needle was fixed. Next, 50 ml of
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the polymer was pipetted and photo polymerized, air was passed through custom-built
system, and the pressure was documented.
Shear strength of BioPEG bioadhesive was obtained by using, two glass (1 cm by
2 cm) that were coated with a 10% (w/v) gelatin in water and dried overnight at room
temperature. 20 microliters of bioadhesive were applied and polymerized between the two
glasses and the BioPEG’s shear strength were measured using a mechanical tester.
For the adhesive strength of bioadhesives. Skin (porcine) was cut into 1 cm X 1 cm
pieces. To simulate wound, an incision was made. 50 microliter of the polymer was
dispensed onto the wound site and polymerized.
4.2.6 Swelling Ratio and Invitro Degradation of BioPEG
The weights of the BioPEG were collected and successively submerged in DPBS.
The weights of the BioPEG sample were noted at different time points. The percentage
water content was then estimated and the degradation of bioadhesives was estimated. The
bioadhesive was fabricated using compression mold. The initial weight of BioPEG was
measured and was incubated in DPBS for various time points, and the final weights of the
samples were obtained at each time point.
4.2.7 Antimicrobial Study of Bio Adhesive
Sterile BioPEG samples were placed into a 96 well, S. aureus and E. coli, P.
aeruginosa were used to estimate the antimicrobial properties. 200 ul of the bacterial
suspension prepared by calculating the optical density at a wavelength of 570nm was
prepared. The bacterial suspension was then added to each sample, incubated at 37 C
overnight. After incubation, samples were washed thrice with DPBS to remove left-over
bacteria.
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For Colony-forming unit analyses, bioadhesive was placed in 1 ml PBS,
centrifuged for 15 minutes at 3000 rpm, which aids the discharge of bacteria from the
BioPEG. Further, it was serially diluted in PBS. Three drops of diluted samples were spread
on agar plates to be incubated at 37 °C overnight. The colonies formed were counted, and
using the dilution factor, CFU were estimated.
For bacterial cell viability, hydrogels incubated in LB broth were collected. After
washing, LIVE/DEAD® BacLight™ kit (ThermoFisher Scientific) was used according to
manufactures instructions.
4.2.8 Invitro Biocompatibility of BioPEG
Human Corneal epithelial cells and Human Corneal keratocyte cells were cultured
in respective media in conventional incubators. 2´105cells/ml were used on each BioPEG
sample.
PrestoBlue assay was used for estimating the metabolic activity. Briefly, cells on
the BioPEG were incubated with dye in media to estimate the relative fluorescence unit.
The viability of corneal epithelial and keratocyte cells was obtained using live/dead
staining. Briefly, calcein AM and ethidium homodimer-1 were diluted in the given ration
in DPBS. The media was aspirated, and 100 ul of prepared staining dye was added and
incubated for 15 min.
Cell proliferation was studied by actin, cell nuclei fluorescent staining as mentioned
previously. Briefly, BioPEG samples, washed thrice and fixed with 4%(v/v)
paraformaldehyde for 30 minutes. After the samples were washed and permeabilized in
0.1% (w/v) Triton X-100 in DPBS for 5 minutes and stained with Alexa Fluor 488–labeled
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phalloidin and DAPI for 30 minutes. Axio Observer Z1 inverted microscope was used for
image acquisition.
4.2.9 Invivo Corneal Surgeries
New Zealand white rabbits, 8- to 12-week-old male were obtained from the Jackson
Laboratories. Animal studies were approved by Rowan IACUC. General anesthesia was
administered, intramuscular injection of ketamine (30 to 50 mg/kg), xylazine (5 to 10
mg/kg). Proparacaine 0.5% ophthalmic solution was used to induce corneal injury as a
topical anesthesia. 3-millimeter punch biopsy was used to create defect in the cornea (right
eye), mimicking 50% depth stromal defect. BioPEG was applied and polymerized using
visible light. After, the rabbits were placed on a heating pad until recovery. AS-OCT was
used to evaluate the eye 2 weeks after surgery.
The corneal samples were fixed in 4% (v/v) PFA for 4 hours and transferred to 30%
sucrose and were incubated overnight at room temperature to be embedded in OCT
compound (optimal cutting temperature) and flash frozen. The frozen samples were
sectioned using Thermo fisher Cryostat, (10 micrometers). For histology staining,
hematoxylin & eosin kit (H&E) (Sigma Aldrich) was used and for immunostaining primary
and secondary antibodies, anti-CD45 antibody, Alexa Fluor 488–conjugated were used
respectively. Axio Observer Z1 inverted microscope was used for image acquisition.
4.3 Results and Discussion
4.3.1 Synthesis and Characterization of BioPEG
In this study, we present a novel transparent corneal adhesive, the synthesis of
BioPEG and its application is illustrated (Figure 9). The conjugation of BILs with the
polymer (PEGDA) is as previously described. Bio ionic liquid was conjugated with
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polyethylene glycol diacrylate at concentrations of 0− 5%(w/v) by adding the BIL with
varying concentrations of PEGDA (7, 10, 15 % w/v). The resulting bioadhesive solution
was then photo polymerized using visible light. LAP was used as the photo initiator to form
corneal bioadhesives, BioPEG. The chemical characterization of bio adhesive was
performed by 1H NMR and FTIR. The peak at 1260 cm−1 in FTIR indicates the conjugation
of choline acrylate with the PEGDA. Similarly, in 1H NMR, the peaks showed as C and E
imply the synthesis of BioPEG, which were absent in the non-conjugated PEGDA. Also,
conjugation of BIL to PEGDA is indicated by the peak at 3.5 ppm.

Figure 9
Synthesis, Application, and Invitro Characterization of BioPEG
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Note. Schematic of the chemical reaction for (a) Synthesis of BIL (b) Synthesis of BioPEG
from polyethylene glycol diacrylate (PEGDA) and BIL for the application of corneal
laceration, (c) application of prepolymer solution on the corneal injury and polymerizing
with visible light to form the BioPEG. Representative mechanical properties, (d) elastic
modulus (e) compressive modulus of BioPEG fabricated using 7%, 10%, and 15% (w/v)
total polymer concentrations with varying BIL concentration of 0%, 2.5%, 5% (w/v) (f)
Swelling Ratio of BioPEG synthesized by using 10% (w/v) polymer concentration and
varying BIL concentration of 0%, 2.5%, 5% (w/v) and photo crosslinking for 60 seconds
(g) In vitro degradation of BioPEG fabricated using 10% (w/v) polymer concentration and
varying BIL concentration of 0%, 2.5%, 5% (w/v) in DPBS and 37°C over time. (h) Digital
image of ex-vivo application of synthesized BioPEG on porcine cornea to show the
transparency (i) Quantification of transmittance calculated at 350nm for polyethylene
glycol diacrylate (PEGDA), BioPEG and Gelatin Methacryloyl (GelMA). BioPEG were
polymerized by using 0.1% LAP as photo initiator and visible light for 60 secs. Data are
reported as means ± SD (*P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001)

4.3.2 Invitro Swelling, Degradation, and Mechanical Properties of BioPEG
Flexibility, ability to resorb, biodegradability, mechanical properties like the
corneal tissue are some of the ideal requisites of a bioadhesive for treating corneal injuries.
The capacity of the hydrogels to take up water, metabolized and degrade via enzymes or
through hydrolysis at various conditions enhances its ability to be used as a
bioadhesive.[115] The hydrogel capacity to uptake water, its swelling behavior needs to be
studied and optimized for in vitro and in vivo conditions to be used as a bio adhesive.
Degradation and swelling ratio of the PEGDA and BIL conjugates are indicated in figure
9. BioPEG exhibited a similar swelling profile regardless of the bio ionic liquid
concentration over time. The time take for the polymer to swell was much faster with
reduced bio ionic liquid percentage, 0% BIL. With the increasing percentage of bio ionic
liquid, the rate of swelling decreased due to the electrostatic interactions interceded by the
functional groups in the bio ionic liquid leading to the crosslinking.
Degradation studies (Figure 9g) indicate that, the degradation percentage increases
for 5% BIL compared to 0% BIL concentration. While the trend of degradation is the same,
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the degradation escalates with increasing concentration of the bio ionic liquid. The trend is
due to the catalytic action of quaternary ammonium head in choline and the water of
hydration. The combined effect of the functional group and the hydrolysis leads to
degradation, therefore with the increase of bio ionic liquid concentration the degradation
rate increases.
Mechanical properties of PEGDA and BioPEG were analyzed by estimating the
tensile strength and compressive strength using the mechanical tester. The modulus
acquired from the mechanical tests are shown in (Fig. 9d). The results indicated that, by
varying the percentage of bio ionic liquid the tensile strength and compressive strength of
the BioPEG adhesive can be varied. The tensile and compressive strength increases, along
with the surge of concentration of both polymer and the bio ionic liquid. For 7% PEGDA0% BIL, the compression strength is 12.33 ± 1.5 kPa, and the tensile strength is 29.0 ± 2.1
kPa. These values increase to 83.0 ± 4.04 and 154.3 ± 12.6 kPa, respectively, for 15%
PEGDA and 5% BIL concentration. Due to the increase in the functional group with the
increase in the percentage of the bio ionic liquid and polymer, the amount of electrostatic
interaction increases. Thus, leading to the increase in the tensile strength and compressive
strength. To indicate the transparency of the BioPEG (Figure 9h and 9i), we performed an
ex vivo application on the porcine cornea. We measured the % transmittance compared to
the polymer PEGDA and GelMA. The BioPEG exhibited higher transmittance indicating
its ability to allow light to pass through.
4.3.3 Invitro Adhesive Properties of BioPEG
BioPEG’s proficiency to aid wound healing is concomitant with its ability to
withstand the stress exerted by the surrounding tissue without damaging the structural
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integrity of the native tissue. To ease these complications that might arise due to the current
standard of care, such as cyanoacrylate, sutures, BioPEG can serve as an effective
substitute. The in vitro adhesive properties were characterized by studying the BioPEG
response to extension, compression, and shear as per modified ASTM standard. (Figure
10g, 10h) shows the adhesive strength and shear strength of varying PEGDA and bio ionic
liquid concentrations. PEGDA’s shear strength increased from 17.2 ± 0.5 (7% PEGDA
with 0% BIL) to 127.3 ± 1.5 kPa for 15% PEGDA with 5 % BIL. With the increase in the
bio ionic liquid concentration the shear strength significantly increased. Similarly, the
adhesive strength for BioPEG improved from 7.9 ± 0.2 kPa for the 7% PEGDA - 0% BIL
to 39.6 ± 2.3 kPa at 15% PEGDA- 5% BIL. The design of the polymer as a corneal adhesive
necessitates modifying the polymer properties to achieve increased mechanical strength
similar the corneal tissue and higher adhesion. With varying the percentage of the polymer
and the BILs, the adhesive and shear strength can be varied, and the material can be
designed based on the extent of the injury.
We conclude from these findings that conjugation of bio ionic liquid to the
backbone of PEGDA recuperates the adhesion of the fabricated corneal bio adhesive,
making it an excellent candidate for bioadhesive. Due to the increase in the molecular
weight and number of functional groups in the adhesive structure with increasing the
percentage of bio ionic liquid, the adhesive properties increase. The higher the number of
functional groups the higher is the related electrostatic interactions. Thus, the conjugation
of bio ionic liquid drastically rises the adhesion without affecting the native tissue structure.
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4.3.4 Cell Viability, Proliferation, and Metabolic Activity on the BioPEG
To study the biocompatibility of the synthesized BioPEG, in vitro cell proliferation,
metabolic activity, cell viability assays were evaluated, determining the viability of HCEC,
HCK cells with PEGDA and BioPEG. Cell growth and cell proliferation on the bioadhesive
were estimated via phalloidin and cell nuclei staining. Figure 11 shown the images of
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immunofluorescence staining, indicating that the cell viability on day 7 was 97.33 ± 0.33%
and 97.0 ± 0.5 % for HCEC and HCK, respectively on BioPEG surface compared to cell
viability of 96 ± 1% and 97.0 ± 1.0 % on PEGDA surface, indicating the biocompatibility
of the adhesive material. Cells cultured along with PEGDA and BioPEG show comparable
proliferation. PrestoBlue assay was used to quantify the metabolic activity, which is seen
to increase throughout the period of culture from 5000± 57.7 to 11833± 412.6RFU for
HCEC and 4766.7 ± 145.3 to 12740 ± 163 RFU for HCK on BioPEG, indicating the
BioPEG can be used as an adhesive for corneal injury repair which will aid cell adhesion,
growth, and proliferation.

Figure 11
Invitro Biocompatibility of BioPEG

Note. Representative images of (a) human corneal epithelial cells (HCEPC) and (b) human
corneal keratocytes (HCCK) seeded on BioPEG, on days 1, 4, and 7 after seeding stained
with (i) Actin/DAPI and (ii) LIVE/DEAD (c) Quantification of cell viability of HCEPC
and HCK on BioPEG after 1, 4, and 7 days of culture. (d) Quantification of cell
proliferation of HCEPC and HCK on BioPEG after 1, 4, and 7 days of culture. (e)
Quantification of metabolic activity using RFU of HCEPC and HCK on BioPEG after 1,
4, and 7 days of culture. Representative Actin/DAPI images of (f) HCK (g) HCEPC (h) co
culture of HCEPC and HCK cells, encapsulated in BioPEG after 1, 4, and 7 days of culture.
BioPEG, fabricated at 10 %(w/v) PEGDA and 5 %(w/v) BIL, and polymerized by using
0.1% LAP as photo initiator and visible light for 60 secs. Scale Bar = 200µm. Data are
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represented as means ± SD (**P < 0.01, ***P < 0.001, and ****P < 0.0001). Scale bar 100µm

4.3.5 Invivo Assessment of BioPEG in a Rabbit and Porcine Stromal Defect Model
The Invivo biocompatibility of visible light cross-linked PEGDA-BIL was
established in our previous study. BioPEG as an adhesive for corneal injury and laceration
was studied in an injury model in rabbits and pigs. 3mm punch biopsy was used to simulate
corneal laceration (Figure 12a, 12b) and the integration of the BioPEG for repair, reepithelization, and sealing of corneal defects was studied. Subsequently, BioPEG solution
was dispensed into the injury site (Figure 12c), followed by photopolymerization for 60sec
(Figure 12d). After photopolymerization, BioPEG adhered firmly to the corneal defect.
The applied BioPEG had a transparent, smooth surface, and the nearby tissue was
noninflamed after surgery. AS-OCT and contact angle images established that BioPEG
could seal the defect and attach it to the stroma (Figure 12f). On day 14 after application,
the injury was completely healed (Figure 12k), whereas, in the case of Dermabond (Figure
12g) and ReSure, the surface was uneven (Figure 12 h). Furthermore, histological
assessment of cryo-sectioned tissues indicated adhesion and regeneration of stroma after
application (Figure 12 o). Also showing a noticeable regrowth of stromal layer like native
cornea in BioPEG compared Dermabond and ReSure (Figure 12p, 12q), which are the
current standard of care. Uniform re-epithelialization in BioPEG treated group was
indicated in the immunostaining (Figure 12 o) after 14 days, like native cornea.
Additionally, CD45 maker was used to detect any leukocyte infiltration, thus showing
regular inflammatory responses during the regeneration and repair process.
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Figure 12
Invivo Application and Histological Analysis After the Application of BioPEG into Corneal
Defects in Rabbits

Note. (a,b) Representative images for creating a 50% depth corneal stromal defect on rabbit
eye. (c) In situ application of BioPEG into corneal defect and photo crosslinking using
visible light (e) attachment of BioPEG on corneal stromal defect. AS-OCT images (e)
healthy cornea (f) after treatment with BioPEG, indicating a smooth surface (g) after
treatment with Dermabond and (h) ReSure,14 days after application. Digital contact angle
images of (i) healthy cornea (j) Injury (k) after treatment with BioPEG, indicating a smooth
surface (l) after treatment with Dermabond and (m) ReSure,14 days after application.
Representative fluorescent immunohistochemical images (DAPI and CD45 marker) (o)
from the native cornea and from BioPEG treated corneal defect at day 14 after surgery (p)
from the native cornea and from Dermabond treated corneal defect at day 14 after surgery
(q) from the native cornea and from ReSure treated corneal defect at day 14 after surgery.
Representative hematoxylin and eosin histopathology images from (r) native rabbit corneas
(without defect) and the cornea defect after application of (s) BioPEG (t) Dermabond (u)
ReSure. Commercially available Dermabond and ReSure were used and BioPEG,
fabricated at 10 %(w/v) PEGDA and 5 %(w/v) BIL, and polymerized by using 0.1% LAP
as photo initiator and visible light for 60 secs. Scale Bar = 200µm.

4.3.6 Invitro Antimicrobial Properties of BioPEG
The prevalence of microbial infection associated with chronic wound healing and
treatment are significantly increasing in recent years. Infection prolongs and impairs the
wound healing process causing tissue morbidity, which can lead to sepsis, specifically in
corneal injuries. These kinds of infections caused by gram-positive and gram-negative
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bacteria are a significant cause of significant vision loss. Due to the need to prevent and
tackle the infection at the injury site is being studied and various strategies are developed
persistently with antimicrobial properties. Thus, we evaluated the antimicrobial activity of
BioPEG using colony-forming unit study and live/dead assays with varying concentrations
of the BILs. We studied different microorganisms, both gram negative and gram-positive
S. aureus, P. aeruginosa, and E. coli. BioPEG [10 % PEGDA and 5 % BIL(w/v)] were
studied, samples were incubated overnight in 106 CFU/ml of all three strains individually.
The harvested bioadhesive sample were processed for the live dead and CFU assay.
CFU assays demonstrated that BioPEG effectively reduced the viability and
colonies, as shown by the decrease in CFU values related to control and PEGDA (Figure
13d). For example, PEGDA had 2.6 X 106 ± 5.5 X 105 CFU/ml compared to BioPEG,
which had 5.3X105 ± 6.1X104 CFU/ml indicating the efficiency of the BioPEG. The
antimicrobial ability of BioPEG was assessed by Live/Dead BacLight Bacterial Viability
Kit (Figure 13e-m). Samples harvested from bacterial cultures were stained and results
indicated the ability of all the strains to colonize on PEGDA with no BILs, as established
by the mostly green fluorescence (Figure 13f,13i,13l). The bioadhesive containing 5 %
(w/v) BIL showed higher red fluorescence indicating the dead bacterial cells (Figure
13g,13j,13m). Previous studies have shown the antimicrobial activity of ionic liquid-based
material and their applications for the progress in wound healing. The mechanism of action
depends on the functional group of the ionic liquid. Hence, choline-based bio ionic liquid
antimicrobial offers an alternate approach that could evade existing limitations in managing
infection at the site of corneal injury.
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Figure 13
Invitro Antibacterial Properties of BioPEG Colony Forming Units Test for PEGDA and
BioPEG

Note. (a) E. coli. (b) Pseudomonas aeruginosa (c) Staphylococcus aureus (d) Quantification
of CFU/ml of control, PEGDA and BioPEG. Representative live/dead images of (e,f,g) E.
coli, (h,I,j)P. aeruginosa, (k,l,m) S. aureus seeded on well plate, PEGDA and BioPEG
respectively. BioPEG were polymerized by using 0.1% LAP as photo initiator and visible
light for 60 secs. Scale Bar = 200µm. Data are reported as means ± SD (*P < 0.05, **P <
0.01, ***P < 0.001, and ****P < 0.0001)

4.3.7 Invivo Antimicrobial Properties of BioPEG
We estimated the in vivo antimicrobial properties of BioPEG in a corneal injury
model in New Zealand white rabbits by creating a corneal laceration using a 3mm biopsy
punch at 50% deep corneal defects and infected with Staphylococcus aureus and
Pseudomonas aeruginosa to study the ability of BioPEG to repair, re-epithelization, and
sealing of corneal defects despite the presence of bacteria. BioPEG precursor solution was
applied to the defect site that was infected with 50 ul of 105 CFU/ml followed by
polymerization via visible light for 60sec. By day 14, after application, compared to the
untreated infected cornea, the BioPEG treated cornea appeared healthy. The untreated
cornea was bright red, indicating the infection (Figure 14a-e). AS-OCT confirmed that the
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BioPEG treated cornea could completely seal the defect and integrate with the stroma and
have a smooth surface than the untreated infected cornea (Figure 14f-k). Also, expression
of CD45 staining serves as a leukocyte infiltration marker indicating standard
inflammatory response through the regeneration process in the BioPEG treated cornea for
both Pseudomonas and Staphylococcus (Figure 14l, 14m).

Figure 14
Invivo Application and Histological Analysis After the Application of BioPEG into Infected
Corneal Defects in Rabbits

Note. Representative digital images for (a)Healthy cornea (b)Staphylococcus aureus
infected injured cornea (c) Pseudomonas aeruginosa infected injured cornea (d) BioPEG
treated Staphylococcus aureus infected injured cornea (e) BioPEG treated Pseudomonas
aeruginosa infected injured cornea. AS-OCT images (f)healthy cornea (g) Pseudomonas
aeruginosa infected injured cornea (h) BioPEG treated Pseudomonas aeruginosa infected
injured cornea after 14 days (i) healthy cornea (j)Staphylococcus aureus infected injured
cornea (k) BioPEG treated Staphylococcus aureus infected injured cornea after 14 days.
Representative fluorescent immunohistochemical images (DAPI and CD45 marker) (l)
from the native cornea and from BioPEG treated Pseudomonas infected corneal defect at
day 14 after surgery (m) from the native cornea and from BioPEG treated Staphylococcus
infected corneal defect at day 14 after surgery. Representative hematoxylin and eosin
histopathology images from (n) from the native cornea and from BioPEG treated
Pseudomonas infected corneal defect at day 14 after surgery (o) from the native cornea and
from BioPEG treated Staphylococcus infected corneal defect at day 14 after surgery. Scale
Bar = 200µm.
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4.4 Conclusion
Corneal repair aims to maintain structural integrity, counteract vitreous fluid
leakage, prevent infection ingress, and heal the surface. The current standards sutures, and
cyanoacrylate glue have a significant drawback. The suture’s inability to seal the defect
altogether causes leaks leading to orb and lens instability, irritation, pain, infection,
neovascularization, and showing changes in corneal curvature, causing astigmatism
requiring corrective surgery.[117] Tissue glue made of cyanoacrylate is not FDA approved
for the eye, is cytotoxic, opaque, inflexible, inflammatory, and non-resorbable. Its brittle
debris cause infections: and its non-transparency hinders vision. It also causes necrosis,
fibrosis, foreign body sensation, and discomfort. Its application and attachment on a wet
cornea are poor; and need a protective contact lens, raising infection risks.[118] To address
the limitations, we developed BioPEG as a biocompatible and transparent adhesive that
will be a superior alternative to sutures and other adhesives by way of application ease and
reduced risks of infection and secondary complications. BioPEG is a functionalized
hydrogel with excellent tissue adhesion and strength. Its transparency, flexibility as
indicated in the invitro, in vivo experiments, allow the smooth corneal repair. Results
suggest that adhesive properties and mechanical strength of the bio adhesive are tunable.
In vitro cell studies substantiate the biocompatibility, cell attachment, and proliferation
after application. Additionally, in vivo studies indicate that BioPEG can promote regrowth
of the stromal layer and efficiently seal corneal defects. Also, as our approach uses a
biocompatible and antimicrobial gel-like substance for suture-less healing of corneal
defects via photo crosslinking exclusive of the need of specialized equipment and advanced
technology, it makes BioPEG practical in a clinical setting. Compared to other PEG-based
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bioadhesives for ophthalmic applications, due to the presence of BILs, BioPEG indicates
superior adhesion to wet tissue and has prolonged holding. Finally, due to the ability of
BioPEG to help repair and regrowth of stroma comparable to the native cornea that leads
to re-epithelialization, this is an excellent candidate for corneal repair and regeneration.
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Chapter 5
In-Situ 3D Bioprinting of Multifunctional Bio-Ionic Liquid Hydrogels for Tissue
Regeneration

Due to the increasing demand for biomaterial-based electronics as a convergence
of biology and electronics, there is an unmet need to develop materials with robust
properties applied to bioelectronics. Despite biomimicking features, hydrogels lack various
properties like robust gelation, cell attachment, tunability. There is a need for developing
robust hydrogels as integration between electronics and biology and as a vigorous
biomaterial with application corresponding to in-situ 3D scaffold bioelectronics and 3D
bioprinting. We developed a tailorable GelMA-based bio-ink functionalized with a choline
BILs visible light photocurable is designed for bioelectronics-integrated tissue engineering.
The resultant photo crosslinked polymer is flexible, conductive, and transparent with
exceptional adhesion, and the properties depend on ratios of GelMA and the BILs. Cell
viability of 98%±1%, 0.279±0.02 S cm-1 conductivity, and 34.3±1.9 kPa adhesive strength
are obtained. Due to manageable crosslinking, the rapid in-situ 3D bioprinting of complex
designs directly on porcine skin is enabled by varying the concentrations. It allows the use
of this bio-ink platform for easy fabrication. Thus, proposing a generalized approach to
fabricate bio-ink by photo conjugating methacrylate biocompatible polymer backbones
with BILs renders versatile compositions for bioelectronics applications.
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5.1 Introduction
Current advances in material science have resulted in the various design and
assembly of biocompatible flexible electronics materials and devices used in wearable and
implantable biomedical systems. Such bioelectronic device designs often employ carbonbased materials, conductive polymers, and metals. While most materials are cytocompatible and flexible, they often showcase significant limitations in mechanical
properties, poor stretchability, or transparency, seen in high aspect ratio nanomaterials or
specific conductive polymers, especially at the levels needed in specialized designs. These
become significant limitations in ultrathin or serpentine device designs, curbing
complexity, footprint, and overall device conductivity [119-123]. The conduction in
polymers occurs vis the movement of electrons and holes, converted to ionic movement at
the electrolyte and electrode interfaces via electrochemical reactions, thus stimulating the
biological systems.[124]
In aqueous systems, as in most biological environments, the interfacial voltage
drops more than water is witnessed. It is also accompanied by local Joule heating, changes
in pH, degradation of electrodes, and generation of reactive chemical species with
concomitant damage to bio tissue. Thus, leading to a long-term, high current
neuromuscular or transcranial direct current stimulation, electroporation, iontophoresis,
wound treatment, and defibrillation.[125] Additional limitations result from cytotoxicity
and an inability to match the supple mechanics of human tissue. Also, the increasing
demand for rapid wearable and implantable biomedical has encouraged intraoperative
approaches, such as in situ bioprinting, which enables the deposition of bio-inks directly at
the injury sites to adapt to their specific structures and shapes. Combining these approaches
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with freshly isolated cells from a patient could fabricate custom-made bioelectronics
implants at the tissue interface. [126-130] To alleviate these limitations, novel
biocompatible electronic device designs which can interface with biological systems are
indispensable. Biocompatible polymeric hydrogels with ion conductivity, transparency,
flexibility, and superior mechanical properties matching those of natural tissue with the
ability of in situ 3D printing are potential candidates for such applications. Their ion
transport aids the requirement of interfacial electron-to-ionic current conversion, ensuring
superior safety in application.[131] An additional advantage of using ionic hydrogel
conductors is separating electrodes from bio-tissues, thus easing out toxic tension brought
about by interfacial chemical and electrochemical reactions.[132] The water content in
these hydrogel structures also helps dissipate heat generated due to current passage, thus
reducing the chances of burns and injuries in a wearable or implantable device. While
ionic hydrogels have been used to conduct electrodes in electrochemical systems and
connectors in circuits on insulating silicon substrates, existing material platforms unstable
in biological environments specifically on aqueous surface. This occurs due to ion
diffusion, low conductivity, and severely limits their applicability in integrated device
designs for biological applications.
BIL can be used to endow polymers with a unique balance of physical, rheological,
electrochemical, and tissue adhesion properties to overcome these challenges.[133]
Choline-based BIL are promising due to their biomimetic, immunomodulatory,
cytocompatibility character. Previously we have shown that conjugation of BIL with
biomaterials imparts conductivity to tissue scaffolds and synchronizes cardiomyocyte
contraction.[134] This paper introduces a platform for conductive, adhesive, and
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rheologically optimized transparent bio-ink for in situ 3D printing for applications at tissue
engineering and bioelectronics interface. A choline BILs is photo-conjugated with a prefunctionalized gelatin methacrylate (GelMA) biopolymer. The resultant crosslinked
polymer has the desired properties to use as an adhesive and conductive scaffold. Photoconjugation and crosslinking allow the use of this bio-ink material platform for easy and
rapid direct in situ 3D bioprinting of tissue scaffolds with complicated 3D designs using
an ALLEVI extrusion bioprinter. The physical and electrical properties of the printed
structure were characterized, and the cell-laden printed structures were found to be
conductive and adherent to the epidermal layer of porcine skin. Thus, this novel bio-ink
material was shown to bring together divergent properties optimally desirable in tissue
engineering applications. The versatility in the properties by varying the functionalization
or the extent of crosslinking allows this to become a general material platform for the
generation of versatile 3D printable structures that can diversify into integrated
bioelectronics. This vastly expands the application repertoire for bioelectronics-integrated
tissue engineering for rapid drug prototyping, clinical translation, and regenerative
medicine.
5.2 Materials and Methods
5.2.1 Materials
Gelatin (Type A), methacrylic anhydride (Sigma-Aldrich), LAP, lithium phenyl2,4,6-trimethyl-benzoyl phosphinate (Allevi, Inc.,). Analytical reagent-grade chemicals
were used without further purification.

70

5.2.2 Synthesis of the Bio Ionic Ink
Here we elaborate a method to synthesize biocompatible BIL and conjugate it to a
natural polymer to yield an immunomodulatory conductive and adhesive bio-ionic ink (BI).
Choline acrylate was synthesized using choline bitartrate and acrylic acid at an equimolar
ratio, as described previously by Noshadi et al. [135]. 10% (w/v) gelatin solution was
methacrylate using 8 mL of Methacrylic Anhydride under inert conditions for 3 hours. The
resultant solution was purified by dialysis (five days) to remove unreacted methacrylic
anhydride and frozen at −80°C for 24h. The frozen acrylate polymer was lyophilized for
seven days. Bio-ionic Ink was synthesized by adding the acrylate polymer and BIL at
varying concentrations and mixed with photo-initiator 0.5%(w/v) Lithium phenyl-2,4,6trimethyl-benzoyl phosphinate (LAP).[136] Bio-ionic Ink was then fabricated accordingly
and photo-crosslinked via visible light in the ALLEVI2 at a wavelength of 450nm, intensity
of 3 MW/cm2 for 60 s.
5.2.3 1H NMR and FTIR Analysis
NMR was performed to characterize Bio-ionic Ink with standard DMSO method
using a Varian Inova-500 NMR spectrometer. 1H-NMR and FITR (Frontier™ FT-IR/FIR)
spectra of bio ionic liquid (choline acrylate), gelatin methacryloyl, prepolymer, and Bioionic Ink were acquired.
5.2.4 Mechanical Characterization of Bio Ionic Ink
The Bio-ionic Ink's mechanical properties were obtained using mechanical tester
(Shimadzu), samples were prepared using fabricated PDMS molds, and the tensile and
compressive strength was estimated.
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5.2.5 Invitro Degradation and Swelling Studies on Bio Ionic Ink
Bio-ionic Ink was fabricated for degradation tests as previously explained and were
lyophilized, weighed, and were incubated in DPBS in well plate or at 37 °C for two weeks.
After 1, 7, 14 days, the samples were lyophilized overnight, and weights were noted at
various time points. The swelling ratio of Bio-ionic Ink was estimated, samples were
prepared using a PDMS mold. Prepared samples were freeze-dried and weighed. After that,
the samples were incubated at 37 °C for 4, 8, and 24 h in DPBS and weighed again.
5.2.6 Invitro Adhesive Properties of Bio Ionic Ink
The shear strength of the Bio-ionic Ink was tested according to the modified ASTM
standard like previous methods. [137] 10µL drop of Bio-ionic Ink was crosslinked between
the two layers and tested at a strain rate of 1mm/min shear strength.
Wound closure evaluated using ASTM standard.[138] A cut was placed store
brought porcine skin with a scalpel. 100 µL of Bio-ionic Ink was placed onto the wound
and polymerized by visible light. The adhesive strength was obtained using a mechanical
tester.
A 5×5 mm puncture was made in the store brought porcine heart's left chamber and
connected to a custom-built apparatus, which comprises a syringe pressure setup, pressure
meter, and 0.5 ml/s of air pass through the syringe pump. The puncture made was sealed
with photopolymerized Bio-ionic Ink. Post rupture of the applied Bio-ionic Ink airflow was
terminated, and the pressure was noted. Burst pressure was estimated according to ASTM
standards.

72

5.2.7 3D Printing of Bio Ionic Ink
Bio ionic ink was prepared as mentioned before. A 10 mL BD syringe, 24-gauge
blunt end needle was used to load the samples. The pressure was varied to change the flow
rate (7-15kPa) of the bio ionic ink and printed into different structures with a layer height
of 0.1mm. The prints were then polymerized using the light in the printer for up to 1 min.
STL files for lattice and multi-layered lattice were obtained from ALLEVI. For the support
bath, Carbopol gel was prepared as described earlier.[139] Briefly, 1.8% (w/v) of Carbopol
ETD 2020 (Lubrizol) was dissolved in 50 mL of DPBS. 1.1 mL of 10 M NaOH was added
to 50 mL Carbopol solution. Next, the Carbopol gel was centrifuged at 1000 × g for 1 hour
until the gel became homogeneously dispersed.
5.2.8 Invitro Biocompatibility Study - Cell Proliferation, Viability, and Metabolic Activity
on Bio Ionic Ink
On the surface of Bio-ionic Ink, 0.05 × 106 cells were seeded with growth media.
Cellular metabolic activity was evaluated using a Presto Blue assay. Cell proliferation on
Bio-ionic Ink was envisaged through fluorescent staining of phalloidin and DAPI for cell
nuclei. The viability of cells on the Bio-ionic Ink was estimated using live/dead viability
kit, Axio Observer Z1 inverted microscope (Zeiss) was used to acquire fluorescent image.
Viable cells and dead cells appeared green and red, respectively.
5.2.9 Invivo Biocompatibility and Degradation of Bio Ionic Ink
IACUC at Rowan University approved the animal experiments. Male Wistar rats,
200–250 grams were obtained from Charles River (Boston, MA, USA). Anesthesia was
induced and assessed by lack of pedal reflex to a toe pinch. Isoflurane 4-5% induction in
an induction chamber, followed by 2% or titrated to effect maintenance dose delivered by
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a nose cone, followed by Pre-emptive analgesia Meloxicam – SR administration 30
minutes before surgery. After inducing anesthesia, slits were made on the posterior skin,
and subcutaneous pockets were made by direct disintegration around the incisions. Bioionic Ink (2× 2 mm disks) were inserted into the pockets and wounds were closed for
recovery from anesthesia. Animals were euthanized at various time points at days 4, 14,
and 28 post-implantations, and samples were collected for further analysis.
5.2.10 Invivo Electrical Stimulation of TA Muscle
IACUC at Rowan University approved the animal experiment. The procedure was
a non-survival surgery. According to previous studies, the muscle stimulation of
engineered hydrogels was evaluated in vivo after in situ 3D printing of Bio-ionic Ink in
Male Wistar rats (weighing 200-250g).[140] Wistar rats were purchased from Charles
River Laboratories. Briefly, anesthesia was induced, and depth of anesthesia was assessed
by lack pedal reflex to a toe pinch, Isoflurane 4-5% was used for induction in the induction
chamber, followed by 2% or titrated to effect maintenance dose delivered by a nose cone.
The hind leg was prepped for surgery. The animal was placed in such a way that the TA
muscle was exposed, using a scalpel, a skin incision was made, and standard platinum
electrodes with 10mm separation (control) were used to stimulate the muscle tissue
electrically. Two different voltages were applied: 0.9v and 2.5v. The actuation and height
data were measured and collected using Keyence LJ-V700 for each voltage.
5.2.11 Histological and Immunofluorescent Staining
The studies were carried out on the collected sample to study the inflammatory
response. The slides were prepared as described in previous sections and used for H&E
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staining and Immunofluorescent staining. Anti-CD68, Alexa Fluor 594-conjugated were
used as primary, secondary antibodies for detection and counterstained with DAPI.
5.3 Result and Discussion
5.3.1 Synthesis and Characterization of the BIL and Bio Ionic Ink
Syntheses of bio ionic liquid and Bio ionic ink have been schematically illustrated
in Figure 15. To integrate differing properties, the backbone of the polymer is conjugated
with BIL. Choline, which is a precursor of acetylcholine, and a methyl donor in lipid
metabolism, is used as an ionic liquid. The ability of choline ion liquid to perform as a
conductive and adhesive tissue scaffold is studied by Noshadi et al. [141]. Figure 15a
illustrates the chemistry of formation of the BIL, and 15b shows the conjugation between
GelMA and BIL to form the conductive and printable bio ionic ink and schematically
illustrates the one-step process of printing the bio-ink into a bioelectronic structure. The
experimental section describes the process of making the BIL and its subsequent
conjugation to the GelMA structure in detail. The synthesis of choline acrylate and
conjugation of the synthesized bio ionic liquid to the backbone of polymer was confirmed
via FTIR and 1H NMR.
1

H-NMR analysis and spectra of synthesized choline acrylate (bio ionic liquid) and

Bio-ionic ink (BI7-4, (7%GelMA and 4%BIL)) were collected to ascertain the
incorporation of the BILs to the backbone of polymer structure. Peaks at ~5.6 ppm and ~6
ppm indicative of the conjugation of the polymer and ionic liquid, leading to BILs
incorporation in the polymer. Peak at 1600 cm-1 in FTIR denotes the configuration of the
ester bond via acrylation, underscoring the formation of choline acrylate. In 1H NMR, the
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peak related to the hydrogen atom of acrylate in the 1HNMR at ~5.7- 6 ppm confirms the
acrylation and effective synthesis of choline acrylate.

Figure 15
Synthesis and Fabrication of Bio Ionic Ink

Note. The panels show schematics for (a) Illustrates the chemistry of formation of the BIL
(b) Conjugation between GelMA and BIL to form the conductive and printable bio ionic
ink and a schematic of the 3D printing of synthesized Bio ionic ink using ALLEVI 2 printer
(GelMA (7–15(w/v) )% and BILs concentration (0 – 10(%w/v) concentration 0.5 (%w/v)
Lithium phenyl-2,4,6-trimethylbenzoylphosphinate (LAP) as a photo initiator at 60 s
visible light exposure)

5.3.2 Invitro Adhesive, Physical, and Conductive Properties of Bio Ionic Ink
Hydrogels inherently have a subdued adhesion to the bond between tissue and its
surrounding in various bioelectronic applications. It is challenging for the existing
biomaterials and relies on engineering the surface and other surface modifications.[142]
To address this, we design the bio ionic ink as an adhesive tissue scaffold that can help in
forming a physical and chemical interaction. The ability of the choline BILs to help in
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hemostasis due to the bond between the choline acrylate and the phosphatidylcholine on
the cell membrane is established to study the capacity of the bio ionic ink to perform as a
firm adhesive scaffold. In vitro sealing properties of the Bio-ionic Ink (BIx-y) were
evaluated with varying GelMA and BIL concentration levels, where the x and y indicate
the GelMA and BIL concentrations in the reaction mixtures in (w/v) %. The polymer
GelMA was used at x=7, 10, 15 (w/v) % while the BIL concentration was kept at y=0, 2,
4, 6 (w/v) %. Each composition was photo-crosslinked using photo initiator, 0.5% (w/v)
LAP. The primary impediments to successful tissue regeneration are stress and tissue
damage [141]. Bio-ionic Ink can mitigate these complications as an alternative strategy,
directly printable on the damaged sites. We characterized the in vitro shear strength,
compression modulus, burst pressure upon the adherence of bio ionic ink to tissue
according to modified ASTM standard for (7, 10, 15 (w/v)) % of GelMA due to the ease
of printing, depending on the application. The shear strength of Bio-ionic Ink is shown in
Figure 16 a,b and increases with increasing BIL concentration, following the same trend
for all polymer concentrations. Also, the shear strength improved with rising polymer
concentration for the same level of BIL content. The shear strength of Bio-ionic Ink
increased from 2.60±0.20 kPa (7% GelMA with 0% BIL) to 32.13±2.50 kPa for BI7-6.
In the form of a wound closure test, the adhesive strength of Bio-ionic Ink, shown
in Figure 16c, d, increased from 3.34±1.35 kPa (7% GelMA with 0% BILs) to 34.3±1.95
kPa for BI15-7. The adhesive strength increases slightly with increasing polymer
concentration for the same BIL loading, although the trend is not monotonic. Similarly, the
burst pressure test establishes the capacity of a bio-ink to resist the pressure exercised by
native tissue fluids at damaged site. We tested burst pressure of Bio-ionic Ink based , shown
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in Figure 16 e,f, with 0% BIL was 1.89±1.7 kPa and 4.95±0.90 kPa respectively for 7%
GelMA and 15% GelMA. This subsequently increased to 32.9±1.1 kPa and 45.00±3.00
kPa, respectively, for BI7-6 and BI15-6. Adhesive property is incumbent on electrostatic
interactions and film-forming properties. Electrostatic interactions between polymer chains
increase with increasing BIL loading, which enhances the film-forming abilities.[143]
With an increase in concentration of bio ionic liquid, the polymer chain's molecular weight
per unit length increases due to a higher degree of functional groups of choline. The bio
ionic liquid functional groups significantly increase ionic interactions and electrostatic
forces, preventing the chains from slipping against each other. This leads to high adhesive,
shear, burst pressure strength. While considering tissue surface adhesion, the choline
groups from the BIL interact with the phospholipidic bilayers of the exposed cell mass of
tissues, forming a polar quadruple hence enhancing adhesion.[144]
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Figure 16
Invitro Sealing Properties of the Bio Ionic Ink (BI)

Note. (a,b) Standard lap shear test to determine the shear strength (c,d) Standard wound
closure test to determine the adhesive strength (e,f) Standard burst pressure test to
determine the pressure (n ≥ 5). Mechanical properties of bio-ionic ink (g) Compression
Modulus and (h) Elastic Modulus with GelMA (7, 10, 15 (w/v)) % and BILs concentration
(0, 2, 4, 6(w/v)) %. Physical characterization of the Bio-ionic Ink (BI) - GelMA (i) Swelling
ratio (j) Degradation ratio with GelMA (7, 10, 15 (w/v)) % and BILs concentration (0, 2,
4, 6(w/v)) % concentration with 0.5% Lithium phenyl-2,4,6-trimethylbenzoylphosphinate
(LAP) as a photo initiator at 60 s visible light exposure. Data are means ± SD. P values
were determined by one-way ANOVA (*P < 0.05, **P < 0.01, ***P < 0.001)
To design a degradable yet electroactive hydrogel with tunable physical and
mechanical properties is vital for the material application at the interface of electronics and
biology. Swelling of Bio-ionic Ink composed of 7% GelMA with varying concentrations
of BIL was determined after 2-, 4-, 8-, and 24-hours Figure 16i. GelMA without BIL
functionalization swelled up faster and greater than other compositions, reaching a
maximum swelling of 34%. The polymers functionalized with 2%, 4%, 6%, and 8% BIL.
The initial water uptake and swelling are gradual, followed by a rapid increase in the latter
part of the experiment. With increasing levels of BIL functionalization, the final swelling
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levels achieved were lower. As polymer chains absorb water, they form overlapping
hydrated regions, the size of which is dictated by the concentration of BIL
functionalization. With 0% BIL functionalization, the intrinsically hydrophilic polymer
slowly opens, allowing water in till the crosslinks prevent any further structural expansion
and swelling. BIL functionalization enhances the interaction between polymer segments
causing them to tether firmly to each other via electrostatic interactions, which act as
physical crosslinks, causing an initial resistance to hydration. The rate of hydration thus
decreases with increasing BIL functionalization. The crosslinking density of the polymer
regulates the swelling ratio, thus the polymer swell to a restricted degree.[145]
Similarly, in vitro degradation tests can be a good indicator of in vivo performance
under physiological conditions. The degradation behavior of the bio-ionic ink
compositions is shown in Figure 16j. The degradation percentage increases with BIL
concentration. The degradation of the material with 0% BIL functionalization increases
from 19% (day1) to 32% (day7) and, degradation of the bio-ionic ink with 6% BIL
functionalization increases from 27% (day 1) to 44% (day7). The quaternary ammonium
head in the choline BIL pendant group conceivably acts as a hydrolysis catalyst to facilitate
degradation via hydrolysis of the functional groups. Further, tensile and compression
modulus of the bio ionic ink were studied to verify the capability of bio-ink to perform
comparable to native tissue and mimic the biomechanical features of the native
extracellular matrix. Figure 16 g, h shows the compression and elastic modulus of the
GelMA-BIL conjugate compositions synthesized using 7% and 10% GelMA with varying
concentrations of BIL conjugation. Indicating that the mechanical properties of the bioionic ink are tailorable by varying the concentration of GelMA and bio ionic liquid. With
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the increase in percentage concentration of bio ionic liquid the tensile and compression
modulus increases. For 0% bio ionic liquid concentration the compression modulus is
2.93±0.9 kPa and tensile modulus is 5.4±2.7 kPa. These values increase to 11.6±5.8 kPa
and 17.1±0.9 kPa, respectively, for bio-ionic ink with 6% BIL, demonstrating the
possibility of tuning properties to obtain high elasticity and durability. Bio-ionic ink
compositions exhibit a trade-off among rigidity and elasticity to resist shear without
altering the structural integrity. Increase in mechanical strength is attributed to increase in
the number of functional groups leading to hydrogen bonds and electrostatic interaction.
Mechanical moduli also increase owing to increase in molecular weight with
functionalization. The functional groups in Bio Ionic Liquid conjugated to the polymer
structure makes the backbone stiff, making chain rotation increasingly difficult.[146].
5.3.3 Invitro Conductivity and Transparency of Bio Ionic Ink
Even though electrically conductive polymers are conventional and reviewed for a
long time, the use of those materials in clinical application is far. A pronounced
electroconductive property, simple preparation, and ease of use in tissue engineering is a
prerequisite to advance biomaterials in the field of bioelectronics.[147] Also, electrical
conductivity is a significant physical aspect in the development of conductive composites.
In Figure 17 a, b, c, the electrochemical impedance spectroscopy frequency response
Nyquist plots with GCE, at 0.1V. In impedance spectroscopy, the impedance is incumbent
on local motion and oscillation of the charged bio ionic liquid groups. It is primarily
denoted by partial circular portion of the graph.[143] The straight-line in the Nyquist
curves represent electric relaxation at low frequencies and is related physically to the
diffusion of the solvent imbued in the polymeric gel matrix and portends to bio ionic liquid

81

group alignment. The linearity of the plots in the low-frequency areas indicates that the
bio-ionic ink behaves like a resistor at low frequencies. As the frequency increases, its
behavior converts like a resistance-capacitance transmission line circuit. Conductivity was
measured using the three-electrode system for Bio-ionic Ink samples, and the results are
shown in Figure 2d. Control samples made with 7% GelMA and 0% BIL functionalization
had conductivity of 9×10-3 S cm-1, 15%GelMA with 0% BIL functionalization showed a
conductivity of 6×10-3 S cm-1.
With the introduction of BIL functionalization, the conductivity was seen to
increase to 13.2×10-2 S cm-1 for BI7-6 and to 27×10-2 S cm-1 BI15-6. Higher levels of BIL
functionalization may polarize the polymer chains, causing mobility of chain segments. A
free and mobile counter ion accompanies each BIL pendant group. Thus, with high levels
of BIL functionalization, there is a higher concentration of mobile counter-ions and hence
higher conductivity. This also results in greater polarization of the solvent molecules, thus
contributing to a further increase in conductivity. To study the transparency of the Bioionic Ink in comparison to commercially available electrolytes, both the commercial
electrolyte and the bio ionic ink were coated on a glass slide. When illuminated with visible
light, the CNT and EMIBF4 electrolytes are opaque. Figure 17f improved optical
transparency of a hydrogel, and the conductivity of the bio ionic ink proffers a good
material for various bioelectronic applications. Especially hydrogels used in electronics
and physical interface must be conductive, highly adhesive, stretchable, and transparent for
the unified integration of electrophysiological recordings and other applications.
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Figure 17
Conductivity of the Bio Ionic Ink (BI)

Note. Nyquist plot (n ≥ 5) with (a) 7% GelMA (b) 10% GelMA (c) 15% GelMA with
varying percentage of BILs (0 – 6(w/v)) % to form various percentages of the Ink. (d)
Quantitative evaluation of the Nyquist plot to represent conductivity value in S/cm.
Comparing the optical transparency of BI7-4, GelMA and Electrolyte made up of CNT,
PVDF and EMIBF4 used as conductive materials in various applications (e) Microscopic
slide coated with the electrolyte and GelMA. Testing the optical transparency of material
by passing light through (f) CNT electrolyte (g) Flashlight passing through uncoated slide
(h) GelMA. Data are means ± SD. P values were determined by one-way ANOVA (*P <
0.05, **P < 0.01, ***P < 0.001)

5.3.4 Invitro Biocompatibility of the Bio Ionic Ink
Biocompatibility of the synthesized ink was estimated using live-dead staining of
fibroblast cells on the surface of Bio-ionic Ink indicating cell viability. Cell proliferation
on hydrogels was assessed through phalloidin and nuclei immunofluorescent staining. In
figure 18, indicates the viability on day 7 was 99%. Cells seeded on the surface demonstrate
comparable viability at day one post seeding. Furthermore, metabolic activity of the
primary cultures quantified by Presto Blue assay was shown to increase significantly
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throughout the culture. These results show the potential of bio-ionic ink to be used as a bio
ink that aids cell proliferation and adhesion.
The F-Actin/DAPI images of cells cultured on bio-ionic ink layer Figure 19a, 19c
stained with Phalloidin and DAPI show enhanced cell proliferation with a visible increase
in both the actin-cell membranes (green) and DAPI- cell nuclei (blue). At days 1, 4, and 7
post-seeding of cells, as cell cultures with the live cells represented green and dead cells
by red fluorescence, demonstrating an increase in the density of live cells and very little
change in the density of dead cells.
Further quantification of the cell proliferation, viability, metabolic activity based
on the number of DAPI-stained cell nuclei, percentage viability of live/dead images, and
Relative Fluorescence Units (RFU). Figure 18e, 18f, 18g, using Presto-Blue assay for both
the control experiment and the bio-ionic ink composition matrix, showed a significant
increase in live cells, indicating important cell viability and cytocompatibility little to no
difference compared to control. Biopolymers degrade via hydrolysis in aqueous media and
buffers to yield oligomers, monomers, and more minor moieties. Despite thermodynamic
favorability, the degradation rate is incumbent and reduced by folding and assembly.[149]
Given the imminent degradation of biopolymers, implant structures should be critically
designed by incorporation of structural moieties which will metabolize to non-toxic
byproducts. A case in point is poly (β-amino ester) (PBAE), a gene delivery polymer,
which upon degradation, causes little cytotoxicity due to benign products of
hydrolysis.[150]
The cytotoxic mechanism is understood via necrosis and organelle damage rather
than apoptosis.[151] Polycations are also thought to induce phospholipid hydrolysis,
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causing elastic stress on the membrane by interaction with the cell membrane creating an
inversion in the bilayer, causing separation of lyso-phospholipids.[152] The molecular
weight of the polycation influences cell membrane lysis. Cytotoxicity is thus incumbent on
a tradeoff between membrane hydrolysis and the intrinsic cellular repair system. The
material remains cyto-compatible if the repair can counterbalance membrane lysis, with
mitochondrial activity powering the repair.[153] Biocompatibility is influenced by the
molecular weight, charge density of polymer chains. Higher charge density causes greater
cellular transfection and higher cytotoxicity. Rigid polymers interact less with cell
membranes causing lower cytotoxicity and polymer with excessive cationic charge
densities cause increased cytotoxicity. [154-157] In the GelMA and GelMA-BIL conjugate
bio-ink structure, the charge density due to BIL conjugation has been kept at low levels.
The gelatin backbone in GelMA, and the methacrylate coupled choline moiety, also limit
conformational flexibility to prevent excess transfection type interactions. This is
augmented by a light cross-linking to form a network, which balances out mechanical
strength with an adequate increase in chain conformational rigidity due to reduced degrees
of freedom, proffering advantage in enabling low cytotoxicity. [158-160]
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Figure 18
Invitro Biocompatibility of BI7-4

Note. Representative (a,c) F-Actin/DAPI fluorescent images and (b,d) Live/Dead images
at days 1, 4 and 7 post seeding of C2C12. (e) Quantification of cell proliferation based on
DAPI-stained cell nuclei (f) Quantification of cell viability of live/dead images (g)
Quantification of metabolic activity, Relative fluorescence units (RFU), using PrestoBlue
assay. Scale Bar = 200µm. Data are means ± SD. P values were determined by one-way
ANOVA (***P < 0.001)

5.3.5 3D Printing of Scaffolds from Bio Ionic Ink and Evaluation of the Biocompatibility
of the Printed Scaffolds
Scaffold fabrication depending on the application is fundamental challenges. 3D
printing is a robust tool for fabricating biomaterials. 3D printing of cell laden structures
using BI7-4 is shown in Figure 19. Digital image of printing bio-ionic ink using ALLEVI
2 printer is shown in Figure 19a. The Bio-ionic ink (BI7-4) can be easily printed into any
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shape or lettering, permitting fine details. The Live/Dead staining of cells encapsulated in
the 3D printed structure is shown in Figure 19 b,c. The cells are encapsulated in GelMA
and visualized in 3D, live cells are depicted in green, and dead cells in red. F-actin/DAPI
staining of the cells encapsulated in the 3D printed structure was carried out as shown in
Figure 19 d,e, actin filaments are stained green, and nucleus are stained in blue
fluorescence. Figure 20n compares the aspect ratio of the cells printed and cultured in 2D.
The aspect ratio is the ratio of the total length to average breadth. In a 2-D culture, the cells
are scattered on top of each other and randomly oriented. When encapsulated and 3D
printed, the cells align, which can be an advantageous feature depending on the intended
application.
Biocompatibility and cell viability comparison between scaffolds printed using 7%
GelMA Figure 19 f, g, h, and BI7-4 Figure 19 i, j, k after culturing for seven days is shown.
In this 3D visualization, the bio-ionic ink with 4% BIL conjugation is like unfunctionalized
GelMA for cell viability and adhesion, underscoring the absence of any adverse effect of
the BIL conjugation. Cell adhesion to various conducting polymers has been known to be
electrically controllable, especially where there are biomolecules that may be differentially
oriented or diffuse. Electrical control is achieved upon the accessibility of surface ligand
to cellular receptors or general protein recognition.[161] The proteins, integrins that are
responsible for the cellular adhesion of cells to a matrix are held to the cellular cytoskeleton
by a Focal Adhesion (FA) complex. Force transmission to the cellular cytoskeleton occurs
via the FA proteins connecting the integrins to cellular actin filaments forming an adhesion
complex. FA formation is critical to cell signaling, migration, proliferation, and
differentiation and hence of utmost importance for tissue engineering applications.[162]
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Figure 19
3D Printing of Cell Laden Constructs Using BI7-4

Note. (a) Digital image of printing bio-ionic ink using ALLEVI 2 printer (b,c) Live/Dead
and (d,e) Actin/DAPI staining of the C2C12 cells encapsulated in the 3D printed structure,
living cells are depicted in green and dead cells are in red. Live/Dead staining of MSCs
Cell and comparison between scaffolds printed using (f-h) 7% GelMA, and (i-k) BI7-4
after culturing for 7 days. Scale Bar = 200µm (l) Digital image and (m) Actin/DAPI
staining of printing MSCs encapsulated bio-ionic ink (n) Comparing aspect ratio of the
MSC’s 3D printed and cultured in 2D. Data are means ± SD. (o) Rheology of GelMA and
BI7-4 with 0.5% LAP as a photo initiator at 60 s visible light exposure. (p, q) Digital image
of printing of solid block, 2,4 and multi-layer lattice bio-ionic ink using Allevi 2 printer,
Scale Bar = 1mm. P values were determined by one-way ANOVA (*P < 0.05, **P < 0.01,
***P < 0.001)
Cells are charged spheres capable of attaching to conventional insulating substrates
through simple electrostatic interactions, wherein the countercharges developed on the
insulating substrate surface cannot be lost to conduction.[163] These counter substrate
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surface charges on metallic substrates are not stable, and cells cannot stick on highly
conducting metal surfaces under ordinary conditions. Thus, the cellular force of adhesion
to an insulating surface is more significant than that for metals. The cellular adhesive
strength can only become greater by cellular deformation leading to a large contact area.
Under such circumstances, the FA complex formation and maturation pathway remain
inactive in favor of the alteration of the cellular shape. This lack of maturation of FA
complexes causes a significant decrease in cell proliferation.[164] The GelMA-BIL based
bio-ionic ink composition can show electrolytic conductivity and a capacitive ability due
to the BIL functionalization, which maintains its conductive advantage as a matrix,
especially for cardiac tissue culture, while allowing for the culture of cardiac tissue cellular
adhesion and proliferation.
Figure 19 o shows the Rheology of GelMA and BI7-4. Since the bio ionic ink is
photo-crosslinked, a quasi-solid state viscoelastic behavior is expected, which is
represented by the storage modulus (G') and loss modulus (G"), the former representing
solid-state behavior of bio ionic ink while the latter representing the liquid-state part of the
sample occurring from internal friction while the material flows. A large storage modulus
leads to hysteresis losses in the form of heat dissipation during the shear deforming 3D
printing process, especially with cells included. The heat dissipation works to the imminent
disadvantage of the sample in the given tissue engineering application as it may adversely
interact with cellular proteins deforming them, impeding cellular adhesion and
proliferation.[165] The elastic portion remains stored in the deformed material as potential
energy, arising from the stretching of the internal substructures, that may be achieved
without bond breakage and works to impart resilience.[166]
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The storage modulus is seen for both the control unfunctionalized GelMA and for
the bio-ionic ink BI7-4 to rise with an increase in step time. However, the bio-ionic ink
composition increase is way more rapid beyond a step-time input of about 250, and this
may be attributed to structure formation owing to much higher inter and intramolecular
electrostatic interactions acting as physical crosslinks at a more rapid pace of deformation.
At a lower deformation rate, time is accorded to the sample to flow and hence the absence
of structure formation, rigidity, and a high storage modulus at low rates of deformation. It
also displays the deviation of the loss modulus with the rate of deformation. Tan Delta, the
ratio of the loss modulus to storage modulus is much lower than 1, indicating the
predominantly elastic nature of the crosslinked polymers, which works to advantage in
tissue engineering, especially those involved in dynamic environments.
Further, to show the printing fidelity, lattice constructs were printed up to 16 layers
by optimizing the speed and pressure figures 19p and 19q. The 16-layer 3D printing of bio
ionic ink was achieved using a Carbopol support bath, which provided structural integrity
to the printed constructs. As anticipated, the printed construct was stable after the
crosslinking. The composition of GelMA and BIL forms bio-ionic ink that is conductive
and adhesive hydrogel matrix and is 3D printed using an extrusion-based ALLEVI
bioprinter. After printing, the structures were measured for conductivity and acquiring the
cell-laden hydrogel structures via encapsulation of the mesenchymal stem cells. The
orientation and shapes of the biostructure can be varied based on the composition of the
polymer, BIL, air pressure, and other parameters in the printer; thus, it can be manipulated
for any application necessary. To use the bio-ionic ink as an adhesive and conductive patch
in vivo application, the interaction between the bio ionic ink and tissue is vital. Despite the
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availability of wearable epidermal bioelectronic devices that have been commercialized
and are in usage, there is a need for a transparent, soft, and flexible material that is on par
with the epidermal layer of the skin.[167]
5.3.6 Exvivo and Invivo 3D Printing of Bio Ionic Ink and Evaluation of Conductivity
To study the printability and shape fidelity of the bio ionic ink, we performed in
vivo and ex vivo studies. The exemplary implementation of a bio-ink as an interface
between biological systems and electronics must exhibit superior performance without
undergoing any significant deformation during the printing process. Figure 20 shows the
3D Printing of different shapes of BI7-4 on the epidermal layer of the porcine skin showing
the ability of the Bio-ionic ink to integrate with the tissue. Figure 20a shows the digital
image of printing bio-ionic ink using ALLEVI 2 printer in different shapes. In Figure 20b,
the polymerized BI7-4 construct is shown to be firmly attached to the skin substantiating
the adhesive property of the ink. Transparency of the Bio-ionic Ink coated on microscope
slide illuminated using a flashlight is shown in Figure 20c, indicating no significant
changes in the transparency of the ink due to the addition of the BIL compared to GelMA
in Figure 17. To verify the conductive property of bio-ionic ink, the printed BI7-4 is
connected to the breadboard setup with an input voltage of 5V. When connected to the
specimen, it acts as a circuit and thus illuminating the LED at 1V power source, and Figure
S3 shows the LED at various voltages. Finally, successful demonstration of 3D Printing of
a conductive and adhesive bio-ionic ink was attainable.
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Figure 20
3D Printing of BI7-4 on Porcine Skin

Note. (a) Digital image of printing bio-ionic ink using ALLEVI 2 printer in different shapes
(b) Digital image showing the adherence and bending of the printed ink on the skin. (c)
Transparency of the Bio-ionic Ink coated on microscope slide illuminated using flashlight
(d) Transparency (%T) of 7% GelMA, and BI7-4 calculated from absorbance at
wavelength 380nm using a spectrophotometer (e) Digital image to show the printed BI7-4
illuminating the LED at 1V power source. In vivo electrical stimulation of TA muscle and
3D printing of Bio-ionic Ink, representing digital images of (f) 3D printing of Bio ionic Ink
on the back of wistar rat, indicating various shapes. (g-h) Incision in the hind muscle,
incorporation of standard platinum electrodes with 10 mm separation, 3D printing of Bioionic Ink in the 5mm separation space, inducing voltage across the electrodes. (i,j)
Quantification of the displacement of TA muscle during electrical stimulation at two
different voltages, 0.9 v and 2.5 v, along with the displacement of muscle without the BI
and only Pt electrode (control) and with the BI. Scale Bar = 800µm. P values were
determined by one-way ANOVA (*P < 0.05, **P < 0.01, ****P < 0.001), ns – nonsignificant

Similarly, figure 20f indicates the ability of the Bio ionic ink to be used as
conductive ink for actuation via in vivo electrical stimulation. It demonstrates the ability of
the Bio-ionic ink to integrate with the tissue. The in vivo electrical stimulation experiment
was shown to establish the ability of the bio-ink to integrate and use as an interface with
soft tissue. Platinum (Pt) electrodes were used, the tibialis anterior (TA) muscle was
exposed surgically after fixing the knee of the Wistar rat for electrical stimulation. The bio
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ionic ink was then printed on the exposed muscle across the Pt electrode. The TA muscle
was electrically stimulated at 0.9 and 2.5 V voltage to measure twitch displacement. The
displacement of the TA muscle was significantly higher when the electrode interface was
connected by 3D printed bio ionic ink compared to control. The displacement increased
from 3.95 mm at a stimulation voltage of 0.9 V to 6.5 mm with stimulation voltages of 2.5
V (Figure 20 i,j). These data denote that the conductivity of the bio ionic ink can be
harnessed and manipulated according to the application, which may be beneficial in the
clinical application where conductive hydrogels are desired. Also, we were able to
demonstrate the bio-ink ability to print on the skin, and it is essential to note that bio ionic
ink can be used as a smart material for flexible electronics due to its tunable functionalities
and versatile design. These data suggest that bio ionic ink can be a potential solution for
the current challenges and limitations of in situ 3D printing electrically conductive
hydrogels.
5.3.7 Invivo Biocompatibility and Degradation of the Bio Ionic Ink
Invivo biocompatibility and degradation of bio-ionic ink was assessed via
subcutaneous implantation of fabricated structures into rat models. The implanted samples
were explanted on given time points of 4, 14, and 28, days for further experiments.
Hematoxylin and eosin staining was used to under the degradation pattern and
morphological changes which indicate the hydrogel presence until day 4, and no substantial
host inflammatory response indicating that the bio-ionic ink may not have caused any
adverse inflammatory reactions. Fluorescent immune-histological staining, CD68 was used
to understand the inflammatory response. Infiltration of macrophages was observed on day
four but not on day 28 via CD68 staining. Figure 21 shows the in vivo biocompatibility of
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GelMA and Bio-ionic ink (BI7-4). Figure 21 a, c shows the representative H&E staining
Fluorescent immunohistochemical analysis. The macrophage (CD68) staining of bio-ionic
ink explanted with surrounding tissue after 4,14, and 28 days are shown in Figure 21 b, d.
The process stains the collagen and displays no infiltration of macrophages, with no
significant changes observed in the color intensities. In Figure 21 b, the reduction in the
spread of the red fluorescence with time emphasizes the nonappearance of inflammation,
with the CD68 expected to stain the macrophages red.
This result indicated that the bio-ionic ink was competently degraded in vivo via
enzymatic hydrolysis of the matrix. Explanted samples were inspected to analyze the
significant infiltration host tissue infiltration within the implanted sample. Due to the short
length of the study, widespread degradation was not observed. Thus, indicating that the
degradation of the bio-ionic ink in vivo can be a parameter that can be adjusted based on
the application. The BIL conjugated GelMA, upon administration in vivo, may be thought
of interacting with plasma proteins and other cell types, resulting in aggregation or
dissociation. In addition, the interactions with cell membranes, extracellular matrix, and
proteins leading to adverse effects.[168]
The tangibility of tissue engineering is the in vivo implantation of the scaffold or
the scaffold cultured with host cells, allowing the ghost body to act as a bioreactor and
continue with reconstruction of the targeted tissue.[169] The scaffold must be
biodegradable, compatible, and resistant to inflammation or immune attack, in addition to
mechanical integrity.[170] The primary limitation of scaffolds made from synthetic
polymer is the absence of biological markers or biomimetic cues that help promote cellular
adhesion. Inadequacy of synthetic polymers is that it lacks biological signals that promote
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cell proliferation. Thus, studies have made attempts to incorporate functionalization and
modifications on both natural and synthetic polymer to improve their biological
recognition. Additionally, there have been studies on the effect of biomimetic surface
marking on scaffolds for tissue engineering.[171] Choline has been studied as a possible
functional group, given the concept of incorporating a recognizable biomarker or a
biomimetic function on polymers. The choline cation as a part of a BIL function is
biodegradable and has low cytotoxicity.[172] Choline, a B vitamin, is available from
natural sources. Choline is known for its function in muscle control and as a precursor to
the acetylcholine neurotransmitter. The choline cation is also mimetic cell membrane
phospholipids.[173] The GelMA structure's functionalization with choline provides it with
a bio recognizable and a bio-mimetic marker or a signal to make it resistant to
inflammation. While at the same time making it conducive to cellular attachment, adhesion,
and proliferation, and the results are reflected in the in vivo studies in Figure 21 c, d.
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Figure 21
Invivo Biocompatibility of GelMA and BI7-4

Note. Representative (a,c) H&E staining Fluorescent Immunohistochemical analysis, (b,d)
Macrophage marker (CD68) of bio-ionic ink explanted with surrounding tissue after (i) 4,
(ii) 14, and (iii) 28 days of implantation , counterstained with nuclei (DAPI). Scale Bar =
200µm
5.4 Conclusion
Here, we have shown the synthesis of a novel in-situ 3D printable bio-ionic ink
composed of GelMA and acrylate BILs conjugated using visible light photo crosslinking.
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The synthesis establishes a general material platform that can be applied to a wide variety
of biopolymers and BILs to obtain printable bio-inks with a wide variety of biomimetic
properties that can aid in cell growth and proliferation act as an electroconductive tissue
scaffold. We demonstrated that physio-mechanical properties and electrical conductivity
of the bio-ionic ink could be enhanced and tailored to suit the requirements of biomedical
and bioelectronic applications by varying the BIL content in the bio-hydrogel backbone.
The printability of the resultant biomaterials was shown by rheological analysis and
structural details in printed constructs. The composite bio-ink was processed into
multilayer scaffolds via 3D printing and visible light crosslinking. Furthermore, cell growth
and viability tests demonstrate virtuous biocompatibility of the bio-ink, allowing cell
proliferation. Functionalization of the biopolymer backbone with the BIL was also shown
to improve cellular adhesion and reduce potential fouling. The versatility of the polymer
backbone chemistry, its processing conditions, and the type and content of BILs
functionalization proffer a generalized platform to produce biomaterial. The material
mimics the extracellular matrix for developing multifunctional electrically conductive
biomaterial that can be 3D printed in-situ and used as a tissue scaffold in expansive vistas
of bioelectronic applications.
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Chapter 6
In Situ 3D Printing of Implantable Energy Storage Devices

The increasing demand for wearable and biocompatible electronic devices requires
novel innovations in the design and fabrication of bioelectronics with microscale
resolution. Rapid, in situ 3D printing of implantable bioelectronic devices can address this
need. However, in situ 3D printing of bioelectronics using currently available materials has
remained challenging due to their suboptimal physicochemical properties. Here, we present
a novel material platform based on BILs functionalized biopolymers which can form a
hydrogel electrolyte when exposed to visible light. Fine-structure, interdigitated,
biocompatible, and implantable micro-supercapacitors (MSCs) were created by 3D in situ
bioprinting of these polymer electrolytes in combination with rheologically optimized
graphene hydrogel-laponite blend as electrode material. The hydrogel electrolyte had a
specific capacitance of ~200 F/g, while the MSC had a specific capacitance of ~16 μF/g at
a current density of 1 A/g, volumetric capacitance of ~44 μF/cm3, cyclic stability up to
10,000 cycles, energy densities nearly as high as implantable batteries, and a power density
level of implantable supercapacitors. This novel material platform enables in situ 3D
printing of flexible implants composed of complex bioelectronic structures with integrated
life-long power source.
6.1 Introduction
Advancements in materials and fabrication technology have enabled the fabrication
of stretchable electronic devices and sensors, which has allowed for the integration of
wearable bioelectronics devices with living tissue[174]. Current techniques have largely
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focused on bypassing restrictions imposed by thermal and mechanical considerations of
traditional microfabrication[175]. Despite the development in additive manufacturing, it
has remained challenging to 3D print functional devices with intricate structural details on
undulating surfaces (e.g., natural living tissues), which has hindered the integration of 3D
printed bioelectronics with biological systems[176]. Such integrative processes will require
closed-loop scan-and-print procedures as well as the development of bio-inks with
processability under conditions conducive to cellular growth and bodily acceptance[177].
Furthermore, a biocompatible, lightweight, and durable energy source is imperative for the
development of miniaturized implantable bioelectronics for advanced personalized
healthcare applications[178].
Biocompatible micro-supercapacitors (MSCs) with high-power density, and a fast
charge-discharge rate are ideally suited for applications to power implantable
microelectronics[179]. Traditional batteries are larger in size and can potentially leak
highly toxic fluids into surrounding tissues. Moreover, weak energy autonomy and costly
maintenance make batteries impractical for implantable devices[180]. To capitalize on the
potential of MSCs, novel materials and engineering designs for in situ 3D printed
implantable energy storage devices are vital. Specially, such materials will need to combine
high energy density, strength to weight ratio, and biocompatibility, and allow for scalable,
rapid, and complex miniature fabrication[181]. Electrochemically active 3D printable
material platforms are also expected to be of value to additional fields such as regenerative
medicine by advancing the engineering of electrically conductive cardiac or neural
tissues[182]. To resolve this challenge, we introduce a new biocompatible electrolyte
material platform based on the functionalization of cross linkable polymers with bio-ionic
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liquid (BIL), which offers novels materials with highly relevant physio-mechanical,
cytocompatibility, and energy storage properties. Here, choline based BIL was used to
showcase and functionalize polymeric backbones of two biocompatible polymers – one
natural and one synthetic – with resultant enhancement in the physical and capacitive
properties of the polymers.
The resultant electrochemical properties and energy densities were very close to
those of batteries while achieving power density of mid-range supercapacitors, which
underlining its potential applications as ionic gel electrolyte. The robust rheo-mechanical
and biocompatible properties of the electrolyte material platform enabled the
straightforward 3D bioprinting of tailored complex structures, allowing for the rapid
prototyping of bio-implantable electronics including MSCs. In addition to the electrolyte,
we also designed and optimized electrochemical and rheological properties of graphene
hydrogel-Laponite (GH-L) composite, which was used as a 3D printable material to create
electrodes[183-185]. A multi material construct composed of BIL functionalized polymers
and GH-L was 3D printed into interdigitated MSC prototype structures with excellent
electro-mechanical and energy storage properties. Subcutaneous implantations were
performed to investigate the 3D printed MSC biocompatibility and in-vivo integration. Our
work demonstrates the possibility of using the BIL functionalized polymer as a tailorable
and robust electrolyte material platform for scalable in situ 3D printing of implantable
energy storage devices that can potentially be utilized as biomedical devices and implants
for healthcare applications.
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6.2 Materials and Methods
6.2.1 Polymer Electrolyte and Electrode Synthesis
The synthesis of the polymer electrolyte entailed mixing the methacrylate polymer
and choline acrylate, BILs in various ratios. Choline bitartrate and acrylic acid were
reacted, at 50°C for a duration of 5hr, in a 1:1 mole ratio, to obtain the BIL, which was
washed using ethyl acetate and dried by rotary evaporation and freeze drying to make the
choline acrylate BIL. The BIL was grafted on gelatin methacryloyl (GelMA) and
polyethylene glycol diacrylate (PEGDA) polymers. GelMA was synthesized in reference
to a previously described method. Gelatin solution of 10% (w v-1) concentration and 8 mL
of methacrylic anhydride were reacted for 3 h. The unreacted anhydride was dialyzing out
for 5 days and the resultant product frozen at −80 °C freezer for 24 h. This was followed
by freeze-drying the frozen acrylated polymer for 7 days. PEGDA was obtained from
Sigma Aldrich (average Mn 700). The Bio Ionic polymer electrolyte series BG and BP were
made by using 20% (w v-1) solution of prepolymer in distilled water to which varying BIL
at a 0, 5 10, 15 and 20% (w v-1) concentration were added along with 0.5% (w v-1) of
Lithium phenyl-2,4,6-trimethylbenzoylphosphinate (LAP) as a photo initiator and visible
light 405 nm for 60 secs.
The electrode is fabricated using reduced graphene oxide synthesized by previously
described methods[186]. Briefly, a 9:1 mixture of concentrated H2SO4/H3PO4 (360:40 mL)
was added to a mixture of 3.0 grams of graphite flakes and 18 grams of KMnO4 the reaction
was then heated to 50 °C and stirred for 12 h. The reaction was cooled to room temperature
and poured onto ice (400 mL) with 3ml of 30% hydrogen peroxide. For workup, the
mixture was sifted through a 300-micrometer metal U.S. Standard testing sieve and then
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filtered through polyester fiber. The filtrate was centrifuged (4000 rpm for 4 h), and the
supernatant was decanted away. The remaining solid material was then washed in
succession with 200 mL of water, 200 mL of 30% HCl, and 200 mL of ethanol, obtained
solid was vacuum dried overnight at room temperature forming graphene oxide. Further,
the graphene hydrogel was prepared using a modified hydrothermal reduction
method[187]. Briefly, 0.3 mL of 2 M ascorbic acid aqueous solution was added into 6 mL
of 4 mg/mL GO aqueous dispersion, and the mixture was sealed in a Teflon-lined autoclave
and maintained at 180 C for 2 h. The autoclave was naturally cooled to room temperature,
and graphene hydrogel was taken out with a tweezer and immersed in 1 M H2SO4 aqueous
solution overnight for the following experiments.
6.2.2 1HNMR Analysis of Electrolyte
The 1H NMR was carried out on a Varian Inova-500 spectrometer. Spectra of
choline bitartrate, choline acrylate (BIL), GelMA prepolymer, and Gel electrolytes were
recorded. Peaks at δ = 5.3 and 5.7 ppm indicated methacrylate groups. The reduction in
C=C double bond signal strength (−∂(C=C) ∂t) of the GelMA methacrylate indicated the
crosslinking extent of composite hydrogel and BIL-GelMA conjugation. The decrease in
area was imputed as follows:

𝐷𝑒𝑐𝑎𝑦 𝑜𝑓 𝑀𝑒𝑡ℎ𝑦𝑙 𝑔𝑟𝑜𝑢𝑝 % = 3

)*+ $)*,
)*+

4 𝑋 100

(7)

PAb and PAa represent the areas of methacrylate group peak before and post photo
crosslinking, respectively. PAb - PAa represents the methacrylate groups that were
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consumed by photo crosslinking. NMR analysis software integrated area under the peaks.
The data was analyzed vis-a-vis phenyl peaks at δ = 6.5–7.5 ppm.
6.2.3 Mechanical Characterization of Electrolyte
The elastic and compressive moduli of the gel electrolyte, of various compositions,
were measured and analyzed. The hydrogel specimens were made using PDMS molds,
designed for tensile tests. For compression tests, cylindrical hydrogels of 5.5 mm diameter
and 4 mm height were molded. Before testing, the hydrogels were put in DPBS and swelled
for 2 hours at 37 °C, and 5 samples were tested for each condition.
For compression tests entailed the cylindrical specimens were compressed at a rate
of 1 mm min-1 between compression plates, while the compressive strain and the stress
were recorded. Compression modulus was computed form the initial tangential slope
between strain values of 0 mm mm-1 and 0.1 mm mm-1. Tensile testing employed hydrogel
samples, clenched between tensile grips, were stretched at 1 mm min-1 unto failure point.
The elastic modulus was similarly computed for the initial slow of the stress-strain curve.
Each data point consisted of the test results from at least 5 samples.
6.2.4 Invitro Degradation Study on Electrolyte
For the degradation tests, the electrolyte sample were fabricated as per previously
described methods for compression tests, followed by freeze-drying. The weighed samples
were dipped in 1ml DPBS in 24 well plates at 37 °C for 2 weeks, refreshing the buffer
solution every three days. The buffer solution was removed after 1, 7, and 14 days, samples
freeze-dried for 24 h and weighed.
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6.2.5 Evaluation of Swelling Ratio of Electrolyte
To evaluate the equilibrium swelling of electrolytes, cylinder-shaped specimens
were prepared as described above and washed thrice with DPBS, lyophilized, and weighed
under dry conditions. The test specimens were immersed in DPBS at 37 °C. They were
weighed at 4, 8 and 24 hours after immersion. The water uptake and swelling ratio were
computed as the ratio of the masses of the swelled and lyophilized samples.
6.2.6 SEM Analysis
The porosity of the electrolytes was evaluated by SEM. The samples were prepared
like described in mechanical tests. The freeze-dried samples were coated with gold before
imaging, where the images were acquired by Phenom. The pore size of the electrolytes was
measured from at least 3-4 images using ImageJ software.
6.2.7 Electrochemical Measurements of Electrolyte and Electrode
Electrochemical properties of the electrolytes, electrode and MSC were measured
by cyclic voltammetry (CV), galvanostatic charge/discharge, and impedance spectroscopy.
The instrument used was a CHI 660 potentiostat from CH Instruments, Inc., a threeelectrode system was used for the measurements. The CV and galvanostatic
charge/discharge tests were carried out between 0–1 V. EIS was carried out between a 105–
0.05 Hz frequency range with an open circuit potential amplitude of 10 mV and varying
scan rate from 10 - 200 mV sec-1. Mass-specific capacitance (C) was computed as follows:
-.(

𝐶 = E/.0F

(8)

I is the constant discharge current, Δt, the discharging time, m, the mass of one
electrode, and ΔV is the voltage drop upon discharging (excluding the IR drop). The
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Ragone plot was used to compute Energy and power densities (E & P, respectively) using
equation 3:

1

𝐸 = E2F 𝐶 𝛥𝑉 3

(9)

4

𝑃 = .(

(10)

6.2.8 Invitro Biocompatibility of the Electrolyte
C2C12 at a cell density of 2× 104cells scaffold-1 were seeded on the electrolyte
surface and fabricated device surface. These were placed in 24-well plates with 500 μl of
DMEM mixed with 10% fetal bovine serum as growth medium. The 2D cultures were kept
for 7 days at 37 °C and 5% CO2 humidified atmosphere. The medium was changed every
48 h. The viability of primary C2C12 growth on electrolyte and fabricated device surfaces
were evaluated by a commercial Invitrogen live/dead viability kit. Tests were carried out
as per manufacturer’s instructions. Staining was done with 0.5 μl ml-1 calcein AM and 2 μl
ml-1 ethidium homodimer-1 (EthD-1) in DPBS for 15 min at 37 °C. The fluorescent images
were taken on 1st, 4th, and 7th day after seeding. The AxioObserver Z1 inverted
microscope from Zeiss was employed for imaging. While viable cells were green,
apoptotic, or dead cells appeared red. Their numbers were estimated using ImageJ. The
number ratio of live cells to the total of live and dead cells was designated as the cell
viability ratio.
The metabolic cellular activity was evaluated at 1,4 and 7 days after seeding, by a
Presto Blue fluorescence assay from Life Technologies as per manufacturer’s instructions.
2D culture of C2C12 was incubated in 400 μL of 10% Presto Blue reagent for 2 h at 37 °C.
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The measurements were carried out at 560 nm (excitation) and 590 nm (emission), using a
SpectraMax. The background was determined using control wells without cells.
The surface spreading was visualized using fluorescent staining of F-actin filaments
and cell nuclei. A 0.1% PBT, fresh fix solution containing 4% PFA in 0.1% PBT was
prepared. The staining solution consisted of DAPI and phalloidin in PBS at a 1:1000
dilution. The cells were removed from the media and dispensed into 150 µl well-1 of 1x
PBS, into each 12-well plate. The PBS was removed by shaking out. 150µl well-1 of fix
solution was dispenses and the cells fixed for 25 minutes. The fix solution was discarded
by shake out method. Around 200 µl well-1 of PBT was dispensed and incubated for 5
minutes. It was shaken out and the process repeated for a total of 3 washes. PBS was
removed by shake out method and to these 50 µl well-1 of 1x PBS was added to keep the
cells hydrated while imaging. Fluorescent images were obtained using Axio Observer Z1
inverted microscope.
6.2.9 Invivo Degradation and Compatibility
The animal experiments were approved by ICAUC (protocol 2018-004) at Rowan
SOM following regulations. The animals - Male Wistar rats (200–250 grams) were
procured Charles River (Boston, MA, USA) and housed under circadian rhythm conditions
in the local animal care facility. 4.0% isoflurane induction caused anesthesia, along with
2-2.5% maintenance, and 0.02 to 0.05 mg kg-1 SC buprenorphine administration. On the
posterior medic-dorsal skin eight 1-cm incisions were made. Lateral subcutaneous pockets
cut out by blunt dissection around the incisions. The fabricated MSC’s in the form of
5 × 5 mm disks were implanted in the pockets. The anatomical wound was closed, and the
animal allowed to recover from anesthesia. The animals were euthanized after 4,14 and 28
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days by anesthesia or exsanguination. The implanted samples and associated tissue were
recovered.
6.2.10 Histological Analysis and Immunofluorescent Staining
Explanted hydrogel samples were cryosection and histologically analyzed to
characterize inflammatory response. The samples were incubated at room temperature for
4 hours in 4% paraformaldehyde after explantation, then incubated overnight at 4 °C, in
30% sucrose. The samples were embedded in Optimal Cutting Temperature compound
(OCT). They embedded samples were flash frozen in liquid nitrogen and sectioned by a
Thermofisher Cryostat. The cryosections of 15-µm dimensions so obtained were mounted
in positively charged slides and stained with hematoxylin and eosin staining as per
manufacturer’s instructions. Immunofluorescent staining carried out on these cryosections
used where anti-CD68 as primary antibodies. They were detected by Alexa Fluor 594conjugated secondary antibody. Invitrogen’s DAPI was used to counterstain these sections.
They were imaged using AxioObserver Z1 microscope from Zeiss.
6.3 Results and Discussion
6.3.1 Synthesis and Chemical Characterization of Flexible Electrolyte
BIL functionalized hydrogel electrolyte was synthesized from Choline acrylate and
biocompatible polymer GelMA [188] or synthetic polymer PEGDA (average Mn 700)
reaction. Choline derivatives with low melting points have been used as ionic liquids.
Mixtures of choline and other salts yield viscous liquids that conducts at or around room
temperature[189]. Lecithin, found in plants and animals, constitutes Choline Bitartrate. It
is an acetylcholine precursor and acts as a methyl donor in lipid metabolism[190]. Choline
Bitartrate can be efficiently converted into Choline Acrylate Fig. 1, which we refer to as
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the BIL, BIL can be conjugated to GelMA and PEGDA. There is also a simultaneous
linking of GelMA-GelMA (or PEGDA-PEGDA) chains leading to an increase in molecular
weight and light crosslinking. BIL conjugation of the polymers was carried out by mixing
20% (w v-1) GelMA or 20% (v v-1) PEGDA with the BIL at a 0, 5 10, 15 and 20%(w v-1)
concentration at room temperature to form Bio Ionic GelMA (BG-0, BG-5, BG-10, BG15, BG-20) and Bio Ionic PEGDA (BP-0, BP-5, BP-10, BP-15, BP-20). The resulting
polymer/BIL was photo cross-linked into the electrolyte gel using LAP (Lithium phenyl2,4,6-trimethylbenzoylphosphinate) initiator, and visible blue light for 60 secs. Figure 25
depicts, schematically, the synthesis and fabrication of the electrolyte materials, and the
MSC structures-based BG and BP polymers. (Figure 22a) depicts the synthesis of Choline
Acrylate BILs, (Figure 22b) depicts the formation of BIL functionalized GelMA (BG),
PEGDA (BP) polymers. (Figure 22c) is a representation of the synthesis of Graphene
hydrogel-Laponite composite by physical mixing. (Figure 22d) schematically represents
the fabrication of 3D printed interdigitated micro-supercapacitor structure.
Structural analysis based on FTIR and 1H NMR confirmed the acrylation of the
choline bitartrate, this resulted in choline acrylate as well as successful conjugation of BIL
to the polymers The acrylate peak at 1720cm-1 in the IR spectrum confirms the choline
bitartrate was acrylated to form with choline acrylate. Further, the hydrogen atom in
acrylate group has been indicated at 5.8 – 6.3 ppm in 1H NMR substantiating the synthesis
of choline acrylate. In addition, BG was analyzed by 1H NMR analysis indicating the
disappearance of the methacrylamide group caused by crosslinking GelMA polymer chains
as well as conjugation of the BIL to the polymer. The characteristic peaks at ~5.7 ppm and
~6.1ppm indicated the conjugation of the polymer and BIL. This peak was absent in the
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non-BIL conjugated polymer. The sharp peak at δ~ 3.1–3.2 ppm that appeared in the
conjugated polymer, corresponds to the three cholinium (ammonium ion) hydrogen atoms,
further confirming BIL conjugation to the polymer.

Figure 22
Synthesis and Fabrication Schematics of BG-MSC and BP-MSC

Note. (a) Synthesis of Choline Acrylate BILs, (b) Bio-Ionic GelMA (BG), and Bio-Ionic
PEGDA (BP). (c) Synthesis of the Graphene hydrogel-Laponite composite by physical
mixing (GH-L). (d) Fabrication of micro-supercapacitor - BG or BP as electrolyte and GHL as electrode forming an interdigitated structure
Scanning electron microscopy (SEM) images revealed that GelMA and PEGDA
polymers were porous. The porosity varies with the concentration of the BIL in the polymer
which indicated that the polymer’s porosity can be tailored to control its global ion
transport.
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6.3.2 Physical and Mechanical Characterization of the Flexible Electrolyte
The swelling ratio and the degradation rates of the gel electrolytes were determined
(Figure 23 a-d). Polymer compositions, irrespective of BIL percent, exhibit a similar
pattern of water uptake, a rapid initial uptake leading to an equilibrium swelling level[191].
BG-0 exhibits the fastest rate of water uptake and maximum equilibrium swelling level.
The maximum swelling ratio of GelMA with 0% BIL, increases from 73.9%±2.5% at 1hr
to 159%±5% at 24hrs after incubation while for BG-20 they are 34.4%±3.4% at 1hr,
increasing to 50.7%±8.7% at 24hrs after incubation. Polymers with 5-20% BIL take up
water gradually. Water absorption by a polymer depends upon chain conformation and
overlapping correlation blob formation in semi-dilute solutions[192]. For BG-0, these
blobs open in water easily, allow more water until crosslinking prevents further physical
expansion and water uptake. With BIL functionalization, strong electrostatic interactions
ensue inside correlation blobs and between correlation blobs acting as physical
“crosslinks”, resisting polymer expansion. The density of crosslinking limits the final
extent of swelling. A similar trend was seen with BIL incorporated PEGDA.
Degradation studies were also carried out on the gels. BG-0 shows the degradation
of 7.3%±0.7% at day 1, increasing to 14%±1% on day 14. These values are 24%±0.8%
(day 1) and 32%±1.0% (day 14) for BG-20. With higher BIL content, the initial
degradation is greater but the rate of degradation with 0%BIL is greater than that with 20%
BIL for both GelMA and PEGDA. Hydrogel swelling plays a key part in degradation[193].
The quaternary ammonium head in choline may catalyze hydrolysis of the functionalities
in the GelMA and PEGDA backbone causing degradation.
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Figure 23
Invitro Swelling, Degradation, and Mechanical Properties of Gel Electrolyte Prepared by
Polymerization Using Photo initiator and Visible Light

Note. (a) Degradation of GelMA with varying BIL concentration (b) Degradation of
PEGDA with varying BIL concentration. (c) Swelling ratio of GelMA with varying BIL
concentration (d) Swelling ratio of PEGDA with varying BIL concentration. All In vitro
Degradation and Swelling measured with 20(w/v) % polymer solutions in DPBS (e)
Compression Modulus of BG Vs BIL concentration (f) Compression modulus of BP Vs
BIL concentration. (g) Elastic Modulus of BG Vs. BIL concentration (h) Elastic Modulus
of BP Vs. BIL concentration. Mechanical properties measured on 20(w/v) % polymer
solution in DPBS. Error bars indicate standard error of the means, asterisks mark
significance levels of p < 0.05 (*), p < 0.01 (**), and p < 0.001 (***)

The mechanical strength of hydrogel has a vital role in solid-state supercapacitors.
An increase in the BIL content from 0 to 5 (% w v-1) causes nearly 50% increase in
compressive modulus (Figure 23 e-h). The compressive modulus of BG-20 content is 8
times higher than unfunctionalized polymer BG-0. BG-0 has compression modulus of
12.8±1.5 kPa and a tensile modulus of 139±28 kPa, whereas in BG-20 they increase to
190±4 kPa and 455±5 kPa respectively. Similarly, BP-0 has compression and tensile
moduli of 8.64±1.18 kPa and 96.5±6.5 kPa whereas, with BP-20 the moduli increase to
74.5±3.0 kPa and 284.7±5.7 kPa respectively. Thus, mechanical properties can be
modulated with BIL concentrations to fabricate the device differently. The enhancements
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are due to increase in electrostatic interactions with BIL functionalization which tethers the
structure together, prevents uncoiling and chain slippage, slipping of chains leading to
enhanced moduli. The increase in compressive strength can be attributed to bulky choline
group’s attachment to the structure and an increase in the overall molecular weight.
The extent of BIL functionalization and hydrogel crosslinking density are expected
to bring about changes to fundamental physical properties of the gel electrolyte. This
swelling and diffusive properties affect the shape and size of ion migration channels[194],
which in turn are expected to influence electrochemical properties. Also, the electroactivity
of the polymer-based hydrogels is associated with electrode-electrolyte interfacial
transport, entailing ionic and electronic transport. Therefore, high porosity and interfacial
areas are expected to be beneficial to electrochemical processing efficiency.
6.3.3 Evaluation of Capacitance and Power Stability, Cyclic Voltammetry (CV) of Ink
Cyclic Voltammetry were performed at scan rates ranging from 10 to 200 mVs-1
for both BG-15 (Figure 24a) and BP-15 (Figure 24b). The CV profiles were measured at
different scan rates, using a voltage window of 1V, and employing GH-L as the working
electrode and Ag/AgCl as the reference electrode. The capacitance retention of BG-15 and
BP-15 was determined for up to 104 cycles (Figure 24 c, d) at a scan rate of 50mVs-1. The
Galvanostatic charge-discharge curve of GH-L as working electrode and PBS and BG-15,
BP-15 as well as BG-0 and BP-0 were determined at 0.1 A cm-3and this is depicted in
(Figure 24e). An increase of BIL concentration exhibits a well-defined discharge voltage
plateau of ~0.5–0.8V with a conductivity of 8.5×10-4 - 3.5×10-3 S m-1 in both the polymers.
Gel electrolyte was tested as an electrochemical capacitor, based on GH-L, synthesized as
electroactive material. Figure 24a and b indicates that the gel electrolyte BG-15 and BP-15
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exhibit a specific capacitance of 238 F g-1 and 262.90 F g-1 at a current density of 1 A g-1 in
a three-electrode system from the calculations. The discharge current had a linear
relationship with the scan rate at least up to 200 mVs-1. The Tafel plot of the control GH/PBS and those of the polymers BG-0, BG-15, BP-0, and BP-15 is shown in (Figure
24f) and discussed to understand the effect of BIL functionalization on the Faraday leakage
current. An ideal polarizable electrode exhibits large change in voltage for a small change
in current. Supercapacitors store large amounts of energy owing to thin double layer charge
between porous plates soaked in electrolyte[195]
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Figure 24
Electrochemical Performance of Electrolytes

Note. CV profile of (a) BG-15 and (b) BP-15 at different scan rates, voltage window 1V,
GH-L (Working electrode), Ag/AgCl (Reference electrode). Capacitance retention of (c)
BG-15 and (d) BP-15 for up to 10000 cycles. (e) Galvanostatic charge/discharge curve of
GH-L (working electrode) and PBS, BG and BP (with 0% and 15% BIL loadings), as
electrolyte at 0.1 A cm-3 (f) Tafel plot of BG and BP hydrogels
The porosity translates into a higher plate surface area conferring greater charge
storing ability which in turn increases the charge-discharge cycles, a property, essential in
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small electronics. The surface area and the pore size distribution of the graphene hydrogel
synthesized upkeeps the charge storage ability. The primary disadvantage of
supercapacitors is high leakage current causing self-discharge and energy dissipation over
charge-discharge cycles. Redox reactions at the electrode - electrolyte interface cause
electronic discharge through the double layer, known as the leakage current. This can be
reduced by using an insulating thin film on the electrode surface, but it decreases the
capacitance. The leakage current understood based on the galvanostatic charge discharge
cycles depends on the average redox potential of all possible faradaic reactions and the
applied voltage, the difference of which is the overpotential and relates to the Tafel
plot[196]. In figure 24f, the overpotential in significantly increased by BIL
functionalization, almost to the level of a liquid, ionized electrolyte, emphasizing reduced
leakage and enhanced storage efficiency with BIL functionalization.
Remarkably, the cycling performance of the electrolyte were obtained for 10,000
cycles. The electrolyte charged and discharged rapidly at a scan rate of 50 mVs-1 with the
maintenance of uniform capacitance indicating high instantaneous power. The ionic
conductivity increases from 8×10-4 ± 7×10-5 S m-1 to 15.3×10-3± 3.3×10-4 S m-1 with increase
of BIL concentration from 0 to 20 (w v-1) %. The graphene hydrogel, studied versus glassy
carbon electrode (GCE) as working electrode, showed improved electrochemical
performance with a nearly rectangular shaped CV, indicating a typical double-layer
capacitive behavior. The shape of CV curves in the scan rate range of 10 - 200 mV s-1
indicate rapid transport or high electrolyte ion polarization and efficient charge transport
on the electrode’s surface[197], and the shape is retained indicating its excellent
capacitance characteristics and reversibility in the experimental potential range. The
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absence of a sharp oxidation - reduction peak indicates that the electrolyte does not undergo
oxidation or reduction process within the applied potential range[198]. This could be in
part due to its complex and entangled polymeric structure, with the electrostatic
polarization being different in different regions throughout the sample, where a differential
continuum of hydration reigns over the structure. The reversibility of the specific
capacitance is also indicated in (Figure 24 c, d) which shows the specific capacitances over
10,000 cycles. The variation in the current density with voltage for BG structures vis-a-vis
BP structures pertains to the greater hydration and polarizability owing to the higher
hydrophilic and polar nature of GelMA compared to the PEGDA main chain. At lower
voltages, polarization causing the formation of the double layer prevents the current density
from building up, but at higher voltages with the greater extent of intrinsic polar groups in
the GelMA structure leads to higher current density in BG-15 than with BP-15 polymer at
the same applied potential despite having the same concentration of BIL. The volumetric
capacitance of BG-15 increases faster than BP-15 with scan rate.

Figure 25
Conductivity of the Polymer Electrolytes
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Note. (b) CV of BG (15% BIL) and BP (15% BIL) electrolyte (GH-L-working electrode,
Ag/AgCl-reference electrode, Scan rates-200 mV/s, Voltage window-1V. (c) Volumetric
capacitance BG-15 and BP-15 vs scan rate
The CV curves at different scan rates and specific capacitance versus scan rate
using GelMA and PEGDA with 0 to 20% BIL were determined. Lower scan rates aid
electrolyte ion diffusion providing them with enough time for interaction with the
electrode. Higher scan rates encourage surface accumulation. This is reflected for polymers
with 0-10% BIL concentration. The diffusing species are water and hydrated BIL counter
ions. The BIL pendant groups are thought to orient, towards the electrodes and provide for
tunneling or interfering in hydrated BIL counter ion passage and transport. An anomaly is
seen with an increase in the BIL from 15% to 20%, wherein the specific capacitance
reduces with a further increase in BIL concentration to 20%. With a significantly high BIL
concentration, a tight network due to electrostatic crosslinking is corroborated by swelling
experiments. This tight network reduces diffusivity of the free BIL counter ions decreasing
specific capacitance, volumetric capacitance at 200 mv s-1 is 294.17±2 F cm-3 and 113.45±1
F cm-3 for BG-15 and BP-15 respectively. The typical rectangular voltammogram of a
capacitor is obtained from relation of current being proportional to the rate of change in
voltage. However, hysteresis or memory in any process would result in an area enclosed
within the forward and backward sweep curves as an indication of electrochemical activity.
Capacitance can be explained through a Stern layer as the first, strongly adsorbed to the
electrode immobile layer of BIL counter ions. The diffuse layer, beyond this first compact
layer consists of ions under the influence of electrostatic forces and entropic diffusion and
its potential slowly decreases with distance from the Stern layer. For a BIL functionalized
polymer, the potential drop must consider the hydrated BIL ammonium which are oriented
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due to the application of potential. The representative electric circuit consists of electrode
resistance, the Stern layer and diffuse layer capacitances in series[199-201].

Figure 26
Cyclic Voltammetry of Polymer Electrolyte with Graphene Hydrogel as Working Electrode
at Different Scan Rate (10 – 200mV/s)

Note. (a) 20(w/v) % GelMA with varying concentration of BIL (0% -20%) (b) 20wt%
PEGDA with varying concentration of BIL (0% - 20%)

The cyclic voltammetry of Graphene hydrogel and GH-L at a scan rate of 100mV
s-1, figure 26. The inclusion of laponite is expected to cause a decrease in capacitance due
to the absence of solvated free ions that can account for the formation of the oriented Stern
and diffuse layers[202]. The charge - discharge profile of ideal capacitors is triangular. In
our case, the distortion from the ideal triangular shape could be due the build-up of pseudo
capacitance while charging or electrolytic degradation. The two super capacitor charge
storage mechanisms are electrostatic storage as the electrode surface double layer and
faradaic storage at the electrode surface as pseudo capacitance[203]. The thermodynamics
118

of the faradaic charge transfer dictates that, a potential dependent charge storage and
release occurs where the rate of charge storage versus applied voltage gives a measure of
capacitance[204]. This charge transfer relates to reversible surface electrode reactions. The
PBS electrolyte has the slowest rate of build-up of potential. As BIL% increases the rate
of charge build up slows. As pendant group polarization progresses it becomes difficult to
further polarize rationalizing the curved tip of the charging cycle. There is a nominal
difference in galvanostatic charge discharge cycles of uncross linked prepolymer liquid
and the crosslinked gel due to reduction in monomer segment and polymer chain mobility
experienced during the pendant group orientation and de-orientation. The charge discharge
cycles proffer an idea of the leakage current which depends on the average redox potential
of faradaic reactions. The difference of the summation of these potentials from the applied
voltage is the overpotential and this is indicated in the Tafel plots, as explained earlier[205].
The Tafel equation relates the faradaic reaction rate and leakage current with the applied
voltage. The faraday reaction rate is controlled by kinetics and ion diffusion[206]. The
overpotential at which this occurs comprises of the overpotentials for mass and charge
transfers redox reactions and adsorption-desorption processes. It is used to find the
exchange current as the intersection point between the cathodic and anodic slopes. It is
advisable to avoid charging supercapacitors to voltages beyond the nominal redox
overpotential to control the leakage[207]. However, energy density is proportional to
charging voltage, a reduction in which decreases the stored energy of supercapacitors. The
overpotential increases with BIL functionalization. This emphasized the enhancement in
energy storage with BIL functionalization brought about by reduced leakage current.
(Figure 28 b) shows the Ragone plot comparing the BG-15 and BP-15 with different energy
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storage devices. The generic data ranges for other devices has reproduced from
references[208]. In energy density BG-15 and BP-15 are towards the higher end of the
supercapacitor spectrum, nearly bordering that of batteries with values ranging between 3
to 33 Wh kg-1 and 11 to 36 Wh kg-1 for BG-15 and BP-15 respectively. In terms of power
density, they are in the mid-range of the super capacitor spectrum with values ranging
between 100 to 1200 W kg-1 for BG-15 400 to 1300 W kg-1 for BP-15. This implies that
the materials can store large amounts of energy in a small mass, a property useful in
miniature electronics applications. Both BG-15 and BP-15 exhibits exceptional energy and
power density than existing biocompatible energy storage devices [209].

Figure 27
Specific Capacitance of the Polymer Electrolyte with Graphene Hydrogel as Working
Electrode at Different Scan Rate (10 – 200mV/s)

Note. (a) 20(w/v) % GelMA electrolyte with varying concentration of BIL (0% -20%) (b)
20wt% PEGDA electrolyte with varying concentration of BIL (0% - 20%) (c) Cyclic
voltammetry of Graphene hydrogel and Laponite-Graphene hydrogel composite electrode
material at a scan rate of 100mV/s (d) Cyclic Voltammetry curve with a voltage window
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of 0.1V of BP and BP-alginate (e) Cyclic Voltammetry curve with a voltage window of
0.1V of the printed BP-MSC

To further evaluate electrical performance, the frequency response of the
supercapacitor with GH-L electrodes and BG-15, BP-15 electrolyte was analyzed by
electrical impedance spectroscopy (EIS). Nyquist plots from EIS of the polymer
electrolyte, with Glassy carbon electrode, at 0.1V, are shown in (Figure 29 a, b). The
Nyquist of 20 % (w v-1) GelMA with varying concentration of BIL, with the inset shows
the high-frequency regions is shown in (Figure 29a) while (Figure 29b) shows 20 % (v v1

) PEGDA with varying concentration of BIL. (Figure 29c) shows the Nyquist plot of BP-

15 and BP-15-alginate material between 0.05 Hz to 1 MHz frequency. The curve’s lower
left portion corresponds to the higher frequency. For impedance spectroscopy on polymer
electrolytes, the sample is considered as a parallel plate capacitor. An equivalent circuit
entails a double layer capacitance electrolyte/electrode, in series with a film resistance and
film capacitance in parallel with each other, which are in turn in series with a double layer
capacitance[59, 60].
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Figure 28
Galvanostatic Charge/Discharge Curve of BG (15% BIL) and BP (15% BIL) and Ragone
plot Comparing the Performance of BG-15 and BP-15

However, neither of the components are pure elements given the depression of the
semicircular region. The total impedance is related to oscillation frequencies for dipole and
dielectric relaxation relating to local motion of the charged BIL pendant groups along the
polymer chain. Permittivity and electric modulus, are related to the straight line on the
Nyquist plots, represented by diffusion and electric relaxation from non-local flow of ions
or solvent moieties[210]. The permittivity at very high frequencies, represents energy
storage without hysteric dissipation. At low frequencies, permittivity represents dielectric
loss which entails BIL group alignment, migration, polymer chain distortion, solvent
convection, and molecular vibration mediated energy dissipation. Supercapacitors are like
resistance and capacitance at high and low frequencies respectively[211]. It is like a
resistance-capacitance transmission line circuit in interim frequencies, affected by
electrode porosity, thickness and ion migration rates through the polymer hydrogel
network. This shifts the low-frequency behavior towards resistive values. The plot is quite
linear in this frequency range. The depressed semicircle in the high-frequency region
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represented by interface charge transfer resistance and a double layer capacitance in
parallel. The straight-line portion indicates Warburg impedance to local and global
diffusion of free, ions through the polymeric network. A short Warburg region is due to
increased ion diffusion[213].

Figure 29
EIS of the Polymer Electrolyte with Glassy Carbon Electrode at 0.1V, Nyquist plots

Note. Plots (a) 20wt% GelMA with varying concentration of BIL (inset shows the highfrequency regions) (b) 20wt% PEGDA with varying concentration of BIL (c) Nyquist plot
of BP and BP-alginate

6.3.4 Fabrication to Construct Flexible Energy Storage Device and In-Situ Printing
Polymer/BIL composite as electrolyte and GH-L composite as electrode has been
illustrated in (Figure 30). To form a miniature implantable device, the electrolyte and
electrode were 3D printed using ALLEVI 2, extrusion-based printing into different sized
interdigitating structures. Laponite is a synthetic clay with 30nm diameter and 1nm thick
disc-like particles[214]. The disks are negatively charged on the sides and on the edges,
positive charged. It is well established that laponite dispersions are used in producing
conductive, antistatic and barrier coatings[215]. Thus, the Laponite and graphene hydrogel
mixture is been used as electrode in order to be able to print[216]. The storage and loss
modulus of the mixture favors the printing. The interdigitating structure increases the
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interaction between the electrode and the electrolyte thus enhancing electrolytic process.
(Figure 30a) shows the additive printing process for the energy storage device. The mass
of the printed and air dried MSC is 26 mg (larger MSC) and 6 mg (smaller MSC). In both
the structures, the electrolyte polymer makes up 74% by mass of the MSC structure, and
the electrodes make up 26% of the MSC structure. (Figure 30 b, c) show the prints, of
various sizes, of BG-15 and BP-15 respectively. They illustrate the feature clarity that can
be attained with the chosen composition and method of printing at different sizes. (Figure
30 d) shows the variation of G’ of BG-15 and BP-15 versus the oscillatory step time. With
BG-15, the storage modulus (G’) increases sharply with an increase in the rate of
oscillatory stepping indicating the ability of the material to become stiffer with an increase
in the rate of mechanical deformation. The rate of increase of G’ for BG-0 is much slower.
This indicates the formation of short length stress structures using hydrostatic and polar /
electrostatic forces in the BG-0 structures, which due to orientation of the polymer chains
prevents further slippage of chains and hence a rapid increase in the elastic modulus.
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Figure 30
3D Printing of BG-15 Electrolyte and GH-L Electrode Through a 0.51mm Nozzle Using
ALLEVI2 Bioprinter

Note. (a) Image showing the printing process, additive printing of the energy storage device
(b) Prints at various size of BG-15 (c) Prints at various size of BP-15, (d) Rheology of BG15 and BP-15 (e) Cyclic Voltammetry curve with a voltage window of 0.1V of the printed
BG-15 supercapacitor with Ag/AgCl reference electrode (f) Specific capacitance of printed
device with varying interdigitation and size

BP-15, on the other hand, owing to the chain structure of PEGDA contains a lower
concentration of electrostatic forces tending to form the stress-oriented structure. Hence
the elastic modulus builds up slowly with the oscillatory strain applied. To be able to print
3 wt.% alginate was added to the BP-15 electrolyte, the CV curve of BP-15 and BP-15alginate reflects very similar values to that of the BG and BG-15. The cyclic voltammetry
of the printed BG MSC (Fig. 30 e, f), using 1V voltage window was performed to reveal
the specific capacitance of printed device with varying interdigitation and the specific
capacitance of the printed BP MSC with the current flow 3 orders of magnitude less than
that of the electrode material has been indicated. The general characteristic of the material
is reflected in the experimental values obtained with the printed design.
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The printing parameters depend on the rheological properties of GH-L. Laponite,
forms a thixotropic gel when dispersed in water. While the dynamic elastic modulus
increases slightly with 3 and 6% Laponite with oscillatory step time, the G’ as well as rate
of increase with 9% Laponite is much higher. There is a minimum concentration that is
needed to form a semi dilute overlapping region for the intercalated layers to interact and
bond to each other. The 3% and 6% solutions are way below that concentration. The G’ of
9% laponite with 1% Gelatin is much higher than that without gelatin which is due to the
polar -polar interaction between the laponite and gelatin structures. The rheological
properties of mixtures with varying percentage of graphene hydrogel with 9% Laponite,
the rheology of the final compositions of laponite and graphene hydrogel composite-9%
Laponite 7% Graphene hydrogel 1% Gelatin - chosen for printing. Also, 7% gelatin
increases the G’ of a 9% laponite dispersion, much more than 3% gelatin concentration.
Again, the inter and intra component interactions are enhanced multifold in semi dilute
regions while dilution beyond a certain level led to a sudden decrease in the mutual polar
and electrostatic interactions. The damping factor - tan delta, a ratio of G” / G’ is less than
1 and decreases with the step time. The material is more “Solid” or “Gel” than “liquid” or
“sol” and this tendency increases with increasing rates of deformation[217]. This is an
important factor in choosing the right parameters for printing and ensuring structural
integrity of the material in applications involving repetitive and oscillatory strains. In past
few years graphene has been produced by chemically reducing graphene oxide (GO) or by
graphene exfoliation or by chemical vapor deposition[218], and other common process for
GO reduction was by employing hydrazine or its hydrate as reductant[219]. However,
hydrazine’s toxic and explosive characteristics precludes its use in biocompatible device
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fabrication. Graphene aerogel has been synthesized using the non-toxic ascorbic acid as
reducing agent, L-Ascorbic acid (L-AA)[220]. The device can be fabricated into different
shapes and sizes thus making it versatile according to the need, the number of
interdigitations was varied to check the capacitance of the device. The specific capacitance
of the printed device with 5 interdigitations being 17.16± 0.83µF g-1 increases to 33.9 ±1.9
µF g-1 with the increase in the interdigitations as indicated in (Figure 33f). Thus, the
performance of the printed energy storage device depends on the size of the device. To
estimate the capacitance retention of the printed device in vivo, the device was explanted
after day 4 of implantation and capacitance was measured as 19.90 ± 0.20µF g-1 indicating
an increase in the capacitance 17.16±0.83µF g-1 before implanting.
To estimate the ability to integrate the printed device to in vivo applications, the
device was printed on porcine skin, both the electrode (9% Laponite 7% Graphene
hydrogel 1% Gelatin) and electrolyte (BG- 15) were 3D printed in various shape on
epidermal layer of the skin (Figure 34). For the first time, proof-of-concept has been
demonstrated utilizing a printable 3D biocompatible graphene-based energy storage device
that has been 3D printed on tissue. Additionally, this 3D printed device platform has been
analyzed towards its ability to illuminate an LED at 1V of input current and exhibit a steady
output (Figure 34 e, f). Previously, Zhao et al has shown the 3D printing periodic graphenebased composite hybrid aerogel micro lattices, similarly we count on this platform as the
basis of futuristic 3D printed energy storage device that can be used in many biomedical
and tissue engineering applications as a free-standing energy storage platform[221]. This
process of 3D printing of our device made up of BIL, directly on the epidermal layer
overcomes the limitation of current polymers electrolyte not being able to have enhanced
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adhesion. For further establishment of in situ 3D printing, the organ and body motion along
with the print head movement needs to be taken into consideration for optimal results,
previously researchers have demonstrated 3D printing of keratinocytes and fibroblasts in
stratified zones throughout the wound bed to fill a skin lesion. Also, advancements in
robotic bioprinters and robot-assisted surgery may also be integral to the evolution of this
technology in the future[222].

Figure 31
Printing of Energy Storage Device Through a 0.51mm Nozzle Using ALLEVI2 Bioprinter
on Porcine Skin

Note. (a) Image showing the printing process (b) BG-15 electrolyte (c) GH-L electrode (d)
Energy storage device (e) Breadboard setup to validate the conductivity of the printed
device (f) 3D-printed energy storage device connected to the 1V power source to illuminate
the LED

6.3.5 Invitro and Invivo Viability of the Flexible Electrolyte
To investigate the potential of BG-15 and BG-MSC to support the growth and
spreading in 2D cultures in vitro, the viability and metabolic activity of C2C12 cells
growing on the surface of the electrolyte and fabricated energy storage device was
determined over a culture period of 7 days (Figure 32a-g). Viability of seeded cells on
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electrolyte and MSC was not affected due to the presence of the BIL. Cells seeded on the
surface of BG-15 and BG-MSC appeared to exhibit 91.6%±1.44% and 91.8%±0.6%
survival rates, respectively, one day post-seeding. Furthermore, primary cultures increased
their metabolic activity consistently through the duration of the culture, during the day one
post seeding were 4467.3±18 RFU and 4624.02±44 RFU for BG-15 and BG-MSC
respectively which increased to 10450.25±414 RFU and 11545.14±596 RFU as shown
indicating the unaffected metabolic activity. In addition, electrolyte contained higher cell
numbers than the fabricated device at day 7 post-seeding, as seen by DAPI-stained cell
nuclei quantification.

Figure 32
Invitro Biocompatibility

129

Note. (a) Live/dead assay, BG-15 (b)F-Actin/DAPI fluorescence assay, BG-15 (c)
Live/dead assay, BG-MSC (d)F-Actin/DAPI fluorescence assay, BG-MSC (e)
Quantification of metabolic activity, relative fluorescence units (RFU), using PrestoBlue
assay (f) Quantification of cell viability of live/dead images (g) Quantification of cell
proliferation based on DAPI-stained cell nuclei

In vivo biocompatibility of conventional electrolytes and energy storage devices are
often a key limitation that hinders safe implantation as these implants often trigger a
persistent inflammatory response owing to prolonged half-lives in the organism[223]. In
this study we investigated the in vivo degradation and interactions of 3D printed energy
storage device BG-MSC and BP-MSC with local tissues. We also looked at the
immunogenicity profile as subcutaneously implants in an animal. Explanted samples, at
days 4, 14, and 28 post-implantations, showed that electrolyte and energy storage device
showed sustained biodegradation through the 28 days of implantation (Figure 33 a-d).
Also, in the CD68 staining when compared to control and day 4 staining, day 28 showed
to have a low number of monocytes (Figure 36 e-h). This observation suggests that the
printed device was efficiently degraded in vivo, potentially by enzymatically hydrolyzing
the hydrogel matrix. Furthermore, polymer/BIL conjugation at different ratios could be
employed for engineering electroconductive hydrogels with varying degrees of
biodegradability. In vivo biocompatibility and degradation of BP-MSC, Hematoxylin and
eosin (H&E) staining of printed device and surrounding tissue for control and after 4, 14
and 28 days of implantation and the fluorescent immunohistochemical analysis,
macrophage (CD68) presence counterstained with nuclei (DAPI) for control and after 4,
14, and 28 days of implantation.
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Figure 33
Invivo Biocompatibility and Degradation of BG-MSC

Note. (a-d) Hematoxylin and Eosin (H&E) staining of printed device and surrounding
tissue (a) control (b) 4 days, (c) 14 days, and (d) 28 days of implantation (e-h) Fluorescent
immunohistochemical analysis, macrophage (CD68) presence (e) control (f) 4 days, (g) 14
days, and (h) 28 days counterstained with nuclei (DAPI) (i,j) Image of subcutaneous
supercapacitor implantation. (k) Specific capacitance of the printed device before and at
day 4 after implantation

6.4 Conclusion
In summary, we developed a novel material platform of bio compatible polymer
electrolytes for MSCs. Conjugation of BIL-choline functionality on Gelatin biopolymer
and synthetic PEGDA polymer was seen to significantly enhance capacitive and
mechanical properties, achieving high cycle stability and material energy densities nearly
as high as batteries without any compromising power densities. Additionally, the bio
compatibility accentuates its application potential in bio implantable devices. We
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optimized the rheological and electro-mechanical properties of GH-L blend for use as
highly conductive electrode, thus combining the novel polymer electrolyte materials with
the GH-L electrodes for scalable 3D printing of interdigitated miniaturized supercapacitor
structures and showed the feasibility of high-charge storage capacity. The ability of the
electrolyte to penetrate the porous high surface are electrode gives these MSC devices high
capacitance retention and high power and energy density. Additionally, enhanced
mechanical stability of the electrolyte due to BIL functionalization made it stronger and
easier to fabricate. The fabricated, bio compatible and biodegradable supercapacitor can be
used in implantable device applications which require high cycle stability and high-power
density. In summation, we designed a novel material platform technology for inducing
tailorable specific capacitance and other electromechanical properties onto bio polymer
and biocompatible synthetic polymers, intended for use as solid-state electrolytes. The
interdigitated 3D printed MSC structures using these materials showed great promise with
respect to their biocompatibility and electrochemical properties bespeak their robustness
and capability of scalable applications in bio-implantable microelectronics and further as
robust energy storage structures for sensors and actuators.
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Chapter 7
Engineering 3D Printed Bioelectronics as Smart Self-Oxygenating Tissue Scaffold

The major setback in engineering large tissue constructs is the limitation of oxygen
transport both in vitro and in vivo applications, ensuring that constructs made via tissue
engineering operate successfully depends on sufficient nutrients and oxygen to cells for an
indefinite period. The cells near the center of scaffolds tend to die due to the unequal
distribution of oxygen, limiting the current effectiveness of tissue-engineered scaffolds for
extensive defect repair in vivo [224]. Similarly, in in-vitro conditions, many efforts have
been made to stipulate oxygen to the fabricated tissue to overcome the effect of hypoxia.
Distributing adequate oxygen and nutrients to the encapsulated cells is one of the most
precarious problems that affect tissues' development by distressing the cells [225-228].
7.1 Introduction
The demand to replace, repair or regenerate damaged and failing organs keeps
growing, particularly with increases in the aging population. The most significant
difficulties faced in the field of organ transplantation is unavailability of donor organs, high
transplantation

costs,

unpredictable

surgeries,

and

life-long

use

of

immunosuppression.[229] During organ transplant matching, donors' availability does not
always meet the demand. There are approximately 20 deaths each day due to the inability
to find a donor match in time. However, the creation of feasible implants has remained a
tremendous challenge. Though proper regeneration of small-sized tissue, current strategies
are unsuited for maintaining the viability of more considerable size tissue regeneration.
Explicitly, small implants rely on the dispersion of nutrients and oxygen. Large tissue
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suffers from limitations such as nutrient diffusion that induce apoptosis due to anoxia and
subsequent tissue regeneration failure.
Hypoxia (<5% oxygen) and anoxia (<0.5% oxygen) occur in the organ size tissue
if the distance among cells and vessels is above 100–200 um [8]. However, hypoxia
stimulates angiogenesis, orchestrates metabolic coping mechanisms, while anoxia hinders
angiogenesis and drives tissue necrosis. Specifically, anoxia prevents aerobic respiration
and adenosine triphosphate production, eventually resulting in cellular death. Anoxia also
destroys vascularization networks, which exacerbates the local oxygen shortage. Anoxic
zones usually originate in engineered tissues larger than a few millimeters and become
progressively more dominant when increasing engineered tissues size.
Consequently, to enable the survival of a bioengineered tissue until its
vascularization has occurred, it needs an active, gradual, and consistent supply for several
days and up to weeks. Systems developed to supply oxygen to cells in implanted or
damaged tissues include angiogenic factors, which only provide oxygen when
vascularization has occurred. Implantation adjacent to vascular-rich tissues, which suffers
from diffusion limitations, helps in better survival. Oxygen carriers such as
perfluorocarbons (PFCs), crosslinked hemoglobin, silicon oils which only release oxygen
for a few hours, have significant shortcomings. Supplementing the cell media with oxygen
carriers enables an oxygen increase in engineered tissues. Perfusion bioreactors are an
alternative method that facilitates the culturing of cells in well-oxygenated environments.
Even though the ability of microfluidic approaches to perform in vitro, the resolution of
microfabrication techniques is not optimal. Researchers use human umbilical vein
endothelial cells (HUVECs) in porous interconnected scaffolds that aid better access to
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growth factors. However, until even networks of blood vessels are formed, the integration
is incomplete, and the tissue scaffold is restricted to oxygen.
More recent strategies entail the design of oxygen releasing biomaterials (ORBs).
ORBs offer localized oxygen delivery to engineered tissues via hydrolysis of solid
peroxides such as sodium percarbonate, calcium peroxide, and magnesium peroxide; upon
exposure to water, stable peroxides rapidly decompose to release oxygen. ORBs enable the
release of an unstable (rapidly declining) bulk of oxygen over a limited time (hours to a
few days). Additional concerns with the use of ORBs are the hydrogen peroxide-based
generation of ROS, the salts deposited, both of which are known to be cytotoxic. In short,
while recent strategies lead to partial success over short-term oxygenation, the challenge
of supplying adequate oxygen until the neo-vasculature is functional remains unsolved.
Thus, currently, there is no effective strategy to oxygenate engineered tissue during their
entire pre-vascular phase.
We hypothesized that Gelatin methacryloyl (GelMA)/Laponite/Cobalt Phosphate
(CoP) composite material will optimizes the oxygen production of the hexavalent cobalt
catalytic reaction. CoP, a stable compound, would be biocompatible, have electrical
stability, and be capable of generating significant amounts of oxygen [230]. The material
is 3D printable and mechanically suited to implantation. This work proposes an implantable
system that can deliver oxygen to cells under hypoxia conditions. The hydrogel electrolyte
was synthesized by mixing polymer and bio ionic liquid in various ratios. Cobalt Phosphate
synthesized is mixed with Laponite and GelMA to be used as an electrode. The chemical
characterization of CoP was carried out by FTIR, elemental analysis (EDAX), physical
characterization by SEM. The mechanical properties of the gel electrolyte of various
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compositions were assessed along with the electrochemical properties. The
biocompatibility invitro and invivo was studied to analyze the compatibility of the
synthesized catalyst. When incorporated the oxygen generating setup helps in the
vascularization of implanted hydrogel encapsulated with mesenchymal stem cells
facilitating the vascular endothelial growth factor production. Likewise, the setup's ability
to aid wound healing was demonstrated in the in vivo study using a diabetic wound healing
model that is mildly increasing the oxygen tension in the wounded site. Hence, SSOT has
a potential to maintain oxygen levels in the engineered tissues facilitating vascularization
and can serve as a preliminary result for oxygen generation through further refinement.
7.2 Materials and Methods
7.2.1 Synthesis and Characterization of the Electrode and Electrolyte
BioGel synthesis requires combining the methacrylate gelatin and choline acrylate.
BIL was synthesized by previously explained procedure, briefly, choline bitartrate, acrylic
acid was reacted in equimolar ratio for five hours at 50 Celsius and purified using rotary
evaporator. The synthesized BIL was conjugated on the backbone of the GelMA. To
synthesis GelMA, 10% (w/v) gelatin solution and eight milliliters of methacrylic anhydride
were reacted for three hours, unreacted anhydride was dialyzing out for five days. The
resultant product was frozen and lyophilized. The BioGel electrolyte was made by using
7% (w/v) of GelMA and 4%(w/v) BIL with 0.5% (w/v) of LAP as photo initiator and photo
polymerized (visible light 405 nm for 60 secs).
CoP catalyst was prepared as described; 0.86 M solution of Cobalt Nitrate
Hexahydrate (Millipore sigma) and 0.57 M of Ammonium Phosphate (Sigma Aldrich)
were prepared. These solutions were mixed and stirred for 2 hours. The mixture was
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transferred to a Teflon and stainless-steel autoclave and heated at 200 C in an oven. After
6 hours, the resulting solid cobalt phosphate was vacuum filtered and washed with 3X
ethanol and 3X deionized water. Further to fabricate the smart self-oxygenating tissue
(SSOT), CoP was mixed with Laponite and GelMA blend at a ratio of 9% (w/v) Laponite,
7%(w/v) CoP and 1% (w/v) GelMA to optimize the rheological properties for printing
[231].
7.2.2 Physical and Chemical Characterization of the BioGel Electrolyte
Scanning electron microscopy was used to evaluate porosity of BioGel, and the
porosity of the CoP synthesized. PDMS mold was used to prepare the samples and freezedried. Synthesis CoP was crushed into fine particles for the catalyst. Both the electrode and
electrolyte were coated with gold before imaging. The pore size was measured using
ImageJ.
For estimating the mechanical properties of the BioGel, the samples were prepared
by means of PDMS molds. For compression tests, the samples were compressed and for
tensile test, the samples were placed with tensile grips. The constant rate of 1 mm/min was
applied to both the tests until failure.
For swelling and degradation study, the BioGel was fabricated as previously
described. The samples were incubated in DPBS at 37 °. For degradation, the samples were
maintained for two weeks. The phosphate buffer was removed at given time points, 1, 7
and 14 days and the samples were lyophilized to measure the weight of the sample. For
swelling, the biogel samples were freeze dried and weighed before incubating in buffer
solution. At 4, 8, and 24 hours after incubation.
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7.2.3 Electrochemical Characterization of the Electrolyte and the Fabricated SSOT
BioGel, CoP electrode, and fabricated SSOT were subjected to cyclic voltammetry
test, charge/discharge test, and impedance spectroscopy analysis using CHI 660E
potentiostat from CH Instruments, Inc., to understand the electrochemical properties. The
electrochemistry of the BioGel was studied by polymerizing the gel into cylindrical shape,
using glassy carbon electrode of the three-electrode system, similarly for the CoP, the
catalyst was mixed with PVDF and casted on the working electrode. To estimate the
individual electrochemical properties, the BioGel was used with glassy carbon electrode
and COP was used with PBS electrolyte, and when estimating the combined SSOT
properties, the working electrode was coated with CoP and BioGel was used as electrolyte.
Further to estimate the electrochemical properties of the fabricated SSOT, the edge of the
fabricated device was attached to the working electrode using an adhesive conductive
copper tape. In all the experiment, Ag/AgCl used as a reference electrode and gold was
used a standard electrode.105–0.05 Hz frequency range was used to carry out EIS with 10
mV amplitude, scan rate of 10 - 200 mV/sec. Cyclic voltammetry and galvanostatic
charge/discharge tests were carried out between 0–1 V, to quantitatively estimate the
amount of oxygen generated by SSOT we employed SevenGo Duo® pro™ SG98
pH/Ion/Optical Dissolved Oxygen Meter from METTLER TOLEDO®
7.2.4 Invitro Biocompatibility of the SSOT
Human umbilical vein endothelial cells (HUVEC), Human dermal fibroblast
(HDF), Mesenchymal stem cells (MSC), 2×104cells/scaffold were cultured on the BioGel
surface and encapsulated in the BioGel to fabricate the SSOT. These were placed in 12
well plates with 1ml of respective medium according to manufacture instructions. The 2D
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and 3D seeding was maintained for 14 days in cell culture incubator. Live/Dead viability
kit was used to assess the cell viability on BioGel, live cells were green and dead cells were
red.
Metabolic activity was studied at 1,4 and 7 days using PrestoBlue assay. Cell
proliferation was analyzed by fluorescent staining of actin filaments and cell nuclei as
previously described.
7.2.5 Invitro Performance of the Fabricated SSOT
To study the performance of SSOT, Human umbilical vein endothelial cells
(HUVEC), Human dermal fibroblast (HDF), Mesenchymal stem cells (MSC) 2×104cells/
scaffold were encapsulated in the biogel (7% (w/v) GelMA and 4%(w/v) choline acrylate).
Once encapsulated, the BioGel solution was polymerized in between printed CoP electrode
(9% (w/v) Laponite, 7%(w/v) CoP and 1% (w/v) GelMA), the electrode was spaced 5mm
apart, and the size of the electrolyte, BioGel was varied. The entire setup was maintained
sterile and polymerized using visible light to be cultured in the respective medium
according to manufacture instructions. A DC power supply, regulated low voltage dc
power supply (B & K precision SE) of 1v was placed on top of the incubator and connected
to the CoP electrode in the culture via platinum electrodes under hypoxic conditions in a
tri-gas incubator, with 5% oxygen and 1% oxygen at and the controls without the power
supply, at timed intervals the voltage in the culture was monitored to make sure the voltage
supply was stable throughout the setup for the entire length of the experiment. Cell media
was changed every 48 hours. To estimate the role of SSOT, the cellular metabolic activity,
cell viability, cell proliferation, and ATP measurements were evaluated.
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7.2.6 Invivo Biocompatibility of the SSOT
Animal experiments were approved by ICAUC at Rowan University. Male Wistar
rats, 200–250 grams were purchased from Charles River (Boston, MA, USA). For
anesthesia, 5% isoflurane induction with 2-2.5% maintenance was used. SC buprenorphine
was administered. On the posterior skin incisions were made to implant the fabricated
SSOT’s (5 × 5 mm) disks. The skin incision was closed using wound clips, and the animal
was recovered. The implanted samples were explanted along with surrounding tissue at
day 4, 14 and 28.
The samples were sectioned and stained with hematoxylin and eosin staining and
Immunofluorescent staining. Anti-CD68 primary antibody and Alexa Fluor 594conjugated secondary antibody was used. AxioObserver Z1 microscope from Zeiss was
used to acquire images.
7.2.7 Subcutaneous Implantation of the Fabricated SSOT to Study the Vascularization
To study the vascularization on the fabricated SSOT, nude rats were acclimated for
at least three days before any manipulation. Male rats between 200-250g and at least 1012 weeks of age were used. Anesthesia was performed 5% isoflurane. While monitoring
the status of the rat, Buprenorphine SR (sustained-release, 1.2-1.5 mg/Kg) or meloxicam
SR (sustained-release, 2.5-5 mg/Kg) was injected subcutaneously 30 minutes prior to
surgery to minimize animal discomfort during and after surgery. The skin was disinfected
under a BSL2 laminar flow cabinet to ensure sterility. The mediodorsal skin of systemically
anesthetized rats was incised by 1 cm in length, and a small lateral subcutaneous pocket
was bluntly prepared. SSOT encapsulated with hMSC were subcutaneously implanted in
the rats. Samples were implanted subcutaneously, and skin incisions was closed with
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wound clips. The whole setup (SSOT and battery) was further secured to the animal using
Tegaderm dressing, wrapping around the chest and back. At the endpoint (7 days), rats
were euthanized, and the scar tissue along with the implanted setup was collected for
further immunofluorescence and histological analysis.
7.2.8 Invivo Diabetic Wound Healing Study
For the study, Diabetic B6.BKS(D)-Leprdb/J mice were ordered from Jax and
acclimated for three days before any manipulation. Hyperglycemia was assessed and
recorded before surgery with a standard glucometer (Bayer) using a drop of blood drawn
from nicking the tail with a sterile needle. Briefly, shaving was performed under light
isoflurane anesthesia. Buprenorphine SR (sustained-release, 1.2-1.5 mg/Kg) or meloxicam
SR (sustained-release, 2.5-5 mg/Kg) was injected subcutaneously 30 minutes before
surgery to minimize animal discomfort during and after surgery. Anesthesia was performed
using 5% isoflurane and maintained at 3% isoflurane during surgery
Skin was disinfected by using 70% isopropyl alcohol followed by 2% chlorhexidine
scrub, three times, for a total of 6 scrubbings, to provide adequate and long-lasting
disinfection with a final iodine paint prep under BSL2 laminar flow cabinet to ensure
sterility, wounds were created in the dorsal skin by punching through both sides of a fold
of skin with a 6mm biopsy punch. Subsequently, two silicone splints (Grace Bio-Labs)
were attached to the skin, a standard step to ensure the wounds will not close by contraction.
(Wang, X. et al.,). For the mice group without treatment, only Tegaderm was used to wrap
the wounds going around the chest and back. For the other groups, SSOT was applied to
the damage inside the ring and connected to a coin battery (6mm) glued to the silicon rings.
The whole setup (rings, SSOT, and the battery was further secured to the animal using
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Tegaderm dressing, wrapping around the chest and back. At the endpoint (full wound
closure or 21 days), mice were euthanized using CO2 and cervically dislocation.
Wound/scar tissue was collected for further histology assessment.
7.3 Result and Discussion
7.3.1 Synthesis, Fabrication, and Characterization of SSOT
Electrolysis converts water into oxygen and hydrogen by passing a mild electrical
current through the liquid. Conventional electrolysis reactions are performed in alkaline or
acidic medium, making these systems toxic and unsuitable for biological applications [23].
For the biocompatible electrolysis system to be used in the engineering of tissues, a solidstate electrochemical cell is required. Fabrication of such a system requires the
development of a biocompatible ion conductive hydrogel as the electrolyte and
biocompatible electrodes. CoP serves as a potential biocompatible electrode in this work
due to its high abundance, superior stability, rich redox chemistry, cost efficiency, and high
catalytic activity. Due to the excellent properties exhibited, CoP was used as an electrode
material. For the synthesis, a reaction between Cobalt Nitrate and Sodium Phosphate was
carried out as indicated in Figure 34 [232]. To characterize the physical properties of the
synthesized catalyst, we performed EDAX - SEM for elemental analysis showing the
various percentages of the elements present in the synthesized catalyst.
Further to estimate the electrochemical properties of CoP, cyclic voltammetry at a
scan rate of 10 mV/s between -1v and 1v were studied along with galvanostatic chargedischarge at 0.1 A/cm3. Figure 34c, 34d. The peak at ~0.9v obtained by CoP indicates the
most profound effects of oxygen evolution and OER activity and durability of the
synthesized catalyst in a three-electrode system, with platinum counter electrode and
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Ag/AgCl reference electrode. Also, the remarkable cycling performance obtained by the
charge-discharge demonstrated the high instantaneous power and the ability to maintain
uniform capacitance and stability. The Brunauer–Emmett–Teller (BET) surface area and
pore size distribution, figure 34e, 34f of the CoP was calculated based on N2 adsorption
isotherms was 217.9 m2/g and showed a successful synthesis of porous cobalt phosphate.

Figure 34
Synthesis and Characterization of CoP Catalyst

Note. (a) Schematics of the chemical reaction for the synthesis of the cobalt phosphate
catalyst (b) SEM-EDS elemental mapping of Cobalt Phosphate (CoP), Analogous
elemental mapping of the elements, Cobalt (Co), and Phosphorus(P), Scale bar 5 μm and
EDS Spectrum of synthesized CoP (c) Electrochemical characterization of CoP, Cyclic
voltammetry of CoP between -1 v to 1 v, as electrode (d) Galvanostatic charge discharge
of the CoP to study the stability of CoP (e,f) N2 adsorption−desorption isotherms of CoP
and pore size distribution

Electrolysis decomposes water into oxygen and hydrogen using an electric current
through an electrolyte [22]. Conductivity is the primary property in electrolyte design for
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electrolysis reactions. The electrolyte can be in the form of a conductive hydrogel.
However, conventional methods to engineer conductive hydrogels (CHs) work by
incorporating conductive nanomaterials and polymers [25]. These methods are associated
with cytotoxicity, reduced solubility, poor processability, and degradability [25]. As a
result, the development of a biocompatible and biodegradable electrochemical cell has
remained a true challenge. A critical step in the making of SSOTs is the engineering of a
biocompatible conductive electrolyte hydrogel. BioGel was used as an electrolyte as it can
perform both as an adhesive and conductive tissue scaffold. BioGel electrolyte was
synthesized by conjugation of bio ionic liquid in the structure of polymer [233]. By mixing
7%(w/v) GelMA with 4%(w/v) BIL, photo cross-linked into the electrolyte gel using LAP
photo initiator for 60 seconds to form BioGel. Figure 35 represents the synthesis of Choline
Acrylate, BIL, formation of BIL functionalized GelMA. The mechanical properties of
BioGel plays a vital role in presenting as a self-oxygenating tissue, as it is crucial to have
mechanical integrity comparable to the native tissue. With increase in bio ionic liquid
concentration 0 – 6% w/v the tensile strength and compressive strength increases. The
compressive and tensile modulus, figure 2c, 2d of 7% w/v GelMA is 4.0±1.0 kPa and
6.43±0.92 kPa, respectively, figure 35c, 35d.
In contrast, the compressive and tensile modulus of BioGel is 8.3±0.3 kPa and
17.83±1.25kPa, respectively, indicating the ability of the BILs to improve the mechanical
properties of the polymer. Likewise, degradation rate and swelling ratio of the BioGel are
shown in Figures 35e, 35f. The polymer itself exhibits a faster rate of water uptake. The
water uptake depends on the chain conformation. When conjugated with the BIL, the chain
conformation and the electrostatic interactions restricts the polymer expansion. Thus, the
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swelling ratio decreases from 33.6±1.15 kPa for 7% GelMA to 24.3±2.00 kPa for BioGel.
The BIL aids in the hydrolysis, the swelling and water uptake also play an essential role in
the degradation. As the percentage of the BIL increases, the degradation rate increases
initially from 15.0±2.0 kPa for 7% GelMA to 30.0±2.0 kPa for BioGel.
Further to show the printability of the BioGel and the electrode, the ALLEVI printer
was used to achieve extrusion-based printing. A blend of laponite, GelMA, and CoP was
prepared as an electrode. The CoP electrode and the BioGel electrolyte were 3D printed
together. BioGel acts as a conductive and adhesive hydrogel scaffold for electrocatalysis
as well as cell proliferation and growth. Conjugation of BIL increases the conductivity of
the electrolyte with the increase in the percentage of the BIL. The conductivity of 7%
GelMA with no BIL is 6X10-4 ± 0.7X10-4 S/m, which increases to 190X10-4 ± 6X10-4 S/m
when the 7% GelMA is conjugated with 6% w/v of BIL. The fabricated SSOT structures
were measured for electrochemical performance and the amount of oxygen generated.
[234-236]
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Figure 35
Synthesis and Characterization of BioGel, 3D Printing of BioGel and CoP

Note. (a) Schematics of the chemical reaction for the synthesis of BIL and Biogel (b)
Digital image of 3D printed BioGel, CoP and SSOT. Mechanical properties of bio-ionic
ink (c) Compression Modulus GelMA conjugated with various percentages of BIL (d)
Elastic Modulus GelMA conjugated with various percentages of BIL. Physical
characterization of the BioGel (e) Swelling ratio of bio-ionic ink (f) Degradation ratio bioionic ink. (g,f) Electrochemical characterization of CoP, Cyclic voltammetry of BioGel,
quantified conductivity and Nyquist plot of the BioGel electrolyte with varying percentage
of the BIL - GelMA (7%w/v) and BILs concentration(0, 2, 4, 6(%w/v)) concentration with
0.5% Lithium phenyl-2,4,6-trimethylbenzoylphosphinate (LAP) as a photo initiator at 60 s
visible light exposure. Data are means ± SD. P values were determined by one-way
ANOVA (*P < 0.05, **P < 0.01, ***P < 0.001)
The amount of oxygen generated in vitro was estimated using an oxygen sensor.
The fabricated SSOT was connected to a DC power supply at 1V. Figure 36b, 36c depicts
invitro setup-initiated oxygen generation. At the 30th minute, the amount of oxygen
generated was estimated to be 0.085±0.021 mg/l, which steadily increased to 0.525±0.035
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mg/l at the end of day 1. On day 2, the oxygen concentration was increased by five times
to 2.45±0.14 mg/l, indicating steady electrolysis.
Additionally, to characterize the performance, cyclic voltammetry as shown in
figure 36d and galvanostatic charged discharge figure 36e were performed. In figure 36d,
the peak in the CV for the bio gel composition in three electrode system indicate OER.
When varying the concentration of the BIL in the electrode, the ability of the material to
generate a stable peak was varied. When the concentration of the BIL was 4% w/v, the
reduction and oxidation reaction aided the peak at -1v and 0.95 v. The change in
concentration of the BIL aids in the shift of the cyclic voltammograms, with the increase
in the concentration both the reduction and oxidation peaks appear at the onset potential of
OER. The steady cycling capacity indicated the stability of the printed setup. To analyze
the effect of varying BIL concentration on the amount of oxygen generated, figure 36h, the
concentration of the BIL was varied from 0-6% w/v, and we estimated the oxygen
concentration, which increased from 2.03±0.10 mg/l for 0% w/v BIL to 7.93±0.4 mg/l for
4% w/v BIL.
To address the significant challenge in engineering 3D tissues in the clinically
appropriate size, inadequate supply of oxygen, we hypothesize that the fabricated SSOT
will support cell survival, growth, proliferation, and vascularization. Toward meeting the
oxygen demand of the engineered tissue scaffold and optimization of the amount of oxygen
supplied. To evaluate the amount of oxygen synthesized by the fabricated device for a
sustained period and test the consistent oxygen supply throughout the fabricated constructs
we performed various invitro and invivo studies. Even though oxidation is a regular and
fundamental process, when there is an imbalance between free radicals and antioxidation
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due to overproduction of oxygen, it negatively affects the cells. Thus, the amount of oxygen
generated while connecting and disconnecting the power source at a constant interval was
estimated. The power source was switched between on and off at a regular 24 hours, during
which the oxygen concentration was measured. At the initial 24-hour period, the oxygen
concentration increased from 0.5 mg/l at 15 minutes to 6.95 mg/l. As the power supply was
disconnected for the next 24 hours, the concentration was reduced to 3.9 mg/l midway
reaching 2.3 mg/l at 48 hours. Throughout the on/off period, the same pattern was
observed. At the end of 30 days, the oxygen concentration was measured to be 1.95 mg/l
indicating that the amount of oxygen synthesized can be controlled via controlling the
power supplied. The ability to hold oxygen invitro will be beneficial as the cell culture invitro falls shorts of reproducing the in vivo environment. The different tissue in vivo
experiences different oxygen tension and requirements, creating a wide range of oxygen
gradients. Consequently, the ability to control oxygen can be harnessed to develop a wide
range of in-vitro 3D models in clinically relevant size and control cell proliferation with
further studies and optimization. Also, controlling the oxygen generation rate supports
addressing other significant concerns like the production of reactive oxygen species, which
is unfavorable for cell survival.
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Figure 36
3D Printing of SSOT and Fabrication

Note. (a) Image showing the printed SSOT (b) Fabrication to study the function of printed
SSOT invitro, indicating the (c) synthesized oxygen concentration in mg/l (d) Cyclic
Voltammetry curve with a voltage window of 1 V of the SSOT with Ag/AgCl reference
electrode (e,f) Capacitance retention of SSOT, galvanostatic charge/discharge curve at 0.1
A cm-3 (g) Oxygen ON/OFF study to estimate the upkeep competence of the oxygen by the
SSOT invitro when connected to 1v DC power supply every other day (h) varying oxygen
concentration produced by varying BIL concentration 0-6% w/v ,(i)indicating the
synthesized oxygen concentration in mg/l for a period of 8 days in invitro culture condition.
Data are means ± SD. P values were determined by one-way ANOVA (*P < 0.05, **P <
0.01, ***P < 0.001)

7.3.2 Invitro and Invivo Biocompatibility and Biodegradability
To investigate the prospective of SSOT for cell growth, attachment, viability,
proliferation, and metabolic activity fibroblast cells were culture for 7 days. Figure 37, the
viability of seeded cells on SSOT was not affected. Cells cultured on SSOT appeared to
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exhibit 98.0±1.0 % cell viability compared to the control, with a 98.3±0.5 % survival rate
seven days post-seeding. The metabolic activity was constantly increased throughout the
culture demonstrating the biocompatibility.[237] Also, in the fabricated SSOT setup the
cell number were high at day seven.
For any biomedical device the invivo biocompatibility is critical, so that they don’t
invoke any adverse inflammatory response.[238] In this experiment, we analyzed the
degradation of SSOT and interaction with native tissue if any. The samples were explanted
at days 4, 14, and 28 indicated SSOT constant degradation (Figure 37 d). CD68 staining at
day 28 showed a low number of macrophage infiltration (Figure 37 c) suggesting that
SSOT was proficiently degraded. H&E staining of SSOT is presented, after 4, 14, and 28
days of implantation and analysis via immunohistochemistry indicate that the macrophage
are present at day four because of the inflammation caused by the surgery.

Figure 37
Invitro and Invivo Biocompatibility SSOT

Note. (a) Live/dead assay, F-Actin/DAPI fluorescence assay of SSOT. (b)Quantification
of cell viability of live/dead images, cell proliferation based on DAPI-stained cell nuclei
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and metabolic activity (RFU). (c) (i, ii) Control (d)(i, ii) SSOT, fluorescent
immunohistochemical analysis, macrophage (CD68) presence, Day4, 14 days, and 28 days
counterstained with nuclei (DAPI). Hematoxylin and Eosin (H&E) staining of SSOT and
surrounding tissue Day4, 14 days, and 28 days. Scale bar = 200µm. Data are means ± SD.
P values were determined by one-way ANOVA (*P < 0.05, **P < 0.01, ***P < 0.001)

7.3.3 Invitro Evaluation of the SSOT Function
To use the implantable SSOTs as a robust tissue scaffold for clinical applications,
it is essential to understand the performance of the fabricated SSOT in vitro. The ability
and feasibility of SSOT to synthesis oxygen and thus aiding in cell proliferation need to be
assessed and established. The preliminary in vitro functionality of selected SSOT was
studied, figure 38. Insufficient oxygen in transplanted tissues raises the chance of
inflammation and infection, decreases the effectiveness of medical treatments, leads to
tissue necrosis and the inevitable subsequent implant failure. We here aim to demonstrate
that SSOT release oxygen in vitro to alleviate anoxia-induced cell death by sustaining the
engineered tissue's metabolic needs. ALLEVI Extrusion 3D printing techniques were used
to fabricate the implantable SSOT. To explore the effect of oxygen generation, the function
of oxygen-generating constructs fabricated with Mesenchymal Stem Cells (MSC), Human
Umbilical Veined Endothelial Cells (HUVEC), and Human Dermal Fibroblast (HDF) cells.
The setup was evaluated under hypoxia (5% oxygen concentration) and anoxia (1% oxygen
concentration) which were compared with control samples (without SSOT) by performing
cell viability, proliferation, and metabolic activity assays. The interaction of HUVEC,
HDF, and MSC cells inside the bio gel was assessed on days 1,4,7, and 14.
On day 4, the number of MSC's per mm2 in normoxia was 1020±105 compared to
815±35 cells/mm2 under hypoxia and 585±40 cells/mm2 under anoxia. In contrast, the cells
count increased to 945±55 and 1005±96 cells/mm2 under hypoxia and anoxia, respectively,
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indicating the oxygen-generated benefits in cell proliferation. Similarly, the number of
HUVEC's per mm2 increased to 1065±105 cells/mm2 from 930±40 cells/mm2 under
hypoxia respectively when cultured with SSOT, indicating the oxygen generated benefits
in cell proliferation. Comparable patterns were observed at day 14, figure 38, the number
of MSC's per mm2 in normoxia were 1236±188 compared to 633±166 cells/mm2 under
hypoxia and 335±166 cells/mm2 under anoxia. In contrast, the cells count increased to
940±90 and 1020±125 cells/mm2 under hypoxia and anoxia, respectively, indicating the
oxygen-generated benefits in cell proliferation. Similarly, the number of HDF's and
HUVEC's per mm2 increased to 1025±80 and 975±95 cells/mm2 from 785±49 and 607±34
cells/mm2 under hypoxia respectively when cultured with SSOT, indicating the oxygen
generated benefits in cell proliferation. The metabolic activity of MSC, HDF, and HUVEC
increased to 5575±86 RFU, 5917±505 RFU, 48807±190 RFU from 1674±427 RFU,
3185±315 RFU, and 2310±375 RFU when culture under 5% oxygen, hypoxic condition.
Likewise, when the fabricated tissue was increased from 0.1cm to 0.5cm, the
electrocatalysis at the electrode-electrolyte junction helped in better cell survival and
proliferation, indicating the ability of SSOT to be performed in varied tissue scaffold sizes.
On day 14, figure 38d, the cell viability of the MSC's were increased from 42±5% to 74±4%
under anoxia, and for HDF's were increased from 46±3% to 79±4%, and HUVEC's were
increased by two folds, from 38.6±7.5% to 78±5% indicating the superior performance.
And the metabolic activity and ATP measurements indicated that the cells under anoxia
and the SSOT proliferated healthier than cells under anoxia without SSOT. The metabolic
activity of MSC increased from 1920±108 RFU for anoxia to 5181±157.8 RFU anoxia with
SSOT. Similarly, the metabolic activity of HDF increased from 2470±286 RFU to
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6975±199 RFU and HUVECS increased from 2183±388 RFU to 5589±498 RFU,
respectively. The cell counting with the SSOT was comparable to the cells counted under
normoxia. For MSC's the cells counted under normoxia were 1902±135 cell/mm2, which
reduced to 451±38 cell/mm2 under anoxia, which SSOT alleviated, and the cells count
increased to 1139±83 cell/mm2. The same pattern was observed for both HDF and
HUVEC's. Therefore, the preliminary results indicate that the electrode's electrocatalysis
via cobalt phosphate catalyst aided oxygen generation, thus alleviating hypoxic stress with
>1% oxygen tension function while exhibiting suitable cell viability and relative metabolic
activity.
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Figure 38
Invitro Functional Evaluation of SSOT

Note. Day 14 F-Actin/DAPI fluorescence assay, Live/dead assay on MSC, HUVEC and
HDF at normoxia, hypoxia (5% oxygen), anoxia (1% oxygen) and hypoxia along with
SSOT, anoxia along with SSOT. (a) 0.1 cm SSOT construct (b) 0.5 cm SSOT construct.
Quantification of metabolic activity, relative fluorescence units (RFU), using PrestoBlue
assay, cell viability of live/dead images, cell proliferation based on DAPI-stained cell
nuclei and ATP assay (c) 0.1 cm SSOT construct (d) 0.5 cm SSOT construct. Scale bar =
200µm. Data are means ± SD. P values were determined by one-way ANOVA (*P < 0.05,
**P < 0.01, ***P < 0.001)
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7.3.4 Self Oxygenation of Engineered Tissue Invivo
While there have been widespread research efforts to fabricate functional tissue and
organs in-vitro, the attainment is limited by the size of the tissue and vascularization of the
cells within the sizeable-sized tissue scaffolds. The vascular networks that are necessary
and efficient to deliver essential nutrients and oxygen for cell survival are controlled by the
oxygen concentration at which the cells are cultured. Sufficient neovascularization in the
fabricated scaffold can be achieved through coordinated and controlled oxygen delivery.
The fabricated tissue scaffold as a smart self-oxygenating tissue was studied for its ability
to aid vascularization. [243-246]
To study the in vivo behavior of hMSC encapsulated SSOT, BioGel containing
2×104 cells/mL hMSCs were fabricated and implanted subcutaneously in rats. The study
showed a difference in appearance between the explanted tissues, figure 39b. The SSOT
with the battery was healthy-looking and vascular, whereas the control tissue did not
exhibit any vascularization. In Figure 39a, the histological and immunofluorescent staining
substantiate the ability of the human MSC to survive in the SSOT/on, as the control tissue
was void of cells by the end of 7 days. It was observed that the SSOT resulted in an
improvement in vascularization and cell survival which might be due to oxygen generated
via electrocatalysis. H&E and Masson trichrome indicated the cell proliferation and
collagen deposits in the implanted tissue scaffold.
Similarly, the TUNEL assay indicated the DNA fragmentation in the implanted
scaffold. The human nuclear antigen staining that reacts with nuclei in the human cellassociated antigen confirmed the proliferation of the human MSCs. Prominently, SSOT
formulations enabled approximately 80% of cells to continue increasing over 14 days in an
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anoxic environment. This cell survival of all engineered tissues was similar irrespective of
anoxic or normoxic culture condition, which indicated that SSOT could efficiently avoid
anoxia-induced cell death. Further, when encapsulated with human MSCs, SSOT cultured
under normoxia, hypoxia, and anoxia secreted VEGF. The VEGF/DNA production
increased from 0.219±0.009 under normoxia to 0.739±0.003 at hypoxia with SSOT and
0.735±0.024 at anoxia with SSOT. It indicated a significant difference between SSOT and
control tissues, which could be described by reduced cell viability due to hypoxic and
anoxic culture conditions.

Figure 39
Invivo Self Oxygenation of Engineered SSOT

Note. Immunohistochemistry and Immunofluorescence of the explanted control and
SSOT/ON (a)(i) Hematoxylin and eosin (H&E), (ii) Masson’s trichrome (TRI), (iii) Human
nuclear antigen (HNA)/C-reactive protein (CRP), (iv) CD31/DAPI and (v) TUNEL/DAPI.
(b)Digital image of the explants (c) quantitative area of the explants. Total amount of
secreted (d)VEGF and (e) DNA were quantified and used to determine (f) VEGF/DNA
ratio of SSOT composed of hMSCs that were cultured under normoxic, hypoxic, and
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anoxic conditions. Scale bar = 200µm. Data are means ± SD. P values were determined by
one-way ANOVA (*P < 0.05, **P < 0.01, ****P < 0.001)

7.3.5 Diabetic Wound Healing Study by Means of the Fabricated SSOT
A serious impediment of diabetes is skin ulcers that are resulted from impaired
wound healing. To address the need for diabetic wound healing and develop a reliable
wound repair model, we performed an SSOT device testing. We created an excisional
wound of 6mm diameter, the surgical set, and a 6mm wound in 12-week-old diabetics mice.
To analyze the outcome of oxygen generated on wound healing, we connected the SSOT
to a battery to supply constant voltage and applied the entire setup on the wound.
Progression of wound healing in diabetic mice is shown in Figure 40a with images of the
injury every other day for 18 days. Further, wound covered with no dressing was used as a
control, and wound covered with SSOT with no battery connection was used as a negative
control, if any, as demonstrated in the illustration in Figure 40b, with the SSOT/ON the
wound size decreases.[247]
To visualize the oxygen generated through the experiment, we monitored the
oxygen using Oxygen Imaging using the PreScens sensor, indicating the digital images and
3D plot of oxygen generated at varying intervals. Figure 40c shows the standard pictures:
oxygen from the reservoir O2 tank was directly passed through the sensor foil, red dots
show the distribution of oxygen and indicates the oxygen in wound covered with SSOT
with no battery connection. Also, the figure shows a distinct peak of oxygen generated on
the injury covered with SSOT and connected to a 1.3V battery. Since the oxygen at the
wound site plays a vital role in wound healing, it is crucial to monitor the amount of oxygen
generated and understand the function of SSOT in wound healing.[248-249] The quantified
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results of the wound as indicated in Figure 40d demonstrate that at day 3, the injury covered
with SSOT and connected to a 1.3V battery had a reduced wound size of 5.5±0.2 mm
compared to the control 5.9±0.052 mm and SSOT with no battery 5.83± 0.05mm.
Similarly, the reduced wound size of the SSOT connected with the battery was seen
on day 11. The wound covered with SSOT and connected to a 1.3V battery had wound the
length of 2.70±0.17 mm compared to the control 5.96±0.05 mm and SSOT with no battery
4.03±0.05mm, indicating the steady decrease in wound size. On day 18, the wound covered
with SSOT and connected to a 1.3V battery had a reduced wound size of 1.3±0.32 mm
compared to the control 6.13±0.32 mm and SSOT with no battery 3.06±0.05mm.

Figure 40
SSOT Device Testing Invivo

Note. (a) Wound covered with no dressing as a control, wound covered with SSOT with
no battery connection and wound covered with SSOT and connected to 1.3V battery. (b)
Schematic representation of the wound healing process day 0, day 11, day 18. Oxygen
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Imaging using the PreScens sensor, indicating the digital images and 3D plot of oxygen
generated (c) Standard: oxygen from the reservoir O2 tank was directly passed through the
sensor foil. Red dots show the distribution of oxygen, wound covered with SSOT with no
battery connection, wound covered with SSOT and connected to 1.3V battery. (d)
Measurements of average wound areas over time (e) H&E and Masson trichrome staining,
wound and SSOT with battery

7.4 Conclusion
The reported electrolysis arbitrated oxygenation of tissues via CoP and BioGel
helps in cell survival and vascularization of tissues. In the preliminary data SSOT has aided
in relieving anoxic stress over a prolonged period in the fabricated setup, which improved
proliferation. Also, SSOT improved overall cell viability in the printed construct via
electrolysis of water in the BioGel with the aid of CoP. Even though SSOT produces
oxygen directly on the scaffold and CoP, a stable compound, shown to be biocompatible,
have electrical stability, generate significant amounts of oxygen. It requires further
evaluation and optimization to harness its full potential in tissue engineering and
biomedical application. As the combination of CoP, laponite, and gelatin is 3D printable
and mechanically suited, this work enables the development of an implantable system that
delivers oxygen to cells under hypoxia conditions. The result of the anoxic condition and
metabolic deprivation in the higher-level engineered tissue when implanted is inevitable.
To curb the effects, we propose the concept of smart self-oxygenating tissue to offer cell
survival and vascularization supporting embedded living tissues and control the oxygen
release those aids in a homogeneous distribution of the oxygen generated.
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Chapter 8
Conclusions and Expanded Recommendation for Future Work
8.1 Conclusion
We developed a novel material platform by conjugating BIL in the backbone of the
polymer structure, thus introducing a new class of biomaterials for various applications in
bioelectronics and tissue engineering. One such hypothesized application being, a novel
type of Smart Self Oxygenating Tissue (SSOT) based on biocompatible electrochemical
cell technology.
The first specific aim was to develop Bio-Ionic Liquid conjugation as a universal
approach to engineer bioadhesive hydrogels. None of the commercially available tissue
adhesives exhibited the requisite properties to behave as an adhesive and hemostatic
material with biocompatibility and flexibility and need superior alternatives. It was
determined that the functionalization of choline molecules increases their adhesive
properties. The shear strength of BioGel and BioPEG with high BIL concentrations are
significantly higher compared to reported values for commercially available tissue
adhesives such as Ethicon’s Evicel and Baxter’s Coseal, two commercially available
adhesives. Also, the in-vitro studies showed that the potential of the bio-adhesive as a
biocompatible sealant material capable of promoting cell adhesion, growth, and
proliferation, along with the ability of the compounds to ensure hemostasis in a Class IV
hemorrhage wound, solidifies their reliability as hemostatic agents. Overall, a Bio Ionic
Liquid (BIL) conjugated polymer was engineered to form a biocompatible adhesive.
The second specific aim focused on the feasibility of the bioadhesive composite to
serve as a robust and transparent bioadhesive for corneal injury and repair. The conjugation
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of BIL with the polymer (PEGDA) as previously described with varied percentage
compositions lead to a photo cross-linkable Bio-Ionic Liquid functionalized PEGDA
(BioPEG) to be used for repairing corneal tears and corneal grafting. The synthesized
material exhibited flexibility, ability to resorb, biodegradability, mechanical properties like
the corneal tissue that are ideal requisites of a bioadhesive for treating corneal injuries.
With varying the percentage of the polymer and the BIL, the adhesive and shear strength
can be varied, and the material can be designed based on the extent of the injury. Further,
the in vivo assessment of BioPEG in a rabbit stromal defect model indicated the ability of
BioPEG to seal the defect and adhere to the stromal bed completely. These results also
suggested that the bioadhesive composite supports the in vivo epithelial regeneration like
native cornea and may serve as a potential standard of care for simple, fast repair of corneal
injuries and provide high adhesion to wet corneal tissue and have long retention.
The third specific aim focused on in situ 3D printing of multifunctional BIL
hydrogels for tissue regeneration. Bio-derived GelMA-based bio-ink was functionalized
with choline BIL to incorporate different properties, making a tailorable bio ionic ink that
can be photopolymerized. The photo crosslinked polymer was conductive, transparent, and
flexible with pronounced cell adhesion and the properties are incumbent on ratios of
GelMA and the BIL. The shear strength of Bio-ionic Ink increase with increasing BIL
concentration, following the same trend for all polymer concentrations. Also, shear
strength improved with increasing polymer concentration for the same level of BIL content.
Along with the shear strength, BIL functionalization, the conductivity, and
adhesive properties also increased. Due to the flexibility and versatile shear modulus, the
bio-ink can be fabricated based on the application necessary by altering the composition of
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the polymer, BIL, air pressure, and other parameters in the printer. The in vivo electrical
stimulation experiment denoted that the conductivity of the bio ionic ink can be harnessed
and manipulated according to the application, which may be beneficial in the clinical
application where conductive hydrogels are desired. Thus, the synthesis of a novel in-situ
3D printable bio-ionic ink demonstrated the ability to be used as a tissue scaffold at an
interface of electronics and biomaterials. The synthesis establishes a general material
platform that can be applied to a wide variety of biopolymers and BIL to obtain printable
bio-inks with various biomimetic properties.
The fourth specific aim tested the hypothesis that the conjugation of choline ionic
liquid to the polymeric backbones of two biocompatible polymers, one natural and one
synthetic polymer would impart conductivity resulting in enhanced mechanical and
conductive performance properties of the biopolymers. The unfunctionalized polymers do
not possess adequate electrochemical property to fabricate an energy storage device. Also,
the mechanical properties can be altered with BIL concentrations to manufacture the device
differently. But when functionalized with the BIL, the resultant material energy densities
were very close to batteries while achieving power density at the mid-range level of
supercapacitors, underscoring potential application as ionic solid electrolytes in bioimplantable micro-supercapacitors. Furthermore, hematoxylin and eosin (H&E) staining
of the implanted printed device and surrounding tissue indicated that electrolyte and energy
storage devices showed sustained biodegradation through the 28 days of implantation.
Therefore, establishing a biocompatible and degradable energy storage device fabricated
using the BIL functionalized polymer.
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The last and fifth specific aim tested the hypothesis that the biopolymer synthesized
can be used as a biocompatible electrochemical cell. For electrolysis, with cobalt phosphate
as a catalyst for oxygen generation under hypoxia conditions, fabricating an oxygen
generating setup. The electrochemistry of the structure shows that the conjugation of BIL
to polymers significantly increases their conductivity and can be used as a conductive
scaffold for oxygen generation. The in vitro results indicate that when combining both the
catalyst and the electrolyte, the 3D printed scaffold could be used under the hypoxic
condition to deliver oxygen for the cells that have been encapsulated in the polymer gel
electrolyte. The in vivo studies showed the ability and feasibility of engineered SSOT to
perform and improve diabetic wound healing.
In summary, we developed a new class of biomaterial via conjugation of BIL to
incorporate the desired properties for the material to be used in various applications. Such
as developing biocompatible and electrochemical cells to generate oxygen within
engineered tissues as a promising pathway towards engineering large tissue constructs.
This approach enables inherent conductivity in polymer networks without the need for
external aid. It will be the first time that a new class of ion conductive hydrogel will be bioprinted and used as a 3D cell-laden tissue scaffold. The presence of BIL improves the
electrostatic bonding between the hydrogel and tissue, which results in the enhancement of
adhesion properties. This developed biomaterial can be used as an electrolyte in
bioelectronics fabrication with improved tissue adhesion, thus leading to a biocompatible
electrolysis system to be used in the engineering of tissues.
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8.2 Expanded Recommendation for Future Work
To improve treatment outcomes, tissue engineering and regenerative medicine need
to be advanced. The need to develop multifunctional hydrogel with a robust interface is
ever-evolving, along with the demand for an engineered organ. Even though hydrogels are
the common tissue scaffold and aids as a supportive matrix, due to the lack of desired
properties innate to human tissues, the developed material platform can be explored in a
wide range of applications like biologically active scaffolds, soft bioelectronics, hydrogels
for cellular therapy, smart hydrogels for three-dimensional printing, actuators, immune
isolation devices. With the ability to tune the properties and detailed fundamental
understanding, the developed material platform can fabricate more sophisticated systems.
Oxygen is a fundamental biomolecule for the survival, function, and fate of
mammalian cells. The ability of biomaterial to generate controlled oxygen can be harnessed
for various tissue engineering applications. Oxygen-generating biomaterials signify a novel
and unique approach to gain control over a variety of in vivo processes. The survival and
performance of implants depend on the improvement or circumvention of anoxia because
of the harmful side effects of the condition. There is induced cell death due to a lower
oxygen gradient, which leads to the failure of cell-based therapies and in vivo
experimentation. Thus, the developed work can be further studied and used in tissueoxygenating strategies to enhance the survival of implants that can repair or regenerate
various tissues. Also, creating in vivo model for evaluation of chronic wound healing and
studying the influence of oxygen on wound healing dynamics is a potential breakthrough
area that can be investigated. The pathophysiology of diabetes-related wound-healing
difficulties is complicated and inadequately understood. It is essential to develop a delayed
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wound healing model in diabetic mice and study the effect of oxygen generated and its
role.
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Appendix
Supplementary SSOT Invitro Data

Figure A1
Schematics of the Electrochemical setup
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Figure A2
Increased thickness of the BioGel in SSOT (1mm)

Note. Representative F-Actin/DAPI, Live/Dead fluorescent images of MSC, HUVEC,
HDF at day 1, post seeding of Control (under traditional CO2 incubator) , Hypoxia (5%
and 1% Oxygen) and CoP catalyst fabricated with laponite and GelMA as electrode
connected with 1V power source. Scale bar = 200µm. Data are means ± SD. P values were
determined by one-way ANOVA (*P < 0.05, **P < 0.01, ***P < 0.001)
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Figure A3
Increased thickness of the BioGel in SSOT (1mm)

Note. Representative F-Actin/DAPI, Live/Dead fluorescent images of MSC, HUVEC,
HDF at day 4, post seeding of Control (under traditional CO2 incubator) , Hypoxia (5%
and 1% Oxygen) and CoP catalyst fabricated with laponite and GelMA as electrode
connected with 1V power source. Scale bar = 200µm. Data are means ± SD. P values were
determined by one-way ANOVA (*P < 0.05, **P < 0.01, ***P < 0.001)
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Figure A4
Increased thickness of the BioGel in SSOT (1mm)

Note. Representative F-Actin/DAPI, Live/Dead fluorescent images of MSC, HUVEC,
HDF at day 7, post seeding of Control (under traditional CO2 incubator) , Hypoxia (5%
and 1% Oxygen) and CoP catalyst fabricated with laponite and GelMA as electrode
connected with 1V power source. Scale bar = 200µm. Data are means ± SD. P values were
determined by one-way ANOVA (*P < 0.05, **P < 0.01, ***P < 0.001)
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Figure A5
Increased thickness of the BioGel in SSOT (5mm)

Note. Representative F-Actin/DAPI, Live/Dead fluorescent images of MSC, HUVEC and
HDF at day 1, post seeding of Control (under traditional CO2 incubator) , Hypoxia (1%
Oxygen) and CoP catalyst fabricated with laponite and GelMA as electrode connected with
1V power source. Scale bar = 200µm. Data are means ± SD. P values were determined by
one-way ANOVA (*P < 0.05, **P < 0.01, ***P < 0.001)
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Figure A6
Increased thickness of the BioGel in SSOT (5mm)

Note. Representative F-Actin/DAPI, Live/Dead fluorescent images of MSC, HUVEC and
HDF at day 7, post seeding of Control (under traditional CO2 incubator) , Hypoxia (1%
Oxygen) and CoP catalyst fabricated with laponite and GelMA as electrode connected with
1V power source. Scale bar = 200µm. Data are means ± SD. P values were determined by
one-way ANOVA (*P < 0.05, **P < 0.01, ***P < 0.001)
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